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Abstract
Chronic obstructive pulmonary disease (COPD) is increasingly common and in
80% of the patients it is caused by cigarette smoking, often over several decades.
Exercise intolerance is a major problem in COPD and there is accumulating
evidence that this is not solely due to reduced lung function but that it also involves
skeletal muscle. It is not known if changes in skeletal muscle tissue occur before
clinical symptoms of COPD are apparent. Therefore the main aim of the work
described in this thesis was to gain insight into the extent to which cigarette
smoking and hypoxaemia affect the functional and morphological changes of
skeletal muscle.
Percutaneous electrical stimulation of the quadriceps muscle (2 minutes 30 Hz with
duty cycle of 0.5; 1 s on, 1 s off) was used to assess fatigue characteristics to
avoid possible problems of differences in voluntary activation.
In non-smoking participants, women were generally more fatigue-resistant than
men. Young men with a relatively short smoking history were more susceptible to
fatigue than non-smoking, age- and physical activity-matched peers. In a larger
cohort of smokers spanning a wide range of age and smoking history, it appeared
that this lower fatigue resistance was not related to smoking history. The similar
contractile speed in smokers and non-smokers suggests that factors other than
differences in muscle fibre composition underlie the reduced fatigue resistance in
smokers. The reduced fatigue resistance might be more related to a possible
acute, and possibly reversible, impairment of smoking on the oxygen supply or the
ability to use oxygen for aerobic energy generation by the muscle.
Subsequently, the effects of chronic hypoxia on determinants of oxygen supply and
oxidative capacity were studied. Adaptations within the rat plantaris muscle to
chronic hypoxia were region- rather than fibre type-specific. Hypoxia resulted in
atrophy in all regions of the muscle. However, capillary proliferation only occurred
in the deep, oxidative region, and mitochondrial biogenesis was restricted to the
superficial, glycolytic region. Model calculations indicate that these adaptations to
hypoxia prevent the occurrence of anoxic areas in the deep region, but that in
superficial regions tissue oxygenation becomes more problematical during hypoxia.
These results are discussed in relation to their possible relevance in understanding
muscle function in COPD patients.
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The work described in this thesis began with an interest in the muscle problems
experienced by patients with Chronic Obstructive Pulmonary Disease (COPD). For
various reasons beyond our control, no patients were ever examined, but the
interest persisted and led to a series of studies that may eventually throw light on
the underlying physiology of this condition.
This chapter begins with an overview of COPD and the involvement of skeletal
muscle in the disease and then discusses the physiology of skeletal muscle.
Smoking is a major cause of COPD while tissue hypoxia may be one of the
consequences that may impact on skeletal muscle structure and function. The last
part of this chapter discusses the way in which the influence of these two factors
on skeletal muscle function may be investigated.
Chronic obstructive pulmonary disease (COPD)
COPD is an increasingly common disease of the lungs and can be manifested as
chronic bronchitis, in which the airways become irreversibly narrowed, and/or
emphysema characterised by loss of elasticity of the lungs and destruction of the
alveoli. Both conditions often occur simultaneously and lead to airway obstruction
during expiration and an impaired gas exchange at the alveolar level. In contrast to
asthma, the airflow limitation is irreversible and progressively worsens over time.
Infections may accelerate the progression of the disease, and such instances are
called exacerbations. Typical symptoms of the disease are shortness of breath
(dyspnoea), a persistent cough, a rapid breathing rate (tachypnoea) and tiredness.
The disease is progressive and is associated with an abnormal inflammatory
response in the lungs to noxious gasses (ATS/ERS, 1999). In 80 % of the patients
the disease is caused by smoking cigarettes for several decades but can also be
caused by exposure to industrial noxious gasses and air pollution. Genetic
susceptibility certainly plays a role as only about a fraction of smokers develop
COPD (Molfino, 2004).
The disease is a major cause of morbidity and death throughout the world. In 2000
about 16 million people suffered from COPD in the USA alone (Mannino et al.,
2002) with the number of women suffering from this disorder increasing (Casaburi,
2001). The severity and progress can be moderated by actions such as smoking
cessation, careful management of infections and appropriate rehabilitation
(ATS/ERS, 1999).
The diagnosis of COPD involves spirometry; more specifically, measuring the
forced expiratory volume in one second (FEV1), the volume of air that can be
breathed out in the first second of a maximal expiration, as well as the forced vital
capacity (FVC), the greatest volume of air that can be breathed out in a maximal
expiration. Normally at least 70 % of the FVC comes out in the first second
(FEV1/FVC ratio >70 %), but in patients with COPD this ratio is <70 % even after
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medication to open up the bronchi (bronchodilators) has been given (ATS/ERS,
1999).
One of the major problems of patients with COPD is exercise intolerance (Gosker
et al., 2000; Casaburi, 2001). Although the disease is characterized by reduced
maximal expiratory flow (ATS/ERS, 1999), the forced expiratory volume in 1 s
(FEV1) in patients with COPD correlates poorly with their exercise capacity (Killian
et al., 1992; Gosselink et al., 1996; Engelen et al., 2000; Gosker et al., 2003b).
Likewise, in single or double lung transplants, exercise capacity improves after
surgery, but was still lower than normal (Ambrosino et al., 1996) indicating that
factors other than lung function alone limited exercise capacity (Evans et al., 1997).
Also in patients with COPD who did not undergo a lung-transplantation, evidence is
growing that their exercise intolerance is not only related to a reduced lung
function, but also involves skeletal muscle dysfunction (Gosselink et al., 1996;
Gosker et al., 2003b). The importance of skeletal muscle dysfunction may increase
over time as the deterioration in exercise capacity is uncoupled from the
progression of airflow limitation (Oga et al., 2005). It is important, therefore, to
know how muscle function is affected, to identify the factors that contribute to the
muscle dysfunction, including muscle wasting, in COPD so as to improve the
management of the disease. Such knowledge may also have wider implications
since COPD is one of a number of common disorders, including chronic heart
failure (Gosker et al., 2000) and some cancers (Tisdale, 2005), where muscle
dysfunction and wasting are serious complications and may be brought about by
similar underlying mechanisms.
Most work on skeletal muscle dysfunction and atrophy has involved patients with
moderate-severe COPD, but there is a gap in our understanding of the earlier
progression of the disease. As most patients with COPD have been smoking for
more than a decade, it is important to understand the changes observed in
smokers not yet diagnosed with COPD. A possible deterioration of muscle function
and mass might then be targeted at an early stage of the disease.
Chronic obstructive pulmonary disease and muscle function
Many studies report muscle atrophy and alterations in the intrinsic properties of the
lower limb muscles in patients with COPD. In most studies, the vastus lateralis
muscle (part of the quadriceps muscle) was investigated and consequently this
discussion will mainly focus on results obtained from this muscle. First, the
adaptations will be discussed and, subsequently, various factors contributing to
these changes.
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Muscle atrophy
A loss of skeletal muscle mass is a common observation in patients with COPD
leading to muscle weakness (Schols et al., 1993; Gosselink et al., 1996; Bernard et
al., 1998; Engelen et al., 2000) and is associated with an increased mortality.
Marquis and colleagues (2002) reported that 50% of their patients with a predicted
FEV1 <25 % and a mid-thigh cross-sectional area (CSA) <70 cm2 died within 3
years, compared to only 12 % of patients with a mid-thigh CSA >70 cm2. Schols
and colleagues (1993) found that about half of the patients with mild to severe
COPD had a reduced body weight, which could be related to both a loss of muscle
and adipose tissue. Since lean tissue depletion could even occur in overweight
patients the prevalence of muscle wasting might be even higher than the estimates
based on changes in body mass alone (De Benedetto et al., 2000).
Besides muscle wasting other factors, such as a decrease in maximal neural drive
to the working muscles (Rutherford et al., 1986), may contribute to muscle
weakness during COPD. Indeed, a reduced neural drive may well explain the
decline in force generating capacity per muscle cross-sectional area (specific
tension) in vivo without a change of in vitro specific tension of isolated bundles
from the same muscle (Debigare et al., 2003). However, COPD patients who were
matched for fat free mass index with control subjects did not show signs of muscle
weakness or atrophy (Heijdra et al., 2003; Degens et al., 2005), indicating that the
neural drive is maintained as long as fat free mass index is maintained.
Shift in muscle fibre type
Most studies of patients with mild to moderate COPD have shown a greater
proportion of type II fibres suggesting a slow-to-fast transition in fibre type
composition (Jobin et al., 1998; Gosker et al., 2002) as a result of the disease. The
slow-to-fast transition appears to be more marked during emphysema than during
chronic bronchitis (Gosker et al., 2002) and to be related to the severity of the
disease in terms of FEV1 (Satta et al., 1997). It is unlikely that the changes in fibre
type composition during COPD, a disease that mostly becomes manifest after the
age of 50, are just a reflection of the ageing process as normal ageing is, if
anything, accompanied by a fast-to-slow transition (Degens & Alway, 2006;
Korhonen et al., 2006). It remains to be established whether the slow-to-fast fibre
type transition is sufficient to cause a change in the rates of contraction and
relaxation during electrically evoked isometric tetani, as they appeared unaltered
during electrically evoked tetani in patients with COPD (Degens et al., 2005). As
type II fibres are less efficient than type I fibres for force generation during
relatively slow movements (Stienen et al., 1996) and do not have a high
mitochondrial density needed for ATP resynthesis, the slow-to-fast-transition in
fibre type composition may be a component of the commonly observed increase in
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skeletal muscle fatigability (Mador et al., 2003) and reduced mechanical efficiency
of COPD patients during one leg knee extensor exercise (Richardson et al., 2004).
Metabolism and capillarisation
Several studies have addressed the metabolic characteristics of muscles from
COPD patients (Jakobsson et al., 1990; Jakobsson et al., 1995; Jobin et al., 1998;
Whittom et al., 1998; Gosker et al., 2002) but with equivocal results. Part of the
discrepancies in the literature can be ascribed to differences in disease severity,
medication and whether locomotor or other muscles have been studied. While the
oxidative capacity of the vastus lateralis muscle of patients with moderate-to-
severe COPD was found to be significantly reduced (Jakobsson et al., 1995;
Gosker et al., 2002), the oxidative capacity in the musculature of the upper
extremity was not affected (Gea et al., 2001b). Also, the mechanical efficiency was
lower in leg muscles, while arm mechanical efficiency was not significantly affected
(Franssen et al., 2002). The different effects on upper body and leg muscles
associated with COPD were so marked that it is referred to as ‘the compartment
theory’ (Gea et al., 2001a). A simple explanation put forward for the differences
between the two ‘compartments’ is the different degree of disuse they experience
during COPD (Gosselink et al., 2000; Gea et al., 2001a). These results highlight
the likely importance of disuse in the skeletal muscle adaptation during the
progression of the disease. Nevertheless, the glycolytic capacity was elevated in
both the leg (Jakobsson et al., 1995) and upper body (Gea et al., 2001b) muscles.
In advanced stages of the disease, energy metabolism in the quadriceps femoris
muscle of patients with respiratory failure becomes increasingly compromised as
reflected by lower levels of glycogen, ATP and PCr (Jobin et al., 1998; Whittom et
al., 1998; Richardson et al., 2004).
Very little is known about the capillarisation of skeletal muscle from smokers and
patients with COPD (Whittom et al., 1998). Although the number of capillaries per
fibre has been reported to be reduced in COPD (Whittom et al., 1998), the capillary
supply per fibre cross-sectional area (FCSA) and total numerical capillary density
was maintained (Richardson et al., 2004). It seems that, at least anatomically, the
capillary network is intact in COPD patients (Jobin et al., 1998). However, Oga et
al. (2007) found an almost 50 % decrease in capillary to fibre ratio and capillary
density, suggesting that a disproportionate loss of capillaries. It remains to be seen
to what extent these discrepant findings are related to the severity and/or
medication of the disease. An alternative approach to examining the extent of
muscle perfusion is to determine muscle blood flow but this is not necessarily a
reliable indication of tissue oxygenation as blood flow may be maintained, passing
through arterioles, and bearing a poor relationship to the critical capillary perfusion.
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Skeletal muscle fatigue
Exercise intolerance, as reflected by a low peak oxygen uptake, is a major
symptom in patients with COPD (Aliverti & Macklem, 2001). The increased load
and consequent oxygen need of the respiratory muscles in COPD patients and
reduced venous return, due to abnormal increases in abdominal pressures during
breathing with expiratory flow limitations, results in a reduced cardiac output and
oxygen delivery to the working muscles (Aliverti et al., 2005). The result of the
increased oxygen demand by the respiratory muscles and the reduction in cardiac
output is an increased competition between respiratory and locomotor muscles,
resulting in a imbalance between oxygen demand and supply to the locomotor
muscles (Aliverti & Macklem, 2008). Under circumstances where the cardio-
respiratory system is unlikely to be the limiting factor, such as during one-leg
exercise, or exercise of a single muscle or muscle group, the capillarisation and
oxidative capacity of a muscle are important determinants of muscle fatigue
resistance, which is often reported to be lower in patients with COPD (Serres et al.,
1998; Allaire et al., 2004; Coronell et al., 2004; Van ‘t Hul et al., 2004; Saey et al.,
2005; Janaudis-Ferreira et al., 2006). However, to what extent this reduction in
oxidative capacity and capillarisation is the primary cause for exercise intolerance
has been a recent topic of discussion (Aliverti & Macklem, 2008).
Besides changes in the muscle itself that may cause an earlier onset of muscle
fatigue in COPD patients, differences in fatigue resistance could also be caused by
an altered central drive. To date, the central component in the development of
muscle fatigue in COPD patients is poorly understood. However, it may play a role
in the development of fatigue as systemic inflammation has been shown to cause
feelings of tiredness (Spath-Schwalbe et al., 1998). However, muscle fatigability
has been determined largely with series of voluntary contractions (Serres et al.,
1998; Coronell et al., 2004; Janaudis-Ferreira et al., 2006), which makes it difficult
to differentiate between central and peripheral factors. Using electrical or magnetic
stimulation, however, one can exclude the contribution of central factors to the
development of fatigue. As far as we know, only two studies (Degens et al., 2005;
Swallow et al., 2007) have assessed peripheral muscle fatigue using electrical
stimulation in patients with COPD, with equivocal results. In the study of Degens
and coworkers (2005), neither differences in contractile properties nor fatigability
were found. This indicates that there were no apparent differences in motivation
between patients and controls matched for fat free mass index and physical activity
level (Degens et al., 2005). Several studies have explicitly stated that the COPD
patients were significantly less active than the controls (Serres et al., 1998;
Coronell et al., 2004). Many of the skeletal muscle adaptations in COPD are also
found with extreme inactivity (Gerrits et al., 1999) and hence disuse may play an
important role (Serres et al., 1998).
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A factor that has not have received much attention in the literature is the effect of
smoking on skeletal muscle structure and function. As mentioned at the start of this
chapter, COPD is mainly caused by cigarette smoking. Smoking is associated with
a marked increase in inflammatory markers (e.g. TNF-α, IL-6) and an acute
reduction in the anti-oxidant capacity (Tsuchiya et al., 2002). Increases in systemic
inflammation and oxidants are commonly associated with muscle atrophy (Li et al.,
2003; Langen et al., 2006) and increased central fatigue (Robson-Ansley et al.,
2004). A selective atrophy of fast-twitch type IIb muscle fibres has been shown in
smokers (Örlander et al., 1979; Nakatani et al., 2003), which is also observed in
patients with moderate-to-severe COPD (Gosker et al., 2003a). Others, however,
found a selective atrophy of type I fibres in non-COPD smokers (Montes de Oca et
al., 2008). Moreover, recently Gosker and colleagues (2009) have shown that a
small degree of fibre atrophy was observed and mitochondrial enzyme function
was mildly impaired in mice exposed to chronic cigarette smoke. As these mice
also featured clinical symptoms of COPD (emphysema), it is not clear at what
stage these changes in the skeletal muscle tissue have occurred. However, few
studies have looked at the skeletal muscle structure and function in otherwise
healthy smokers and non-smokers.
Mild hypoxaemia may develop in patients with COPD (Chaouat et al., 1997),
resulting in tissue hypoxia. Mean arterial oxygen pressures of 63 mm Hg have
been reported for stable patients with COPD (115 mm Hg in healthy subjects)
(Chaouat et al., 1997), which is similar to what would be seen in healthy people at
an altitude of ~4000 m (Wagner et al., 1986).
Impaired oxygen delivery, systemic inflammation and oxidative stress all seem to
contribute to adaptations of skeletal muscle and the development of fatigue (for a
more detailed review, see Wüst & Degens (2007) and the discussion of Aliverti &
Macklem (2008)). Skeletal muscle adaptations, such as wasting and weakness,
have frequently been observed with exposure to hypoxia (i.e. Green et al., 1989;
Ferretti et al., 1990; Cerretelli, 1992; De Paula Brotto et al., 2001; Deveci et al.,
2002). For instance, just 8 weeks at altitudes greater than 5000 m has been shown
to cause as much as a 10 % reduction in muscle mass and peak power (Ferretti et
al., 1990; Green et al., 1989). Although a decrease in fibre CSA is associated with
exposure to hypoxia, other confounding factors such as decreased food intake,
due to hypoxia-induced expression of leptin, together with detraining, may
contribute to muscle wasting (Westerterp & Kayser, 2006). Moreover, hypoxia may
also induce inflammation (Orth et al., 2005), causing muscle atrophy through
inflammatory pathways that may activate the ubiquitin proteosome pathway and
hamper the regenerative capacity of the muscle (for more details, the reader is
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referred to Wüst & Degens, 2007). It is therefore not surprising that hypoxaemia is
thought to contribute to the muscle adaptations observed during COPD (Gosker et
al., 2000; Raguso et al., 2004; Wüst & Degens, 2007).
There are a variety of factors that could lead to the changes in muscle mass and
function in COPD and these include the systemic consequences of the
inflammatory changes in the lungs and tissue hypoxaemia occurring as a
consequence of the impaired lung function (Gosker et al., 2000).
Summary of skeletal muscle involvement in COPD
Although COPD is primarily a disease of the lungs there is ample evidence that
skeletal muscle is also involved in many patients and this gives rise to weakness
and, probably, excessive fatigue, all of which have deleterious effects on the
quality of life. Smoking, which is a major cause of COPD, may have direct effects
on muscle function and it is interest to know, first, whether such changes are
evident before clinical symptoms of lung disease become apparent and, secondly,
the possible mechanism of any such action. Tissue hypoxia is a likely
consequence of severe lung disease and could lead to muscle wasting, that may
be detrimental, but also changes in metabolic characteristics that could be
protective.
These aspects are investigated in the chapters describing the experimental work of
this thesis but before doing so it is appropriate to consider the basic physiology of
muscle to see how structure is related to function and the factors that determine
strength, speed and fatigability.
Structure related to function in healthy muscle
Skeletal muscle constitutes 40-50 % of the healthy human body mass, and
provides the means to move, communicate, feed and breathe. By any standards it
is, therefore, an important tissue. Understanding its structure and function and how
these may change with age, use, abuse and disease is a fascinating task and one
that has engaged the scientific community for over a century. The word “muscle”
comes from the Latin word musculus, being the diminutive of mus (mouse) and it is
said that this came about because the movement of muscles under the skin,
possibly the twitching of the biceps, resembles the movement of mice under a
sheet.
The primary function of skeletal muscle is to generate force and movement and
this is very dependent on the nature and physical arrangement of the contractile
proteins and associated control systems.
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Figure 1.1. Organization of sarcomeres, mitochondria, T-tububles and
sarcoplasmatic reticula within the muscle fibre. MyHC: myosin heavy chain, MyLC:
myosin light chain). Adapted from Korfage et al. (2005).
An overview of skeletal muscle structure
Skeletal muscle consists of bundles of contractile muscle fibres that join a tendon
at each end, generally running over at least one joint and thus causing a moment
around that joint. The skeletal muscle fibres themselves are multinucleated cells
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and in mature, undamaged fibres the nuclei are located just beneath the
sarcolemma. The contractile material, which is mainly made up of interdigitating
thin (actin) and thick (myosin) filaments, is arranged in sarcomeres, running from Z
line, or disk, to Z line (Figure 1.1).
The contraction of skeletal muscle is controlled by the nervous system. One motor
nerve (innervated by a motoneuron in the spinal cord) can branch into tens,
hundreds, or even over a thousand branches, each one terminating on a different
muscle fibre. One motoneuron, its axonal nerve and all of the fibres that it
innervates is called a motor unit. When a motoneuron in the spinal cord is
activated, an action potential is sent down the axonal braches to the
neuromuscular junction (NMJ). Upon arrival at the NMJ acetylcholine is released
from the axon terminal, binds to acetylcholine-receptors in the post-synaptic
membrane, activating ligand-gated ion channels that allow sodium to enter and
depolarize the muscle cell membrane. This depolarization of the cell membrane
spreads across the surface of the muscle fibre and into the transverse tubules (T-
tubules). Modified calcium channels (dihydropyridine receptors) in the T-tubules
are activated in response to electrical stimulation, causing the calcium-release
channels (ryanodine receptors) on the adjacent membrane of the sarcoplasmic
reticulum (SR) to open. The [calcium] in the cytosol rises from ~10-9 M at rest to
~10-4.5 M during maximal activation and binds to troponin C which modulates the
orientation of the tropomyosin on the actin, allowing the myosin head to bind to the
thin filament. Force and movement are generated by the bending of the neck
region of the myosin which draws both Z lines closer to each other, shortening the
muscle. This process requires utilization of adenosine-5’-triphosphate (ATP). The
process from neural excitation to the activation of the thin filaments is known as
excitation-contraction coupling.
An overview of skeletal muscle function
Skeletal muscle comes in a variety of colours, forms and functions. As early as
1873, Ranvier recognized that there are red and white muscles which exhibit
different contractile properties and functional characteristics (Ranvier, 1873). In the
second half of the twentieth century adult muscle fibres types were classified
mainly according to their expressed myosin ATPase isoforms by using
histochemical techniques (Brooke & Kaiser, 1970; Guth & Samaha, 1970).
Three functional output measures that are important in skeletal muscle function are
strength, speed and fatigability. The requirement for strength is evident when
considering the task of simply moving the body mass or external objects, and a
certain minimum strength is required to live an independent life. The force that can
be exerted is mainly determined by the cross-sectional area of a muscle, that is,
the amount of contractile material arranged in parallel sarcomeres. The maximal
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speed by which the muscle contracts depends partly on the length of the muscle
but also on the intrinsic properties of the myosin heavy and light chains that affect
the rate at which they interact with the actin filaments (Jones et al., 2004). There is
a variety of different “types” or isoforms of myosin that have been the basis for
identifying different types of muscle fibre (Sant'ana Pereira et al., 1995; Pette &
Staron, 2000). This variety in muscle fibre type is the major link between structure
and function (Harridge et al., 1996; Pette & Staron, 2000).
Muscle power is the product of force and speed of the contraction. Since work
output is the main feature of movement and mobility, the power that can be
generated by a muscle has a major impact on physical activity, whether this is in a
sporting context or determining the extent of an independent life of an elderly
person or patient. Some tasks, such as jumping or throwing require only brief
efforts but many activities associated with mobility, and therefore quality of life,
require sustained efforts. In these circumstances the ability of the muscle to
withstand the development of fatigue is important. Resistance to fatigue varies
between different types of muscle fibres and is affected by factors such as use and
disuse.
Clearly, limitations in power generating capacity and an excessive loss of fatigue
resistance of the muscle can seriously limit performance and daily activities, and
these changes in muscle function can become critical in various disease states
such as cancer, HIV and COPD.
Skeletal muscle fibres
Skeletal muscle fibre types
To identify the different types of myosin ATPase in muscle sections by histological
means, they are pre-incubated at either an alkaline or acid pH. Although the values
vary somewhat from species to species, in general, fast myosin ATPase is
unstable and inactivated at acid pH (about pH <4.6) while slow myosin ATPase is
inactivated at a pH>9.4. Having pre-incubated the section and inactivated the
ATPase activity in one set of fibres, the remaining activity can be visualised by
incubating the section with ATP and an excess of calcium at an alkaline pH. After a
couple of chemical steps that convert inorganic phosphate, the product of the
ATPase reaction, into a black or dark brown precipitate, the fibres with remaining
myosin ATPase activity can be identified (Brooke & Kaiser, 1970; Guth & Samaha,
1970). An example of this staining method is given in Figure 1.2A. Based on these
ATPase staining methods, developed in the 1960s, muscle fibres in all species
were divided into type I, IIa and IIb. These types are a reflection of the type of
myosin heavy chain (MyHC) within the fibre with type I, IIa and IIb fibres containing
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type I, IIa and IIb myosin heavy chain, respectively. Twenty years later it was
shown that there is also an intermediate type, sometimes known as IId (Termin et
al., 1989) but more commonly referred to as IIx (Larsson et al., 1991).
Subsequently it was shown that for human muscle, what had been classified as IIb
was similar to rat IIx myosin (Pereira Sant'Ana et al., 1997) and it appears that
human muscles do not express the IIb MyHC isoform found in smaller mammalian
species. Histochemical techniques generally demonstrate just one myosin isoform
in a fibre cross-section. However, electrophoretic separation of MyHC from single
muscle fibres or immunohistochemical staining show that while the majority of
fibres express just one isoform, they can express two, and occasionally more,
MyHC isoforms (Sant'ana Pereira et al., 1995; Yu et al., 1998).
Figure 1.2. Serial sections of the human vastus lateralis muscle stained for A
myofibrillar ATPase (mATPase) according to Brooks and Kaiser (1970)
(preincubation at pH 4.55), with black fibres representing type I, white are type IIa
and grey are IIx fibres, B cytosolic glycerol-3-phosphate dehydrogenase, as a
marker for glycolytic capacity, C succinate dehydrogenase (SDH) - activity, an
enzyme bound to the inner membrane of the mitochondria and D capillaries
(lectin). Sections taken from a biopsy given by a young male participant described
in Chapter 6. #,* and o depict a type I, IIa and IIx fibre respectively.
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Glycolytic capacity
It is possible to visualise a number of enzyme activities as indicators of glycolytic
potential, one commonly used being glycerol-3-phosphate dehydrogenase (GPDH)
(also known as alpha-glycerol phosphate dehydrogenase). Although this enzyme is
not part of the chain of glycolysis, it is related to the glycolytic pathway because it
shuttles NADH into the mitochondria. An example of this staining method is given
in Figure 1.2B.
Mitochondrial enzyme activities
Staining for mitochondrial activity requires a substrate that is oxidised and an
electron acceptor that is reduced by one of the components of the electron
transport chain and, as a result, changes colour. Using succinate as substrate and
tetrazolium blue as the electron acceptor gives a measure of complex II activity
(succinate dehydrogenase, SDH, Pool et al., 1979a; Pool et al., 1979b). The
measured activity is proportional to the mitochondrial density and the integrated
SDH activity (SDH x FCSA) is linearly related with the maximal oxygen uptake of
the cell (in nmol mm-3 s-1, Van der Laarse 1989). An example of this staining
method is given in Figure 1.2C.
Capillary supply
Ultimately, oxygen is used during oxidative phosphorylation to generate ATP from
NADH and FADH2 generated during glycolysis, fatty acid oxidation and the citric
acid cycle. For this process to take place an adequate supply of oxygen is required
and heat, water and carbon dioxide (CO2), being waste products from this process,
have to be removed. The exchange of oxygen, heat and waste products between
the blood and tissue takes place in the capillaries. It is thus not surprising that the
capillary supply, in terms of capillary density, to a muscle fibre is higher for
oxidative than glycolytic fibres (Degens et al., 1992) and that capillary recruitment
and blood flow varies with the level of activity of the muscle fibres (Terjung &
Engbretson, 1988). Given these conditions, it is likely that the capillary supply of
the muscle plays a significant role in the resistance to fatigue, as has been
observed in control and chronically stimulated muscles (Hudlicka et al., 1977).
Capillaries can be visualized in muscle cross-sections by histological stains, e.g.
alkaline phosphatase, or lectin (Figure 1.2D). The capillary density of skeletal
muscle tissue is usually expressed as the number of capillaries per unit of tissue,
or the capillary to fibre ratio. From these measures, indications of tissue
oxygenation can be obtained by modelling oxygen transport from the capillaries to
the centre of the muscle fibres (i.e. Krogh and Hill models, Krogh (1919); Hill
(1965)). There is an apparent relation between capillary density and maximal blood
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flow within a muscle, but flow is primarily determined by arterioles and not
capillaries (Egginton, 2009).
Contractile properties
In general, type I fibres predominate in muscles which have a red appearance and,
as Ranvier observed, are slow contracting. Pale “white” muscles are fast
contracting (Ranvier, 1873) and contain a predominance of type II fibres. Muscle
fibres expressing mainly type I MyHC are characterised by having slow speeds of
contraction and relaxation. They also tend to be fatigue resistant and have a
relatively high activity of oxidative enzymes. On the other hand, type II fibres have
short contraction and relaxation times, they fatigue more rapidly and mostly rely on
glycolysis to obtain their energy during activity.
Figure 1.3. Example of force generated during stimulations with different
frequencies in isolated mouse from A soleus and B extensor digitorum longus
muscles (25 °C). From Jones et al. (2004).
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Figure 1.4. Relationship between force and stimulation frequency in isolated
mouse soleus and extensor digitorum longus (EDL) muscle. Note the left-shift in
the muscle with predominantly type I fibres. From Jones et al. (2004).
In mammals the soleus is an example of a red muscle that is composed mainly of
type I fibres while the extensor digitorum longus (EDL) is pale in appearance and
has mainly type II fibres. The soleus and EDL are extreme examples; most muscles
contain a mixture of different fibre types. Although mammalian skeletal muscles all
show similar varieties of fibres when classified by their histochemical properties,
there are considerable differences between species as regards contractile
characteristics.
The time it takes for the muscle to achieve its maximal force (contraction time) and
the time to fully relax (relaxation time) are both much faster in the EDL compared
to the soleus muscle (see Figure 1.3). At a stimulation frequency of 10-20 Hz, the
EDL muscle relaxes fast enough for the force to fall back to baseline before the
next impulse. However, for the soleus muscle, the next impulse comes before total
relaxation of the previous twitch is complete and the next contraction is
superimposed on the remaining force. In this way, the individual twitches fuse. The
fusion frequency at which a smooth contraction (tetanic contraction) is generated is
therefore higher in fast-twitch, compared to slow-twitch fibres and as a result, the
force-frequency relationship between these two muscle types differs (Figure 1.4).
The characteristics of a skeletal muscle are strongly related to its functional
demands (Flück & Hoppeler, 2003). Depending on the altered environmental
conditions, specific muscular adaptations occur as a result of increased use, such
as an increase in oxidative capacity in response to endurance training or
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hypertrophy after resistance training (Hudlicka et al., 1977; Holloszy & Coyle,
1984), atrophy after chronic disuse (Larsson et al., 1990; De Boer et al., 2007) and
disease (De Haan et al., 2000; Gosker et al., 2000; Debigare et al., 2003), but also
environmental conditions such as hypoxia where muscle atrophy and loss of
oxidative capacity have been observed (Ferretti et al., 1990; Green, 1992).
The mechanisms underlying differences in contractile properties
The difference in contractile properties between fibre types is mainly attributable to
differences in MyHC composition (Harridge et al., 1996), such that the maximal
speed of shortening of the fibres is in the order MyHC I << MyHC IIa<MyHC
IIx<MyHC IIb (Bottinelli et al., 1996). However, factors that control Ca2+ flow and
activation also play a role in the contractile speed and fatigability of the muscle
fibre (Allen et al., 2008b). When a muscle action potential is initiated at the NMJ,
the action potential transmission is conducted down the T-tubules to the voltage
sensors in the T-tubular membrane. Type II fibres have a higher density of
dihydropyridine receptors (Hollingworth & Marshall, 1981), a 50 % times higher
density of the SR (Cullen et al., 1984) and a higher density of ryanodine receptors
(Franzini-Armstrong et al., 1988). Consequently the release of Ca2+ from the SR
into the cytoplasm is greater and faster for fast-twitch compared to slow-twitch
fibres (Briggs et al., 1977). Moreover, the isoform of troponin in type II fibres
contains two Ca2+-binding sites, rather than one for the slow type troponin isoform
(Schiaffino & Reggiani, 1996). The SR Ca2+-pump expressed in fast fibre type
(SERCA1) is faster compared to the isoform found in type I fibres (confusingly
called SERCA2). These processes involved in the activation and deactivation of
the contractile elements in different fibre types correspond with the rate of cross-
bridge interaction and account for the differences in contractile properties such as
illustrated in Figures 1.3 and 1.4.
The higher attachment and detachment rates of the type II myosin cross-bridges
leads to faster rates of shortening and higher power output but this advantage
comes at the expense of a higher ATP consumption per cross-bridge cycle
(Stienen et al., 1996). The 6-fold larger density of SR Ca2+ pumps in the type II
fibres (Everts et al., 1989) results in much quicker reuptake of Ca2+ in the SR, but
also at a higher cost of ATP. These two processes mean that ATP turnover is
considerably higher in fast fibres and leads to a more rapid depletion of intracellular
energy stores if not met by a commensurate higher energy production. The
balance between rates of energy utilization and production has a major impact on
the rate at which muscle fibres fatigue.
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Muscle fatigue
Fatigue is a common phenomenon experienced in daily life and during exercise. It
may come about for a variety of reasons and has a number of consequences for
muscle function. Studies of muscle fatigue in the literature vary with regard to the
exercise model, protocol, output variables and definitions for fatigue, so that
comparison of the results is often difficult. Some studies focus on functional
aspects, such as changes in running speed; others concentrate on specific aspects
of changes in function of single muscles or muscle fibres, or changes in metabolite
concentrations. Vøllestad (1997) defined fatigue as: ‘any contraction-induced
reduction in the capacity to generate force’ although this could be amended to
include changes in contractile speed that have consequences for power output. It
might also include the stipulation that the changes should be reversible within a
“reasonable” time frame to distinguish fatigue from damage that can also result
from prolonged activity.
The generation of force or movement involves a long chain of command originating
in the motivation of the individual, involving the motor cortex, the descending
neural pathways, the processes of excitation-contraction coupling and ending with
the interaction of the actin and myosin cross bridges. Therefore, at least in theory,
a reduction in the capacity to generate force could be the result of an impairment of
any of the factors mentioned above. Fatigue due to factors proximal to the
neuromuscular junction is conventionally called “central” fatigue while fatigue
occurring at, or distal, to the neuromuscular junction is called “peripheral” fatigue.
Although causes of failure at these two sites are generally site specific they may
sometimes affect multiple steps in the chain. For instance, fatigue due to a lack of
oxygen supply could affect central processes (cerebral hypoxia), or peripheral
(referring to the impaired energy metabolism in the muscle fibre) fatigue.
Central fatigue
Central fatigue is defined as a progressive reduction in the voluntary activation of
the muscle during exercise (see review by Gandevia, 2001). During a voluntary
contraction the central nervous system may not maximally activate all the
motoneurons of an individual muscle and this proportion may decrease during
prolonged activity as a consequence of afferent feedback from mechano-, chemo-
and/or thermo-receptors activated by the physical activity (Bigland-Ritchie et al.,
1978) or as a consequence of increased activity of inhibitory circuits within the
brain itself. An inability to voluntarily contract all the muscle fibres can be assessed
by comparing the voluntary contraction with one elicited by electrical stimulation,
usually of the peripheral nerve branches, which removes any contribution of the
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central nervous system (Merton, 1954; Edwards et al., 1977; Bigland-Ritchie et al.,
1978; Rutherford et al., 1986; Newman et al., 2003).
Peripheral fatigue
Fatigue resulting from changes at or distal to the neuromuscular junction is known
as peripheral fatigue. Failure of the neuromuscular junction (exhausting stores of
neurotransmitter) does not seem to occur in maximal isometric contractions of up
to 60 s (Bigland-Ritchie et al., 1982) or during electrically evoked contractions at
optimum muscle length with a frequency of 30 Hz (Sacco et al., 1994). Once an
action potential is successfully transmitted across the neuromuscular junction, it
propagates along the surface membrane of the muscle fibre into the T-tubular
system leading to the interior of the fibre. At high stimulation frequencies (80-100
Hz in human muscle) failure of the membrane propagation occurs already after a
few seconds (Jones et al., 1979), possibly due to a build up of a high [K+] in the T-
tubules, a phenomenon sometimes referred to as ‘high-frequency’ fatigue (Jones,
1996). However, this is thought not to be a serious problem in vivo as the initial
voluntary firing rate is around 30 Hz during sustained contractions, which then
declines as the contraction continues (Bigland-Ritchie et al., 1986).
A reduction in the calcium release from the SR can contribute to the development
of fatigue (Allen et al., 2008a). The application of caffeine, which opens the
ryanodine receptors in the SR membrane, to a fatigued muscle fibre restores most
of the loss of isometric force and provides strong evidence of an impaired Ca2+
release from the SR, probably as a consequence of phosphate accumulating in the
SR and chelating the calcium (Fryer & Stephenson, 1996). While reductions in
[ATP] do not appear to play a significant role in the development of fatigue,
increased concentrations of inorganic phosphate (Pi), as a result of PCr
breakdown, inhibit force production by direct actions on the cross bridge function,
through an impaired release of Pi from the actomyosin complex during the force-
generating step of the cross bridge cycle, resulting in a reduction in tetanic force at
a given pCa (Martyn & Gordon, 1992). During prolonged exercise, lasting several
hours, ATP resynthesis may become limited as a result of glycogen depletion
within the muscle. Although ATP is critical for muscle contraction, there is little
evidence of major changes in ATP levels in fatigue. Nevertheless in situations
where ATP synthesis is limited there are major changes in the concentration of
associated metabolites, PCr, Pi, ADP, AMP and lactate, and it is likely that these
are the critical factors giving rise to the altered contractile function that characterise
fatigue.
Fatigued muscle also demonstrates (1) slowing of contractile properties, evident as
a decrease in both rates of contraction and relaxation, (2) reductions in the
maximal shortening velocity and (3) reductions in power output during loaded
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contractions (Jones et al., 2006). Relaxation of the skeletal muscle fibre involves a
set of steps: 1) SR Ca2+ release stops, 2) Ca2+ is pumped back into the SR, 3) Ca2+
dissociates from the troponin and 4) detachment of cross-bridges (Allen et al.,
2008a). All four steps could be involved in the slowing of relaxation during fatigue
in vivo although there is little evidence that the kinetics of calcium release or re-
accumulation are seriously affected. There is, however, clear evidence that cross
bridge kinetics are affected by fatigue (de Haan et al., 1989). More recently, Jones
and colleagues (Jones et al., 2006) showed in healthy individuals, a strong
relationship between an increased curvature of the force-velocity relationship (a/P0)
and the slowed relaxation in vivo, indicating that altered cross-bridge kinetics
contributes to the slowing of relaxation in fatigue. As the shape of the force-velocity
curve, given by a/P0, is one of the main determinants of the power output of muscle
(Sargeant, 2007), a decrease in a/P0, indicating an increased curvature, during
fatigue greatly reduces power (Jones et al., 2006).
Electrical stimulation
In the studies described in this thesis, brief electrically evoked contractions have
been used to test muscle function as opposed to voluntary contractions of the
quadriceps muscle (see Figure 1.5 for an example). Electrical stimulation of the
quadriceps muscle can be achieved by either direct stimulation of the femoral
nerve, or percutaneous stimulation of the motor nerve branches within the muscle
belly.
Although percutaneous stimulation of the quadriceps muscle recruits particularly
motor nerve branches (and subsequently muscle fibres) in the superficial parts of
the muscle, deeper areas are also activated (Adams et al., 1993). A fatigue
protocol in which the muscle is activated by electrical stimulation eliminates any
change in force generating capacity due to central factors. Although electrical
stimulation of this type activates between 30-50 % of the muscle the recruitment
pattern during electrical stimulation may differ from that during submaximal
voluntary contractions of a similar strength in that the electrical stimulation will tend
to recruit a slightly greater proportion of fast motor units. The stimulated fatigue test
is therefore similar to a series of repeated maximal contractions.
Fatigue resistance during protocols such as illustrated in Figure 1.5 is mainly
determined by the interplay of two factors, namely energy utilisation and energy
production of the fibre, that is, the differences between ATP utilisation and ATP re-
synthesis, although, as explained above, it is probably the levels of the associated
metabolites that actually affect contractile function. Type I muscle fibres require
less ATP for a given contraction at a low speed and are therefore more efficient
compared to the type II fibres. During any prolonged period of activity, the re-
Introduction
21
synthesis of ATP depends on aerobic metabolism, and for this the mitochondrial
density and oxygen supply to the muscle are key factors.
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Figure 1.5. Example of the fatigue test with electrically-evoked contractions
applied in this study (A), with in B the first (continuous line) and last (dotted line)
contraction enlarged. Features of a post fatigued contraction are the reduced
maximal force and prolonged contraction and relaxation times.
Aim and objectives of the thesis
It can be concluded from the work discussed above that, in general, patients with
mild-to-moderate COPD have lower muscle mass and strength and experience an
earlier onset of fatigue during daily life activities. Since smoking is the principle
cause of COPD and many patients with COPD suffer from hypoxaemia during
exercise, and often at rest, the main objective of the present thesis was to obtain a
better understanding of the effects of cigarette smoking and systemic hypoxaemia
on skeletal muscle structure and function with an emphasis on fatigue resistance.
To this end, smokers were studied who did not suffer from clinical signs of COPD.
To minimise bias related to potential differences in physical activity level between
smokers and non-smokers, special care was taken to match the smoking and
control groups with regard to physical activity level.
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To investigate the effect of systemic hypoxaemia on skeletal muscle morphology
and skeletal muscle oxygenation, Wistar rats were exposed to hypobaric hypoxia
(410 mm Hg, equivalent to ~5000 m). After 4 weeks exposure, muscle morphology
was investigated and the data used to estimate the skeletal muscle tissue
oxygenation with mathematical models (Krogh, 1919; Hill, 1965).
In Chapter 2 a fatigue protocol using percutaneous muscle stimulation (with and
without ischaemia) was used to assess the peripheral muscle fatigue resistance in
healthy individuals, with special relevance to sex differences in muscle fatigability.
The outcomes of the fatigue protocol were related to muscle size and contractile
properties.
Young smokers and their peers underwent the same protocol for the measurement
of maximal strength, contractile properties and fatigue to study the effect of
smoking on muscle function in young, healthy male smokers. The results and
discussion of this study are presented in Chapter 3.
As muscle strength and fatigue resistance might deteriorate faster over time in
smokers compared to non-smokers, the results from a cross-sectional study on the
relationship between smoking history and muscle function are shown in Chapter 4.
In Chapter 5 results that link capillarisation (and hence oxygen supply) to muscle
fibre size, type and oxidative capacity are presented. Moreover, the differences in
capillarity and oxidative capacity between human biopsies and animal models are
shown. Histological data from smokers and non-smokers using similar
methodology are compared in a study presented in Chapter 6 of this thesis.
In Chapter 7 changes in fibre size, oxidative capacity and capillarisation in the
plantaris muscle of Wistar rats exposed to 4 weeks of chronic hypoxia are
presented.
In the general discussion in Chapter 8 the main results are summarised and
discussed, suggestions for future work are given and final conclusions are drawn.
An extended version of the methods described in each chapter can be found in the
Appendix.
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Abstract
To explore the cause of higher skeletal muscle fatigue resistance in women than
men, we used electrically evoked contractions (1 s on 1 s off, 30 Hz, 2 min), which
circumvents motivational bias and allows examination of contractile properties. We
compared 29 men (26.5 ± 7.0 yr, mean ± SD) with 35 women (25.4 ± 7.6 yr).
Strength of the quadriceps muscle was higher in men than women (P<0.001). The
lower maximal rate of relaxation in women (P=0.002) indicates that their muscles
were slower than those of men. The torque declined less in women than in men
(37.7 ± 10.7 % vs. 29.9 ± 10.0 %; P=0.002), and was not related to muscle
strength or size, as determined with MRI. The sex-difference in fatigability was also
seen when the circulation to the leg was occluded (torque declined 76.9 ± 10.8 vs.
59.5 ± 16.9 % in men vs. women respectively; P=0.008). The maximal rate of
relaxation correlated with the fatigability of the muscle under all conditions
(correlations ranging from 0.34 to 0.51, P<0.02). We conclude that the sex-related
difference in skeletal muscle fatigue resistance is not explicable by differences in
motivation, muscle size, oxidative capacity and/or blood flow between sexes, but
might be related to differences in fibre type composition.
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Introduction
Whilst men have, on average, bigger muscles and hence are stronger than women
there is accumulating evidence that women can sustain continuous, as well as
intermittent, muscle contractions at similar relative low to moderate intensities
better than men (Fulco et al., 1999; Russ & Kent-Braun, 2003; Hunter et al., 2004a;
Hunter et al., 2004b; Russ et al., 2005; Hunter et al., 2006b). There are many
possible causes for this phenomenon and, broadly, they can be summarised as 1)
differences in motivation and the ability to sustain central drive, 2) differences in
blood supply to the working muscles, and 3) intrinsic differences in the composition
and fatigue characteristics of the fibres making up the muscle.
The possibility that has received most attention concerns the fact that during a
contraction the blood supply to the working muscle will be occluded to some
degree and the extent of this will depend on the forces developed within the
muscle (Barcroft & Millen, 1939; Sadamoto et al., 1983). A large male muscle
working at the same percentage of maximum as a smaller female muscle will
generate more force, occlude the circulation to a greater extent and, consequently,
fatigue more rapidly during sustained submaximal contractions. The absence of
sex-related differences in fatigability during sustained and intermittent volitional
contractions under ischaemic conditions (Russ & Kent-Braun, 2003; Clark et al.,
2005), where blood flow is no longer a factor, and the observation that during
sustained contractions the time to fatigue is a function of absolute force (Hunter &
Enoka, 2001; Hunter et al., 2006b) support this view. On the other hand the
increased fatigability in men during intermittent submaximal isometric contractions
is not dependent on maximal strength (Hunter et al., 2004b; Gonzales &
Scheuermann, 2006) and even when matched for absolute strength, men were
more fatigable than women during both intermittent and sustained contractions
(Fulco et al., 1999; Hunter et al., 2004b; Gonzales & Scheuermann, 2006).
Consequently there remains uncertainty as to whether differences in blood flow to
the working muscles can explain the differences in fatigability of men and women.
Whether a muscle fibre fatigues or not will depend largely on the balance between
the rate of energy consumption associated with the contractile activity and the rate
at which ATP can be regenerated by anaerobic (i.e. ATP generated by hydrolysis
of creatine phosphate and glycolysis) and aerobic (i.e. ATP generated by oxidative
phosporylation) processes. The various muscle fibre types differ, with the faster
fibres having greater energy demands but lesser capacity for oxidative
phosphorylation compared with the slower fibre types. Therefore, the proportions of
the different fibre types in a muscle will affect its fatigue characteristics. Several
studies have reported higher muscle glycolytic enzyme activities (Jaworowski et al.,
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2002; Russ et al., 2005) and lower oxidative capacity (Nygaard, 1981; Green et al.,
1984) in men compared to women, which is consistent with a lower proportion of
slow, fatigue-resistant, type I fibres in men (Nygaard, 1981; Carter et al., 2001;
Roepstorff et al., 2006).
Little attention has been paid to differences in central drive. Recently, however, it
was shown with superimposing stimulation that sex-related differences in fatigue
during a series of sustained maximum voluntary isometric contractions were not
related to differences in voluntary activation but were likely to have been of
peripheral origin (Hunter et al., 2006a). Surprisingly, there appears to be no studies
in which muscles have been fatigued by the use of electrical stimulation, an
experimental situation that completely removes the volitional element and allows a
direct comparison of the extent of peripheral fatigue in men and women.
Our primary objective, therefore, was to expand on the work of Hunter and
colleagues (2006a) by using electrical stimulation to directly determine whether
there are differences in susceptibility to peripheral fatigue in men and women. Our
second objective was to determine whether any differences in fatigability during an
intermittent protocol could be attributed to differences in blood supply to the
muscle. We have done this by comparing the extent of fatigue seen with an intact
circulation with an identical fatigue protocol carried out under ischaemic conditions.
The hypothesis was that if the differences are attributed to differences in blood
supply or oxidative capacity of the muscle then no sex differences will be evident
when the blood supply is occluded.
Methods
Participants
Sixty four volunteers (29 men, 35 women) aged between 19 and 45 years
participated in the study. Men and women were matched for age and physical
activity, the latter assessed by questionnaire (Baecke et al., 1982). Exclusion criteria
were smokers, known respiratory, cardiovascular or neuromuscular diseases, and
any lower limb injury. Written informed consent was obtained from each participant
prior to testing. The study was approved by the local Ethical Committee to the
standard set by the Declaration of Helsinki.
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Experimental procedures
Muscle size
Anatomical cross-sectional area (ACSA) of the quadriceps muscle was measured
at 50% femur length with magnetic resonance imaging (MRI), using a fixed 0.2-T
MRI-scanner (E-scan, ESAOTE Biomedica, Genova, Italy). Scans were obtained
with a T1-weighted, high resolution, gradient echo profile, with the following
scanning parameters: echo time: 0.016 s; repetition time: 0.1 s; field of view: 0.33 x
0.254 m; matrix: 256 x 256 and a slice thickness: 0.005 m.
Torque measurements
All torque measurements were performed on the right quadriceps femoris muscle
with a Cybex norm dynamometer (Ronkonkoma, New York, USA). Participants
were familiarised with the testing procedures on a separate occasion prior to data
collection. Participants were seated with the hips (90° flexion) and shoulders
strapped to minimise extraneous movements. The participants received visual
feedback of the torque signal and verbal encouragement during the maximal
voluntary contractions (MVC). Maximum voluntary contractions were repeated 2 or
3 times at knee joint angles of 60, 70 and 80˚ (full extension=0˚) in a random order
with two minutes of rest in between each contraction to prevent development of
fatigue. The angle at which the highest torque was achieved was defined as the
optimal joint angle. All further measurements were done at optimal knee joint
angle. To account for differences in muscle cross-sectional area between the two
groups, maximal knee extensor torque was scaled with quadriceps ACSA
(Maughan et al., 1983) and expressed as MVC/ACSA (Nm cm-2).
Electrical stimulation
Percutaneous electrical stimulation (square wave, pulse width 50 s; DSV
Digitimer Stimulator, Digitimer Ltd., Herts, UK) was applied using carbon-rubber
pads (76 mm x 127 mm, Versastim, Conmed Corp., N.Y., USA). The anode was
placed over the proximal region of the quadriceps and the cathode over the distal
third of the upper leg.
Voluntary activation (VA)
To assess the ability of the subjects to activate the knee extensors during isometric
contractions, voluntary activation levels were determined using a variant of the
interpolated twitch technique (Shield & Zhou, 2004). For the test, a doublet (inter-
pulse interval 10 ms) was applied with the subject in a relaxed state and a second
interpolated doublet was delivered during the plateau phase of the MVC. The
current used to test for activation was determined using single pulses with the
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subject in a relaxed state, starting from 100 mA, and increasing until no further
increase in torque was observed. Throughout the experiments, the voltage was
kept at 400 V.
Torque-frequency relationship
The intensity of stimulation for the determination of the torque-frequency
relationship and fatigue protocols was adjusted so that a 1 s 100 Hz tetanus
produced 28.6 ± 6.7 (SD) % of maximal voluntary isometric torque. Five minutes
after the last MVC, the quadriceps muscle was stimulated with 1 s 1, 10, 15, 20,
30, 50 and 100 Hz trains in random order, each separated by 1 min to assess the
torque-frequency relationship.
Fatigue tests
Five minutes after determining the torque-frequency relationship of the quadriceps
muscle, the resistance to fatigue was determined by a series of electrically evoked
isometric contractions (60 contractions, 30 Hz, 1 s on 1 s off; the standard fatigue
test)
On two subsequent occasions, a subgroup of subjects also performed two more
fatigue tests that were metabolically more demanding. In the first the rest period
was reduced from 1 s to 0.5 s, while leaving the total duration of the test the same
(12 men and 18 women). In the second test the blood supply to the muscle was
occluded with a pneumatic thigh cuff (Accoson, Harlow, UK) inflated to ~240 mm
Hg before and during the standard fatigue protocol (12 men and 10 women). The
occlusion prevented the return of blood in the intervals between the stimulated
contractions and hence oxidative recovery (Russ et al., 2002).
Analysis of variables
The torque signal was stored with a sampling frequency of 2000 Hz (Acknowledge,
Biopac Systems, Santa Barbara, CA, USA) and off-line analysis was performed
using Matlab (Matlab, the Mathwork Inc., S. Natik, MA, USA). Each torque signal
was filtered with a low-pass fourth order Butterworth filter with a 30 Hz cut-off
frequency. The maximal rate of relaxation (MRR, s-1) was determined from the 30
Hz tetanus and calculated as the lowest value of the differentiated torque signal
expressed relative to the highest torque recorded during that contraction.
Statistical analysis
Differences in MVC, ACSA and MRR between the sexes were tested using an
independent Student’s t-test for all dependent variables. Voluntary activation levels
were analysed with the non-parametric Mann-Whitney U test, because the values
were not normally distributed. Differences were considered significant at an alpha
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of 0.05. Results are presented as means (SD), unless otherwise stated. Torque
data from the three fatigue tests and torque-frequency relationships were analyzed
using repeated measures ANOVA with time and frequency, respectively, as within
factor, and as between-subject variable sex.
Results
Subject characteristics, muscle strength and size
Mean physical activity scores were [mean ± SD (range)]: 8.5 ± 1.3 (6.0– 0.8) vs. 8.5
± 1.0 (6.0–10.4) in men and women, respectively, indicating that we successfully
matched the sexes for physical activity level. A physical activity score < 6 indicates
a sedentary life-style, whereas values > 9 represent a high level of activity (Baecke
et al., 1982). Mean age was 26.5 ± 7.0 (20–45) vs. 25.4 ± 7.6 (19-45) years in men
and women respectively.
Table 2.1. Quadriceps muscle properties.
Men (n=29) Women (n=35)
ACSA (cm2) 75.5 ± 10 55.6 ± 6.9 *
MVC (Nm) 339 ± 82 255 ± 51 *
MVC/ACSA (Nm cm-2) 4.50 ± 0.18 4.34 ± 0.15
VA (%) 93.4 ± 9.2 90.1 ± 5.3
Optimal angle (°) 75 ± 7 71 ± 9
MRR30 (s-1) -15.6 ± 2.4 -14.1 ± 1.8 *
ACSA: anatomical cross-sectional area; MVC: maximal voluntary
contraction; VA: voluntary activation; MRR30: maximal rate of relaxation
from the 30 Hz stimulus, normalised to maximal torque during that
contraction; *: different from men at P<0.01.
Maximal voluntary torque and ACSA were lower in women (P<0.001), but there
were no significant differences between men and women in their ability to
voluntarily activate their quadriceps muscles (Table 2.1).
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Figure 2.1. The torque-frequency curve of the quadriceps muscle determined by
electrical stimulation in men (●) and women (○). Values are expressed as a 
percentage of the torque generated by 100 Hz stimulation. Error bar represent
SEM. Insert shows a typical series of torque records when stimulating at 1, 10, 15,
20, 30 50 and 100 Hz.
Torque-frequency relationship and maximum relaxation rate
Individual torque–frequency curves were normalised by expressing the data
relative to peak (100 Hz) torque (Figure 2.1). Women generated marginally more
torque at low frequencies of stimulation, but this was not significant. Only the
percentage torque at 10 Hz was 4 % higher in women compared with men but this
did not reach statistical significance (P=0.063; Figure 2.1), while at 15 Hz and 20
Hz no differences were observed (P=0.15 at 15 Hz and P=0.26 at 20 Hz).
Contractile speed, as assessed by the rate of relaxation (MRR30) from a 30 Hz
tetanus, of the female muscles was appreciably slower than that of the men
(P=0.002; Table 2.1).
Fatigue tests
Torque
The development of fatigue, as indicated by the progressive decline in torque
during the two minutes of the fatigue tests, is shown in Figure 2. In the standard
fatigue test (Figure 2.2A) torque declined significantly more in men (by 37.7 ± 10.7
%) than in women (by 29.9 ± 10.0 %, P<0.01).
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Figure 2.2. Torque during the fatigue protocols in men (●) and women (○). The decline in
torque is expressed as percentage of the initial torque during the fatigue protocol for (A) 1 s
on, 1 s off (29 men and 35 women), (B) 1 s on, 0.5 s off (12 men and 18 women) and (C) 1 s
on, 1 s off, with circulatory occlusion (12 men and 10 women). Data are plotted every 2 s
during the complete stimulation protocol for both sexes. Error bars represent SEM. Torque
declined significantly more in men than women (all tests P<0.01). Arrows indicate the first
contraction with a significant difference between the sexes (after 78 s, 37.5 s and 72 s for A,
B and C respectively).
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Figure 2.3. Relationship between the torque during a maximal voluntary contraction (MVC)
and fatigue resistance (remaining torque as a percentage of initial torque, in %) for men (●) 
and women (○). Note that while pooling all the data, significant correlations were observed in 
the non-occluded fatigue test (A: standard (29 men and 35 women) and B: 0.5 s off (12 men
and 18 women)), while this relation did not occur within sexes. In the occluded standard
fatigue test (C, 12 men and 10 women), no significant correlations were observed.
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Decreasing the recovery time between the tetani from 1 s to 0.5 s (Figure 2.2B)
increased the rate of fatigue and differences between men and women became
apparent earlier than during the standard fatigue test; i.e. after 37.5 s as opposed
to 78 s into the standard fatigue test. Using this protocol, the differences in torque
decline between men and women also became more marked (55.7 ± 8.1 vs. 42.8 ±
13.4 % decline; men vs. women, P<0.01).
The standard fatigue test carried out under ischaemic conditions (Figure 2.2C)
visually showed a slightly different time course than in either of the other two
protocols. Significant differences between men and women became apparent after
72 s and the difference in loss of torque between men and women (76.9 ± 10.8 vs.
59.5 ± 16.9 %; men vs. women, P<0.01) was greater than in either of the fatigue
tests with intact circulation. Our hypothesis that sex-related differences would be
abolished under ischaemic conditions had to be rejected, as we observed that in
the standard and ischaemic fatigue test, women fatigued about a third less than
men.
The subjects who had larger and stronger muscles, in general the men, also
tended to fatigue most rapidly. This was reflected by the significant correlation
between MVC and fatigue resistance (i.e. remaining torque as a percentage of the
initial value) for the pooled data of the standard fatigue test (Figure 2.3A).
However, this correlation does not necessarily indicate a causal relationship.
Indeed, for the standard protocol (Figure 2.3A) there was a weak relationship
between strength and fatigability within the women only, but not in the men. In the
second protocol, the recovery interval was shortened (Figure 2.3B) and hence the
duration of occlusion of the circulation is longer. The weak correlation between
MVC and fatigue resistance in the women even disappeared, although for the
combined data there remained a weak relationship. To entirely remove the
possible role of differences between sexes in occlusion of the circulation during the
fatigue tests an ischaemic fatigue protocol was performed (Figure 2.3C). In this
case the absolute torque would not affect blood flow as it is already minimised. As
expected no significant relationships between strength and fatigue, either for each
sex separately or for the pooled data were found.
A significant relationship existed between the MRR of the unfatigued muscle and
the decline in torque in the standard fatigue test (R2=0.12; P=0.005), the second
fatigue protocol (R2=0.26; P<0.001) and the standard fatigue test under ischaemic
conditions (R2=0.40; P=0.02; Figure 2.4). Similar results were obtained from the
men and women separately. Moreover, the correlations did not change after
controlling for MVC.
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Figure 2.4. Significant relationship between the maximal rate of relaxation (MRR)
and fatigue resistance (remaining torque as a percentage of initial torque, in %) for
men (●) and women (○) during the occluded standard fatigue test (R
2=0.40,
P=0.002; 12 men and 10 women).
Discussion
Our results add weight to those reports suggesting women are more fatigue
resistant than men. The new finding is that the difference between men and
women is evident during electrically stimulated contractions, which eliminates any
possible problems associated with activation. Moreover, it persists during a fatigue
protocol that largely eliminated oxidative phosphorylation, indicating that the key
difference does not involve questions of blood flow or the oxidative capacity of the
muscles. Our results show that the difference in fatigability between men and
women is a consequence of higher energy utilisation in men and could be related
to the differences in contractile speed that we have observed.
Central and peripheral fatigue
Maintaining continuous, or even intermittent, muscular contractions is a demanding
task that requires concentration and motivation. It is conceivable that one sex may
be slightly better at these tasks accounting for the differences that have been
reported with fatigue protocols involving voluntary activation. However, Hunter et
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al. (2006a), using a superimposed twitch technique, have shown that the decline in
activation during a series of voluntary contractions was similar in men and women.
We have taken this one step further by both fatiguing and testing the muscle using
electrical stimulation, a situation where voluntary activation plays no role.
Consequently, the observed difference in fatigability clearly has a peripheral cause
as opposed to an origin in the central nervous system. In addition this method also
circumvents possible bias related to motor unit rotation that may occur during
voluntary contractions, all factors that have been suggested to play a role in the
sex-related differences in muscle fatigue (Hicks et al., 2001; Clark et al., 2003;
Hunter et al., 2004b; Clark et al., 2005). The question therefore is what aspect of
peripheral muscle physiology or metabolism can account for the differences in
fatigability between men and women?
Transmission failure
During repetitive electrical stimulation there is the possibility that transmission at
the neuromuscular junction may be impaired, possibly as a result of acetyl choline
depletion, or failure of action potential propagation along the sarcolemma or T-
tubule membranes. The protocol we have used was designed to minimise the
likelihood of such transmission failure by keeping the stimulation frequency
relatively low (30 Hz) and allowing repeated recovery intervals since transmission
failure recovers rapidly when the contraction stops (Jones, 1996). It would appear,
therefore, that differences between men and women are unlikely to be due to
differences in transmission across the neuromuscular junction or along the
sarcolemma and T-tubular membranes.
Oxidative metabolism
The rate of fatigue during the standard protocol we have used will be a balance
between the depletion of energy stores during activity and the extent of recovery
metabolism. In turn, the extent of aerobic recovery will depend on the oxidative
capacity of the fibres, the degree to which blood flow is occluded during the
contraction, and the duration of the recovery period between contractions. Given a
long enough interval there will be complete recovery, while shortening the interval
will increase the stress on the oxidative processes to fully replenish the energy
stores. When, in the second protocol, there was only 0.5 s between the
contractions and relatively less blood flow and thus aerobic recovery, the rate of
fatigue was increased but, interestingly, the women fatigued a third less compared
to the men, similar to the results we found in the standard fatigue test. This could
be reflection of a lower capacity of aerobic energy regeneration in men than
women and/or a higher rate of energy utilisation in men than women.
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Our male subjects were, on average, stronger and had larger quadriceps muscles
and it is possible, therefore, that the blood supply to the working muscles during
the contraction phase was impeded to a greater extent in the larger and stronger
male than female muscles. The data shown in Figure 2.3A, suggest that there may
be a small component of fatigue in the female participants which could be
explained in this way but there is not a simple relationship between force and blood
flow. Considerable intramuscular pressures are developed in even comparatively
small rabbit muscles (Degens et al., 1998) and it has been shown that the
oxygenation of the muscle depends on the relative, rather than the absolute, torque
the muscle generates during a contraction (De Ruiter et al., 2007). However, the
most persuasive argument that differences in fatigability between men and women
has nothing to do with blood flow or oxidative capacity of the muscle is our
observation that the differences between men and women were still evident when
the blood flow was occluded. This clearly shows that there are differences between
male and female muscle that must reside in the rate at which energy is used by the
muscle fibres rather than the oxidative recovery rates. We conclude that the
observation that men, with stronger muscles, also fatigue more rapidly, is
coincidental and not causal, there being some other reason for the faster rate of
fatigue.
Our results contrast with the findings presented by Russ and Kent-Braun (2003),
who reported that sex differences in muscle fatigue were absent under ischaemic
conditions and concluded that blood flow and/or substrate utilisation differ between
men and women. The difference between the present study and their results may
be due to the study design. Problems of voluntary activation become very
important during sustained ischaemic contractions and this may well have
obscured any differences between male and female subjects, and it is possible that
there may be differences between the calf muscles used by Russ and Kent-Braun
(2003) and the quadriceps muscles investigated here.
Possible differences in muscle fibre characteristics between men and women
Compared to type II fibres, type I fibres have a slower speed of contraction and
consequently a slower rate of energy utilisation (Stienen et al., 1996; Hamada et
al., 2003) and, characteristically, fatigue at different rates and this can be seen in
the fatigue characteristics of human muscle (Gordon et al., 1990; Hamada et al.,
2003). The female participants had muscles that were, on average, slower than
those of the males. There was a small, although not significant, difference in the
torque-frequency relationship (Figure 2.1) and the MRR was significantly slower
(Table 2.1). The relationship between MRR and rate of fatigue (Figure 2.4)
suggests that the fatigability of the muscle is related to the contractile speed; the
slower the muscle the more fatigue resistant (Gordon et al., 1990; Hamada et al.,
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2003). The logic of this argument is that female muscle should contain more type I
slow fibres than male muscle. However, there is controversy as to whether male
and female muscle differ in their fibre type composition but the available evidence
tends to show a (5 %) larger percentage of type I fibres in pre-menopausal women
than men (Nygaard, 1981; Simoneau et al., 1985; Simoneau & Bouchard, 1989;
Mannion et al., 1997; Staron et al., 2000; Jaworowski et al., 2002; Roepstorff et al.,
2006; Yu et al., 2007). Interestingly, when extrapolating the data from Hamada et
al. (2003), a 5 % change in the proportion of type I fibres would result in a ~7.5 %
change in fatigue resistance during a non occluded, volitional fatigue test.
Conclusion
In conclusion, we can confirm that fatigue resistance during a series of intermittent
contractions is lower in men compared to women when matched for age and
physical activity. As the differences were observed using electrical stimulation, we
can conclude that this higher fatigue resistance has a peripheral origin. It is unlikely
that differences in blood supply and/or oxidative phosphorylation underlie this
difference, as fatigue resistance was also higher in muscles from women than men
when the circulation was occluded. Intrinsic sex-related differences in skeletal
muscle properties, such as contractile speed and rate of energy utilisation probably
play a key role in the sex related differences in fatigue.
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Abstract
To determine whether muscle function is compromised in healthy smokers in
comparison with activity-matched non-smokers, nine male smokers (aged 22.2 ±
2.5 yr: mean ± SD) with a smoking history of 2.5 ± 3.1 pack years, and ten male
control participants (25.4 ± 2.9 yr) matched for physical activity level participated in
this study. Knee extensor strength was measured using Isometric maximal
voluntary contractions. Voluntary activation of the quadriceps and co-activation of
the biceps femoris were determined using interpolated twitches and surface
electromyography, respectively. The frequency-torque relationship and fatigue
resistance were assessed with electrically evoked contractions. A fatigue index
was determined as the ratio of final torque to initial torque during series of isometric
contractions (1s on 1 s off, 30 Hz, 2 min). Quadriceps anatomical cross sectional
area was measured with MRI at 50 % of femur length. Maximal voluntary
contraction torque, quadriceps anatomical cross sectional area, knee extensor
torque/quadriceps cross sectional area, activation, co-activation and force-
frequency relationship were similar, whereas the fatigue index was 17 % lower in
smokers than non-smokers. In young men smoking does not significantly affect
quadriceps muscle cross sectional area and contractile properties, but does reduce
fatigue resistance of the quadriceps muscle, which was not attributable to
differences in physical activity.
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Introduction
Smoking is a recognised risk factor for cardiovascular disease, lung cancer and
chronic obstructive pulmonary disease (COPD). Many patients with COPD and
chronic heart failure suffer from muscle dysfunction, which is not directly related to
changes in lung or heart function (Gosker et al., 2000). Besides muscle wasting,
which results in weakness (Franssen et al., 2005), there is a reduction in the
oxidative capacity (Gosker et al., 2000) and a shift towards faster fibre types (Satta
et al., 1997) which may explain the reduced muscle endurance in COPD patients
(Van ‘t Hul et al., 2004).
In addition to damaging the lungs, smoking may also affect skeletal muscle (Agusti
et al., 2003; Gan et al., 2004; Gan et al., 2005). Smoking has been reported to
cause a decline in muscle strength (Örlander et al., 1979; Al-Obaidi et al., 2004).
As muscle cross-sectional area is the major determinant of strength (Maughan et
al., 1983) it is likely that the lower muscle strength in smokers is attributable to a
smaller muscle mass. However, where differences in muscle strength have been
reported between smokers and non-smokers, muscle size has not been measured.
Furthermore, a shift from high-oxidative type I (slow-twitch) fibres towards a higher
percentage of low-oxidative type II (fast-twitch) fibres and a reduction in fibrillar
mitochondrial volume fraction occurs (Örlander et al., 1979); changes that are likely
to result in a reduction of fatigue resistance (Degens & Veerkamp, 1994). It has
been suggested that the differences in skeletal muscle between smokers and non-
smokers is at least partly due to a lower physical activity level of smokers (Örlander
et al., 1979). It is important to minimize this bias when studying the effects of
smoking on skeletal muscle. Indeed, disuse induces the same changes in skeletal
muscle. Therefore, it is important to take into account the physical activity level to
separate the effects of disuse from those of smoking per se.
Thus, the aim of the present investigation was to determine whether i) smokers are
weaker than non-smokers, ii) any weakness is the result of neural and/or muscular
factors, iii) there is any difference in contractile properties between smokers and
non- smokers and iv) fatigue resistance is altered in smokers compared to non-
smokers. To exclude the role of disuse, control male participants were activity-
matched with healthy smokers. To circumvent possible differences in motivation
between smokers and non-smokers, electrically evoked muscle contractions were
used to test muscle function. Considering the role of smoking in the development
of COPD and its potential effects on skeletal muscle, the present study may reveal
changes in skeletal muscle function of young healthy smokers (i.e., free from any
pre-existing medical condition) before any clinical signs of COPD develop.
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Methods
Participants
Nine male smokers and ten male non-smokers (Table 3.1) participated in the
study. Smokers and non-smokers were matched for age and physical activity level.
Written informed consent was obtained from all participants and all procedures
were approved by the local ethics committee of Manchester Metropolitan
University. Potential participants who suffered from respiratory, cardiovascular or
neuromuscular diseases or had any lower limb injury were excluded from the study.
All participants abstained from smoking and caffeine ingestion for two hours prior to
testing. Physical activity (PA) levels were assessed using a previously validated
questionnaire
Table 3.1. Participant characteristics
Smokers (n=9) Non-smokers (n=10)
Age (years) 22.2 ± 2.5 25.4 ± 2.9
Mass (kg) 79.9 ± 14.0 76.1 ± 8.7
Height (cm) 180.2 ± 6.5 179.9 ± 6.4
BMI (kg m-2) 26.6 ± 2.3 23.5 ± 1.5
FVC (L) 4.4 ± 0.8 5.0 ± 0.6
FEV1%pred 91.3 ± 13.7 104.7 ± 9.9
Physical activity score 8.3 ± 1.6 8.7 ± 1.5
Smoking history (pack
years)
2.5 ± 3.1 -
BMI, body mass index; VC, vital capacity; FEV1%pred, the percentage of the age
and height adjusted predicted FEV1.
(Baecke et al., 1982); where <6 indicates a sedentary lifestyle and >9 a high physical
activity level. All participants were relatively inactive with a mean score of around 8-9
for each group (Table 3.1). Smoking history was assessed by questionnaire and
smoking volume was determined by pack-years, which is defined as the number of
cigarette packs smoked per day, multiplied by the number of years smoking. The
vital capacity (VC) and forced expiratory volume in 1 second (FEV1) was assessed
with spirometry (Vitalograph Ltd. Bucks, UK) and used to determine the percentage
of the age- and height-adjusted predicted value (FEV1%pred; Crapo et al., 1981).
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Experimental procedures
Muscle size
Anatomical cross-sectional area (ACSA) of the quadriceps was measured with
magnetic resonance imaging (MRI), using a fixed 0.2 T MRI scanner (E-Scan,
ESAOTE Biomedica, Genova, Italy), at 50 % of femur length. Scans were obtained
with a T1 weighted, high resolution, gradient echo profile, with the following
scanning parameters: echo time: 0.016 s; repetition time: 0.1 s; field of view: 0.33 x
0.254 m and a slice thickness of 0.005 m. Subjects were supine for 15 min prior to
the scan to make sure any fluid shifts had stabilised. To account for differences in
muscle cross-sectional area between the two groups, maximal knee extensor
torque was scaled with quadriceps ACSA (Maughan et al., 1983) and expressed as
MVC/ACSA (Nm cm-2).
Participants were familiarised with the testing procedures on a separate session
prior to data collection. All knee extension torque measurements were performed
on the right leg with a Cybex norm dynamometer (Ronkonkoma, New York, USA).
Participants were seated with the hip joint at 90° flexion with the hip and shoulders
strapped to prevent any extraneous movement. Before the experiment, participants
warmed-up by performing 5 submaximal isokinetic contractions. Torque was
displayed on a computer screen, interfaced with an acquisition system
(Acknowledge, Biopac Systems, Santa Barbara, CA, USA) used for analogue-to-
digital conversion. The sampling frequency was 2000 Hz. Each torque signal was
filtered with a low-pass fourth order Butterworth filter with a 30 Hz cut-off
frequency.
Torque measurements
The optimal angle for torque generation was 80° (full knee extension=0°) in all but
two participants (data not shown). Therefore, to reduce the influence of joint angle
on twitch characteristics all subsequent measurements were performed at a knee
joint angle of 80°. MVCs were maintained for 4 seconds (sufficient to reach a
plateau) with 2 min of rest in between each contraction to prevent development of
fatigue. To maximize performance, visual feedback of the torque signal and verbal
encouragement was given to all participants. The highest torque reached during a
contraction was recorded, and the highest value of the two contractions was given
as the MVC.
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Electrical stimulation
Voluntary activation
Voluntary activation levels were determined with the interpolated twitch technique
as described previously (Allen et al., 1995). Briefly, the muscle was stimulated
percutaneously, with the anode (76 mm x 127 mm, Versastim, Conmed Corp.,
N.Y., USA), placed over the proximal region of the quadriceps and the cathode
over the distal third of the femur length. To assess the supra-maximal current,
single pulses (pulse width 50 s; DSV Digitimer Stimulator, Digitimer Ltd., Herts,
UK) were administered at 30 s intervals with increases in current of 50-100 mA,
until no further increase in torque was observed. For the interpolated twitch
technique, a first doublet (pulse width of 50 s, 100 Hz) was applied with the
participant in a relaxed state and a second during the plateau phase of the MVC.
The ratio of interpolated and resting doublets was used to provide an index of
activation (Allen et al., 1995) as follows:
Voluntary activation (%)=100 x
(1 – (superimposed doublet torque/resting doublet torque))
where the superimposed doublet torque is the additional torque during the MVC
caused by the doublet.
Antagonist co-activation
To determine whether antagonist co-contraction affected the measured torque
during a knee extensor MVC, the electromyographic (EMG) activity of the biceps
femoris was recorded as described previously (Kellis & Baltzopoulos, 1997). Two
10-mm, pre-gelled, Ag-AgCl percutaneous unipolar electrodes (Medicotest,
Olstykke, Denmark) were placed along the mid sagittal line of the biceps femoris
muscle to reduce the level of cross talk. To ensure that EMG recordings were
made beyond the motor point of the biceps femoris, electrodes were positioned at a
third of total femur length (Zipp, 1982), with the reference electrodes placed over
the lateral epicondyle of the femur. The raw EMG activity was acquired with a
sampling frequency of 2000 Hz and processed with a multi channel analogue-
digital converter (Biopac Systems Inc., CA, USA). The raw EMG signal was filtered
with low and high-band pass filters set at 500 Hz and 10 Hz respectively, and
amplified with a gain of 2000. The level of co-activation of the biceps femoris was
assessed using the root mean square (RMS) of the raw EMG signal which was
integrated over 1 s about the peak MVC torque during knee extension and was
expressed as the percentage of activity recorded from the biceps femoris during
maximal knee flexion (Klein et al., 2001).
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Contractile properties
The frequency-torque relationship and fatigue resistance were determined with
electrically evoked contractions essentially as described previously (Degens et al.,
2005). Briefly, the intensity of stimulation throughout the test was such that about
30 % of MVC toque was developed during a 100 Hz contraction.
Five minutes after the last MVC, the quadriceps muscle was stimulated with 1, 10,
15, 20, 30, 50 and 100-Hz trains for 1 s, separated by 1 min, to assess the
frequency-torque relationship. Frequencies were delivered in a random order.
From the 100 Hz tetanus of the frequency-torque relationship, the contraction time
was measured as the time from activation until 90 % of the maximal torque was
reached, and the relaxation time as the time for the torque to decline to 50 % of
maximal torque after cessation of stimulation (Degens et al., 2005).
Fatigue test
Five minutes after the contractions for the frequency-torque relationship the
resistance to fatigue was assessed by stimulating the quadriceps muscle with 30
Hz trains, 1 s on 1 s off, for 2 minutes (Degens et al., 2005). Fatigue index (FI) was
expressed as the torque at the end of the test divided by that at the start of the test.
Statistical analysis
Data are reported as means (SD). To determine the effects of smoking an unpaired
two-tailed Student t-test was performed. None of the parameters violated the
assumptions of the t-test except for physical activity scores which were compared
using a non-parametric Mann-Whitney test. Differences were considered significant
at P<0.05.
Results
Subject characteristics
Table 3.1 shows the subject characteristics. Body mass, stature and body mass
index (BMI) did not differ between smokers and non-smokers (Table 3.1). The
smokers and non-smokers were successfully matched for physical activity as the
PA scores did not differ significantly (Table 3.1). Smoking history ranged from 0.4 -
11.1 pack years, with a median of 1.7 years (Table 3.1). The non-smokers had
never smoked. VC and FEV1%pred did not differ significantly between smokers
and non-smokers (Table 3.1).
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Table 3.2. Quadriceps function and contractile characteristics from male smokers
and non-smokers
Smokers (n=9) Non-smokers (n=10)
MVC (Nm) 335 ± 73 351 ± 72
ACSA (cm2) 74.9 ± 11.6 78.9 ± 6.7
MVC/ACSA (Nm cm-2) 4.5 ± 0.5 4.5 ± 0.9
Activation (%) 92 ± 3 93.3 ± 8.6
Co-activation (%) 27 ± 17 18 ± 10
Contraction time (ms) 334 ± 125 293 ± 67
Half relaxation time (ms) 112 ± 6 117 ± 8
MVC, maximal voluntary isometric knee extension torque; ACSA, anatomical cross-sectional
area; MVC/ACSA, MVC torque relative to ACSA; for further details see the Methods section.
Strength and muscle size
Knee extensor MVC torque was not significantly different between smokers and
non-smokers (Table 3.2). This and the similar ACSA were reflected in the absence
of a significant difference in the MVC/ACSA between smokers and non-smokers
(Table 3.2). Also, the level of voluntary activation and co-activation of the
antagonist muscles during an MVC were not significantly different between
smokers and non-smokers (Table 3.2).
Contractile properties
The contraction times of the 100 Hz tetani were not significantly different between
the smokers and non-smokers (Table 3.2). Similarly, half relaxation time was
comparable in the two groups. In line with this the frequency-torque relationship of
the quadriceps of smokers and non-smokers showed no difference (Figure 3.1).
Fatigue index
In figure 3.2 it can be seen that the quadriceps muscles of the smokers were more
susceptible to fatigue than those of the non-smokers (P<0.05); after two minutes of
30 Hz stimulation the FI was 54 ± 8 vs. 62 ± 9 % in smokers and non-smokers,
respectively. The variation in FI among the smokers did not correlate with either
smoking volume in terms of pack years (R2=0.09, P>0.05) or FEV1%pred (R2=0.28,
P>0.05).
Chapter 3
62
Figure 3.1. The frequency-torque relationship in healthy young male smokers (○, 
n=9) and non-smokers (●, n=10).  
Discussion
The main finding of the present study was a decrease in fatigue resistance in
young male smokers compared with a group of physical activity-matched non-
smokers, while strength and other contractile properties did not differ between the
groups. Based on the present results the decrease in fatigue resistance cannot be
explained by disuse, or restricted airflow. The electrically stimulated fatigue test
eliminates the possibility that differences in fatigability are due to differences in
motivation and it is probable that the cause of the lower fatigue resistance in
smokers is located within the muscle, at or beyond the level of the neuromuscular
junction.
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Figure 3.2. Fatigue resistance of the quadriceps muscle in healthy young male
smokers (○, n=9) and non-smokers (●, n=10). The torque, elicited by electrical 
stimulation (1 s on 1 s off, 30 Hz) of the quadriceps muscle, is presented as
relative to the torque generated during the first contraction. The torque decline was
larger in smokers than non-smokers (P<0.05).
Strength
We observed no differences in knee extension strength between smokers and non-
smokers. Two other studies, however, have reported a decline in maximal
voluntary strength in smokers (Örlander et al., 1979; Al-Obaidi et al., 2004). Such a
decline can, at least theoretically, be a consequence of a smaller muscle mass, a
reduced ability to voluntarily activate the muscle and/or increased activation of
antagonistic muscles during a maximal contraction. These factors could be
secondary to lower levels of activity in the smokers in these previous studies.
Indeed, it has been suggested that a lower level of physical activity underlies the
decline in strength previously observed in smokers (Örlander et al., 1979). In the
present study, smokers and non-smokers were matched for physical activity level
and, similarly to Larsson et al. (1984), we did not observe a difference in strength
between smokers and non-smokers. Thus, the decrease in strength observed in
previous studies is likely to be explicable by a reduced activity level in smokers,
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rather than an effect of smoking per se on maximal knee extensor strength or other
determinants of strength (activation, co-activation and ACSA).
Fatigue
Although strength was not affected by smoking, the fatigue resistance of the
quadriceps muscle was significantly reduced. Others, however, have not observed
a change in the fatigue resistance during maximal voluntary contractions in
smokers (Örlander et al., 1979; Larsson, 1984). This discrepancy is difficult to
explain but may, in part, be related to the type of fatigue tests performed. Previous
studies have used a series of fast dynamic contractions where the recovery interval
between contractions was probably around half a second, compared to the one
second interval in the present study. Dynamic contractions are more energetically
demanding than the isometric contractions we have used. Consequently, previous
work may have been testing predominantly anaerobic function whilst our protocol
emphasises more the aerobic capacity of the muscle and the ability to recover
between successive contractions.
The acute neural stimulation effect of nicotine in cigarette smoke is well
established (Cryer et al., 1976) and Mündel and Jones (2006) have demonstrated
that nicotine has a beneficial effect on cycling endurance. It might be hypothesised
that the stimulant effect of nicotine during voluntary fatigue tests may counteract
some peripheral mechanism which contributed to the greater levels of fatigue in the
smokers in the present study.
Smoking is the primary cause of COPD, which is characterised by a decline in
FEV1, and it has been reported that smoking itself causes an increase in
pulmonary airway resistance (Nadel & Comroe, 1961). However, we did not
observe a significantly lower FEV1%pred in smokers than non-smokers, or any
correlation between fatigue resistance and FEV1%pred. Therefore, it is unlikely that
lung function and the ability to oxygenate the blood play any role in the lower
fatigue resistance of smokers. Indeed, as the fatigue test was performed on one
leg, with activation of only about 30% of the quadriceps, blood oxygenation was
probably not the predominant limiting factor.
Lower levels of habitual physical activity level might lead to reduced oxidative
capacity, but in the present investigation the similar activity levels suggest that it is
cigarette smoking itself which is responsible for the observed reduction in fatigue
resistance.
A number of mechanisms (both acute and chronic) may be responsible for the
observed decline in fatigue resistance, these include alterations in muscle fibre
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type composition and/or a decreased oxidative capacity (Örlander et al., 1979;
Larsson, 1984). Although the frequency-torque relationship and contraction and
relaxation times are not unequivocal indicators for changes in fibre type
composition, the absence of significant alterations in these parameters indicates no
major changes in fibre type composition.
Mitochondrial enzyme activities (citrate synthase and 3-hydroxyacyl-CoA
dehydrogenase) have been reported to be decreased in the muscles of smokers
(Örlander et al., 1979). Interestingly, healthy ex-smokers did not show a decline in
activities of enzymes of oxidative metabolism (Larsson, 1984) and COPD patients
who stopped smoking exhibited normal fatigue resistance (Degens et al., 2005).
This suggests that the smoking-induced alterations in the activity of oxidative
enzymes and muscle fatigue resistance might be reversible. Furthermore, the fact
that we found no relationship between pack years and fatigue resistance suggests
an acute effect of smoking. Cyanide and carbon monoxide (CO) in smoke are
possible candidates for acutely affecting fatigue resistance. Cyanide and CO inhibit
cytochrome c oxidase (complex IV in the mitochondrial chain), causing an overall
decline in mitochondrial function and oxidative capacity (Alonso et al., 2003), and
thus potentially a reduced fatigue resistance of the muscle.
Besides acting on cytochrome c oxidase, CO in cigarette smoke increases
carboxyhemoglobin (COHb) levels (Puente-Maestu et al., 1998), which reduces the
O2 carrying capacity of the blood. However, a reduced O2 carrying capacity of the
blood induced by breathing hypoxic air had no effect on fatigue resistance during
the same test as employed in the present study (Degens et al., 2006). COHb also
hampers the release of O2 as reflected by the left-ward shift of the O2-Hb binding
curve. Furthermore, the facilitated diffusion of O2 by myoglobin within the muscle
may be impaired by the formation of carboxymyoglobin (Wittenberg & Wittenberg,
1987). It has been reported that raised levels of COHb reduce O2 extraction during
stimulated contractions with in situ canine gastrocnemius, which was accompanied
by a reduction in muscle tension (King et al., 1987).
Besides changes in the muscle itself, another possibility for the earlier onset of
fatigue in smokers might be related to neurotransmission failure. Using direct
muscle stimulation superimposed on nerve stimulation, it has been shown that
neurotransmission failure contributes to an earlier onset of fatigue during hypoxia
(Zhu et al., 2006). With the present stimulation protocol we are unable to state
whether neural transmission failure contributed to the earlier onset of fatigue in
smokers.
We assume that the more rapid fatigue, whatever the cause, is a consequence of
changes occurring as a result of smoking. However, we cannot exclude the
possibility that there may be some genetic component that, for instance, influences
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the likelihood of smoking and, at the same time, influences fatigue properties of the
muscle.
The relationship between the changes in fatigue resistance we report here and the
muscle dysfunction frequently seen in COPD patients is unclear. Given that fatigue
resistance is not affected in COPD patients who stopped smoking (Degens et al.,
2005) and the fact that we saw no association between pack years smoked and FI,
it is likely that the reduced fatigue resistance in the present smokers is acute in
nature. If it is an acute response, the underlying factors of this fatigue are most
likely changes in the oxidative capacity of the muscle brought about, for instance,
by a reversible effect of cyanide and/or CO on mitochondrial enzyme function and
tissue oxygenation. Indeed, 28 days of smoking cessation has been shown to
result in a return to normal mitochondrial respiratory chain function (Cardellach et
al., 2003). Therefore, future studies may be directed towards the acute effects of
CO, smoking and smoking cessation on skeletal muscle function, oxygenation and
fatigue resistance.
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Abstract
Although smoking-related diseases, such as chronic obstructive pulmonary
disease (COPD), are often accompanied by increased peripheral muscle
fatigability, the extent to which this is a feature of the disease or a direct effect of
smoking per se is not known. Skeletal muscle function was investigated in terms of
maximal voluntary isometric torque, activation, contractile properties and
fatigability, using electrically evoked contractions of the quadriceps muscle of 40
smokers (19 men and 21 women; mean ± SD) cigarette pack years: 9.9 ± 10.7)
and age- and physical activity level matched non-smokers (22 men and 23
women). Maximal strength and isometric contractile speed did not differ
significantly between smokers and non-smokers. Muscle fatigue (measured as
torque decline during a series of repetitive contractions) was greater in smokers
(P=0.014), but did not correlate with cigarette pack years (r=0.094, P=0.615),
cigarettes smoked per day (r=-0.092, P=0.628), respiratory function (%FEV1pred)
(r=-0.187, P=0.416), or physical activity level (r=-0.029, P=0.877). While muscle
mass and contractile properties are similar in smokers and non-smokers, smokers
do suffer from greater peripheral muscle fatigue. The observation that the cigarette
smoking history did not correlate with fatigability suggests that the effect is either
acute and/or reaches a ceiling, rather than being cumulative. An acute and
reversible effect of smoking could be caused by carbon monoxide and/or other
substances in smoke hampering oxygen delivery and mitochondrial function.
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Introduction
Smoking is a recognised risk factor for many chronic diseases, such as chronic
obstructive pulmonary disease (COPD). Patients with COPD often complain of
exercise intolerance and fatigue, which can be attributed to deterioration in lung
function and systemic effects such as muscle atrophy and a slow-to-fast transition
in fibre type composition (Chapter 1). However, also otherwise non-symptomatic
smokers often complain of an increased sensation of whole body fatigability
(Corwin et al., 2002). The aetiology of this earlier onset of whole body fatigue in
smokers is unknown and it is unclear as to whether smoking itself contributes to
this phenomenon or other factors such as a decreased level of physical activity
(Örlander et al., 1979; Larsson & Örlander, 1984; Larsson et al., 1988). In Chapter
3 we reported that in young male smokers, matched for physical activity with
control subjects, smoking itself causes a significant decline in skeletal muscle
fatigue resistance. The decline in fitness during prolonged smoking (Bernaards et
al., 2003) suggests, however, that long-term smoking may also cause a
progressive deterioration of skeletal muscle fatigue resistance.
Here, we hypothesised that the reduction in skeletal muscle function and fatigue
resistance would be related to the cumulative dose of smoking. Consequently we
have examined the muscle fatigability of subjects with a range of exposures to
smoking. To assess the effects of smoking duration on muscle function we have
used electrically evoked contractions of the quadriceps muscle of otherwise
healthy smokers. Electrical stimulation avoids possible motivational bias and also
allows determination of contractile properties such as the force-frequency
relationship and the rate of relaxation. The intermittent fatigue protocol used in this
study mimics, to some extent, the rhythmic muscle contractions involved in
activities of daily life such as cycling, walking and stair negotiation.
Methods and materials
Participants
Males and females were analysed separately, because of sex differences in
fatigability (Chapter 2), smoking reportedly only affecting the experience of fatigue in
men (Corwin et al., 2002) and differences between sexes in vulnerability to COPD
(Gan et al., 2006). Eighty-five people volunteered for the study after giving written
informed consent. All procedures were approved by the local ethics committee and
were in accordance with the Helsinki Declaration.
The smokers and non-smokers were matched for age and physical activity. Physical
activity was assessed by questionnaire (Baecke et al., 1982). Low values (< 6)
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represent a low physical activity level. Smoking history was assessed by
questionnaire and smoking volume was determined by pack-years, which is defined
as the number of cigarette packs smoked per day, multiplied by the number of years
smoked. Exclusion criteria were known respiratory, cardiovascular or
neuromuscular diseases and leg injuries. Participants were asked to refrain from
smoking and caffeine intake two hours prior to testing. The force expiratory volume
in one second (FEV1, L), predicted FEV1 (%FEV1pred), forced vital capacity (FVC) and
FEV1/FVC (%) were determined with standard spirometry (Vitalograph, Buckingham,
England).
Measurement of anatomical cross sectional area (ACSA)
ACSA of the quadriceps muscle at 50 % of femur length was measured with
magnetic resonance imaging (MRI) using a fixed 0.2 T MRI scanner (E-Scan,
ESAOTE Biomedica, Genova, Italy). See the appendix for more details.
Measurement of maximal isometric voluntary knee extension strength
All knee extension torque measurements were performed on the right leg with a
Cybex norm dynamometer (Ronkonkoma, New York, USA) with the hip joint at 90°
flexion. For more details on the procedures, see the appendix and the methods
section of chapter 2.
Voluntary activation
Beside muscle wasting, loss of strength can also be caused by a diminished ability
to maximally activate the muscle. This ability was determined using the
interpolated twitch technique (Shield & Zhou, 2004). Doublet pulses (pulse width
50 s, 100 Hz; DSV Digitimer Stimulator, Digitimer Ltd., Herts, UK) were applied
percutaneously using stimulation pads (Versastim, Conmed Corp., N.Y., USA) with
the anode placed proximally and the cathode distally over the quadriceps muscle.
The current required for supra-maximal stimulation was assessed by administering
single pulses at rest. The ratio of electrically evoked force superimposed on an
MVC to the force of a pre-contraction doublet provided an index of voluntary
activation (VA). After the VA was determined the stimulation current was set at a
level to produce approximately 30 % of MVC torque when stimulating at 100 Hz
and this current was used throughout the rest of the experiment.
Torque-frequency relationship and contractile speed
The torque-frequency relationship and maximal rate of relaxation (MRR) both give
an indication of the contractile speed and fibre type composition of the muscle
(Scott et al., 2006). The force-frequency relationship of the quadriceps muscle was
assessed by stimulating in random order at 1, 10, 15, 20, 30, 50 and 100 Hz for 1
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s, each separated by 1 min. Differences in the torque–frequency curves were
assessed using the 10/100 Hz ratio (FF10/FF100). The MRR was determined from
the 50 Hz contraction (MRR50) as peak dF/dt normalised to the maximal torque
generated during that contraction.
Fatigue test
Five minutes after determining the torque-frequency relation, fatigue resistance
was assessed by stimulating the quadriceps muscle with 30 Hz trains for 2 minutes
(1 s on 1 s off). Torque and MRR for each contraction were expressed as a
percentage of the first contraction. The percentage torque remaining after 2
minutes was defined as the fatigue index. The coefficient of variation between days
was 2.3 and 5.3 % for the force-frequency relationship and fatigue test,
respectively (n=3 non-smokers).
Statistical analysis
Differences between groups were tested using a 2 x 2 ANOVA with factors: smoke
(non-smokers and smokers) and sex, with age as a covariant using SPSS (SPSS
Inc., Chicago, IL, USA). The correlations between smoking habits and fatigability
were performed using a partial correlation, correcting for age and gender.
Differences were considered significant when P<0.05. Results are presented as
means ± SEM unless otherwise stated.
Results
Subject characteristics
Table 4.1 shows the anthropometric characteristics of the participants. Age, physical
activity levels, body mass, body mass index and lung function (FEV1, FVC or
FEV1/FVC) were similar in smokers and non-smokers, although %FEV1pred tended
to be significantly lower in smokers (P=0.092). Although we did not check whether
the airflow limitation in three smokers with an FEV1/FVC < 70 % was reversible, this
value suggests that they might have (undiagnosed) mild to moderate COPD (GOLD
stage I or II). The inclusion of their data, however, did not alter the results of the
present study.
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Table 4.1. Subjects characteristics. Values are displayed as mean ± SD (range)
Male
non-smokers
Male
Smokers
Female non-
smokers
Female
smokers
n 22 19 23 21
Age (yr) 38.1 ± 17.8
(21 - 73)
37.0 ± 18.4
(18 - 72)
42.4 ± 20.4
(19 - 72)
37.5 ± 17.4
(18 - 66)
Body mass
(kg)
77 ± 9
(63 – 95)
77 ± 12
(62 – 99)
66 ± 3
(53 - 83) **
74 ± 12
(56 – 96) **
BMI (kg m-1) 24 ± 2
(22-29)
24 ± 3
(18 – 30)
24 ± 3
(19 – 29)
27 ± 4
(22 - 34)
FVC (L) 5.4 ± 1.0
(3.6 – 7.3)
5.1 ± 1.3
(3.6 – 7.2)
3.6 ± 0.7
(2.5 – 4.8) **
3.7 ± 0.8
2.4 – 5.3) **
FEV1 (L) 4.3 ± 1.0
(2.8 – 6.1)
4.0 ± 0.9
(2.6 – 5.6)
3.0 ± 0.6
(2.0 – 3.9) **
2.9 ± 0.8
(1.5 – 4.2) **
%FEV1pred 99.3 ± 13.2
(78.7 – 125.5)
91.0 ± 11.5
(81.0 – 111.8)
101.2 ± 14.7
(76.4 – 127.8)
92.0 ± 19.5
(47.6 – 119.9)
FEV1/FVC (%) 78.7 ± 6.6
(60.2 – 91.6)
78.0 ± 9.4
(66.4 – 93.4)
81.7 ± 4.8
(71.9 – 88.6)
77.9 ± 10.5
(51.7 – 93.0)
Cigarette pack
years -
10.0 ± 12.8
(0.4 – 35.3) -
9.8 ± 8.9
(0.4 – 28.0)
Physical
activity score
8.2 ± 1.4
(6.0 – 10.8)
8.3 ± 1.4
(5.6 – 12.0)
8.1 ± 1.2
(5.8 – 9.5)
8.1 ± 1.4
(5.8 – 10.5)
No differences were observed between smokers and non-smokers, ** denotes P<0.005
from men. FVC: forced vital capacity; FEV1: forced expiratory volume in 1 s in L or as a
percentage of predicted
Muscle strength, size and voluntary activation level
The VA was higher in the smokers (Table 4.2). Maximal torque capacity (MVC
corrected for VA; MTC) was lower in women than men (Table 4.2) and decreased
significantly in both men (R2=0.43) and women (R2=0.46) during ageing (P<0.001;
Figure 4.1). If we consider smoking or non-smoking there was no difference in
MTC and ACSA (Table 4.2). However, stepwise linear regression showed that
height, age, gender, physical activity level and years smoked significantly predict
the ACSA (R2=0.793; P<0.001), while cigarette pack years and cigarettes smoked
per day did not improve the model.
Contractile properties
No differences were observed in the torque-frequency relationship or MRR50
between smokers and non-smokers (Table 4.2). Women however, had, on
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Figure 4.1. Maximal torque capacity (MTC), maximal voluntary torque corrected for
voluntary activation of the quadriceps muscle expressed as a function of age in
male (A) and female (B) smokers and non-smokers. MTC decreased significantly
with age in men (R2=0.43) and women (R2=0.46; both P<0.001). The decrease in
maximal strength over time (and smoke exposure) was similar between smokers
and non-smokers (NS).
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average, slower contractile properties than men as reflected by the less negative
MRR50 and the higher FF10/FF100 (Table 4.2).
Table 4.2. Values for muscle strength, size and contractile properties.
Male
non-smokers
Male
smokers
Female non-
smokers
Female
smokers
VA (%) 85.9 ± 3.0 92.0 ± 2.3 † 88.1 ± 2.2 90.0 ± 3.3 †
MVC (Nm) 286 ± 21 280 ± 18 190 ± 12 ** 204 ± 15 **
MTC (Nm) 330 ± 18 300 ± 19 213 ± 12 ** 219 ± 15 **
ACSA (cm2) 72 ± 2 65 ± 3 53 ± 2 52 ± 2
FF10/FF100 31.3 ± 1.4 31.4 ± 3.0 33.3 ± 1.5 * 38.0 ± 2.0 *
MRR50 (s-1) -15.1 ± 0.3 -16.0 ± 0.7 -12.7 ± 0.4 ** -12.9 ± 0.8 **
† P<0.05 from non-smokers; * P<0.05 from men; ** P<0.005 from men. VA:
voluntary activation; MVC: maximal voluntary contraction; MTC: maximal torque
capacity (maximal voluntary contraction corrected for VA); ACSA: anatomical
cross-sectional area; FF10/FF100: force frequency relationship: torque produced at
10 Hz relative to 100 Hz; MRR50 : maximal rate of relaxation at 50 Hz.
Figure 4.2. Representative example of a fatigue test (A), with in B the first
(continuous line) and last (dotted line) contraction enlarged.
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Fatigue
Figure 4.2A and 4.2B show a typical example of the fatigue test (A), and an
example of the reduction in torque and rate of relaxation from the first to the last
contraction (B). In all groups there was a progressive decline in torque (Figure 4.3)
and MRR, the latter indicating a slowing of the muscle (Figure 4.4). Women were
more fatigue resistant than men (P<0.001), both in terms of torque and MRR. In
both men and women, the fatigue resistance was lower in smokers than non-
smokers (P=0.014; Figure 4.3). The absence of a smoke x sex interaction indicates
that the effect of smoking was similar in both sexes.
The fatigue index in smokers was not related to cigarette pack years (Figure 4.5),
packs smoked per day (r=-0.092, P=0.628), years smoked (r=0.242, P=0.321),
physical activity level (r=-0.029, P=0.877), age (r=0.101, P=0.557) or lung function
in terms of %FEV1pred (r=-0.187, P=0.416) or FEV1/FVC (r=0.03, P=0.824). Also,
there was no relationship between lung function (FEV1pred) and fatigue index (r=-
0.027, P=0.921) when controlling for cigarette pack years, the number of smoking
years and number of cigarettes smoked per day. Similar results were obtained for
the decline in MRR. Stepwise linear regression revealed that gender (P=0.015) and
being a smoker or non-smoker (P=0.024) explained 19.2 % of the variance in
fatigue index between the participants.
Discussion
We observed that smoking, in the absence of overt lung disease, is not
accompanied by muscle weakness and wasting or changes in contractile
properties of the quadriceps muscle after taking into account age, sex and physical
activity. Despite an absence in changes in contractile properties and muscle
weakness, the muscles of smokers were, however, more fatigable. This effect was
similar in men and women. In chapter 3, we have shown that young smoking men
show greater fatigability and here we hypothesised that the effect would increase
with increasing smoking volume. The absence of correlations between muscle
fatigability and any measure of smoking volume contradicts this hypothesis and
suggests that the effect of smoking on skeletal muscle fatigability is of an acute
nature and/or reaches a ceiling where an increased daily smoking volume does not
aggravate the effect.
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Figure 4.3. Torque, expressed as percentage of initial value, during the fatigue
protocol is plotted every 2 s during the fatigue protocol for male (A) and female (B)
smokers (open symbols) and non-smokers (closed symbols). Women had a
significantly higher fatigue resistance (P<0.001). Both male and female smokers
fatigued more than the non-smokers (P=0.014). Note that (A) is almost identical to
Figure 3.2, but (A) includes more participants.
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Figure 4.4. Maximal rates of relaxation (MRR), expressed as percentage of initial
value, during the fatigue protocol are plotted every 2 s during the stimulation for
male (A) and female (B) smokers (open symbols) and non-smokers (closed
symbols). Significantly higher values were obtained in the females compared to the
males (P<0.001). MRR decreased to a significantly lower level in the smokers
compared to the non-smokers (P=0.008).
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Figure 4.5. Relationship between cigarette pack years and fatigue resistance of
the quadriceps muscle for male (●) and female (□) smokers of the fatigue test. 
Fatigue index was calculated as torque at the end of the test as a percentage of
the initial value. The correlation coefficient was 0.095 (P=0.618) for fatigue index
and similar results were obtained from other measures of smoking history (see
text).
Maximal strength, size and voluntary activation
We did not find a lower maximal voluntary torque in smokers, despite a slightly
higher voluntary activation level. The higher VA might be due to an increase in
sympathetic nerve activity in smokers (Narkiewicz et al., 1998), possibly due to a
central stimulant action of nicotine (Mündel & Jones, 2006). Yet, this effect is
insignificant as the maximal capacity of the muscle to generate torque (maximal
torque corrected for VA) was also similar between smokers and non-smokers.
Others (Örlander et al., 1979; Al-Obaidi et al., 2004), however, did report a lower
maximal strength in smokers than non-smokers, but smokers and non-smokers
were not matched for physical activity level, a factor very likely to affect maximal
voluntary force. Other factors that may contribute to muscle weakness via muscle
wasting are systemic inflammation and oxidative stress (Gan et al., 2005; Wüst &
Degens, 2007). The observation that the amount of years smoked predicted the
ACSA of the quadriceps muscle suggests that long term smoking produces a small
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degree of muscle wasting. Surprisingly, we did not observe similar differences in
the maximal strength of the quadriceps.
Contractile properties
The force-frequency relationship did not differ between smokers and non-smokers,
suggesting that no significant, if any, shift in fibre type composition had occurred
with smoking. Moreover, the MRR, a broad measure of muscle speed and fibre
type composition (Hamada et al., 2003), was not different between smokers and
non-smokers. In line with our observation, it has been found that different doses of
cigarette smoke did not lead to changes in fibre type distribution in the rat
(Nakatani et al., 2003). Örlander et al. (1979), however, found a lower percentage
type I fibres in smokers, but this may be related to differences in physical activity
level which was not controlled in their study.
Peripheral muscle fatigability
The main finding of the present study is a lower skeletal muscle fatigue resistance
in smokers. Interestingly, the reduction in fatigue resistance was similar in men and
women and, contrary to our hypothesis, was not related to several measures of
smoking history. The increased fatigability could be caused by neuromuscular
transmission failure, a shift to a more fatigable fibre type, reduction in oxygen
supply to the muscle and/or the oxidative capacity of the muscle (Degens &
Veerkamp, 1994).
The likelihood of electrical failure either at the neuromuscular junction or T-tubules
was minimised by keeping the stimulation frequency relatively low and allowing
sufficient recovery intervals (Jones, 1996). Therefore, the site of fatigue is most
likely distal to the neuromuscular junction (Bigland-Ritchie et al., 1982).
Another factor possibly affecting muscle fatigue is the fibre type distribution of the
muscle since type II fibres have a higher ATP turnover for the same isometric
tension than type I fibres (Stienen et al., 1996). Also, they generally have a lower
oxidative capacity and fatigue more rapidly (Degens & Veerkamp, 1994). However,
we did not observe any differences in maximal rate of relaxation or force-frequency
relationship, both a qualitative in vivo suggestion of a different fibre type
composition. It is thus unlikely that this explains the higher fatigability in smokers.
Another factor influencing muscle fatigue is the oxidative capacity of the muscle.
Earlier studies have found that smokers have a lower activity of mitochondrial
enzymes, such as cytochrome oxidase (Örlander et al., 1979; Larsson & Örlander,
1984). The present study does not allow us to draw firm conclusions regarding
oxidative capacity.
Smoking history and muscle function
83
Impaired oxygen transport to skeletal muscle
The absence of a significant correlation between cigarette pack years and
fatigability of the muscle and no indication for changes in fibre type composition
that could explain the reduced fatigue resistance in smokers suggest that smoking
acutely hampers the oxygen and/or energy delivery and/or utilization. An impaired
oxygen delivery may occur if the blood flow is diminished or the oxygen content of
the blood is lower than normal. Exercise-induced vasodilatation has been reported
to be lower in smokers than physical activity matched non-smokers (Gaenzer et al.,
2001), which may be due to an impaired nitric oxide generation (Montes de Oca et
al., 2008) and/or an increased oxidative stress (Gaenzer et al., 2001; Tsuchiya et
al., 2002).
A diminished oxygen delivery can also result from a reduced oxygen content of the
blood. In smokers this could arise when the oxygen binding sites on haemoglobin
(Hb) become occupied with carbon monoxide (CO), resulting in hypoxaemia.
Indeed, carboxyhaemoglobin (COHb) may reach levels of up to 9 % in smokers
(Rietbrock et al., 1992). Yet, we showed previously that subjects were no more
fatigable in acute hypoxia when using the same protocol (Degens et al., 2006). It
therefore seems unlikely that hypoxaemia is the factor that distinguishes the
smokers from the non-smokers. The effect of CO via its action on Hb can,
however, not completely be excluded as, in contrast to hypoxaemia, the oxygen
dissociation curve exhibits a shift to the left, inhibiting the release of oxygen from
Hb (Rietbrock et al., 1992). Indeed, inhalation of CO acutely impaired maximal
oxygen consumption in both healthy participants (Aronow & Cassidy, 1975;
Seppanen, 1977; Klausen et al., 1983) and patients with COPD (Aronow et al.,
1977). Moreover, experimentally elevating blood COHb to 6 % in non-smoking men
resulted in an increased fatigability in a test identical to our fatigue protocol (Morse
et al., 2008).
Besides the effect of CO on oxygen supply to the tissue, CO might also bind to Mb,
limiting intra-cellular facilitated diffusion of oxygen. Also, CO blocks complex IV of
the mitochondrial respiratory chain causing an overall decline in mitochondrial
function (Alonso et al., 2003). Cardellach et al. (2003) showed that mitochondrial
respiratory chain function (complex III and IV [cytochrome oxidase]) in lymphocytes
was decreased in smokers, but returned to normal values after smoking cessation.
Combined with the data in the present study this suggests that smoking may have
an acute and reversible effect on skeletal muscle fatigability caused by CO
(amongst other chemicals) in cigarette smoke. This then would result in a lower,
but reversible, fatigue resistance in smokers. It should be noted, however, that not
only CO, but also tar (Pryor et al., 1992) and cyanide (Nelson, 2006) in the
cigarette smoke could directly reduce mitochondrial respiratory chain function. This
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is further supported by the similar fatigue resistance (using the same fatigue test as
in the present study) in non-smoking patients with COPD (Degens et al., 2005).
In conclusion, skeletal muscle from smokers is more fatigable than that of age- and
physical activity-matched non-smokers, while contractile properties of the skeletal
muscle were not different. The decrease in fatigue resistance was similar in men
and women and not related to smoking history. This suggests that smoking itself
acutely affects skeletal muscle fatigue resistance. We speculate that this may
occur via an acute and potentially reversible smoking-induced oxygen delivery to
the working muscle and/or impairment of the function of haemoglobin and
myoglobin due to carbon monoxide. Moreover, CO and other factors in smoke
inhibit enzymes in the respiratory chain (such as cytochrome oxidase). If smoking
indeed has an acute effect on muscle fatigue resistance, smoking cessation may
be helpful in the management of the exercise intolerance and sensations of fatigue
in smokers, whether or not they suffer from clinical symptoms of chronic diseases
such as COPD or heart failure. It may also help to break the vicious circle of disuse
in order to prevent sensations of fatigue that in turn will cause a further decrease in
physical fitness.
References
Al-Obaidi SM, Anthony J, Al-Shuwai N & Dean E (2004). Differences in back
extensor strength between smokers and nonsmokers with and without low
back pain. J Orthop Sports Phys Ther 34, 254-260.
Alonso JR, Cardellach F, Lopez S, Casademont J & Miro O (2003). Carbon
monoxide specifically inhibits cytochrome c oxidase of human
mitochondrial respiratory chain. Pharmacol Toxicol 93, 142-146.
Aronow WS & Cassidy J (1975). Effect of carbon monoxide on maximal treadmill
exercise. A study in normal persons. Ann Intern Med 83, 496-499.
Aronow WS, Ferlinz J & Glauser F (1977). Effect of carbon monoxide on exercise
performance in chronic obstructive pulmonary disease. Am J Med 63, 904-
908.
Baecke JA, Burema J & Frijters JE (1982). A short questionnaire for the
measurement of habitual physical activity in epidemiological studies. Am J
Clin Nutr 36, 936-942.
Bernaards CM, Twisk JW, Van Mechelen W, Snel J & Kemper HC (2003). A
longitudinal study on smoking in relationship to fitness and heart rate
response. Med Sci Sports Exerc 35, 793-800.
Smoking history and muscle function
85
Bigland-Ritchie B, Kukulka CG, Lippold OC & Woods JJ (1982). The absence of
neuromuscular transmission failure in sustained maximal voluntary
contractions. J Physiol 330, 265-278.
Cardellach F, Alonso JR, Lopez S, Casademont J & Miro O (2003). Effect of
smoking cessation on mitochondrial respiratory chain function. J Toxicol
Clin Toxicol 41, 223-228.
Corwin EJ, Klein LC & Rickelman K (2002). Predictors of fatigue in healthy young
adults: moderating effects of cigarette smoking and gender. Biol Res Nurs
3, 222-233.
Degens H, Sanchez Horneros JM, Heijdra YF, Dekhuijzen PN & Hopman MT
(2005). Skeletal muscle contractility is preserved in COPD patients with
normal fat-free mass. Acta Physiol Scand 184, 235-242.
Degens H, Sanchez Horneros JM & Hopman MT (2006). Acute hypoxia limits
endurance but does not affect muscle contractile properties. Muscle Nerve
33, 532-537.
Degens H & Veerkamp JH (1994). Changes in oxidative capacity and fatigue
resistance in skeletal muscle. Int J Biochem 26, 871-878.
Gaenzer H, Neumayr G, Marschang P, Sturm W, Kirchmair R & Patsch JR (2001).
Flow-mediated vasodilation of the femoral and brachial artery induced by
exercise in healthy nonsmoking and smoking men. J Am Coll Cardiol 38,
1313-1319.
Gan WQ, Man SF, Postma DS, Camp P & Sin DD (2006). Female smokers beyond
the perimenopausal period are at increased risk of chronic obstructive
pulmonary disease: a systematic review and meta-analysis. Respir Res 7,
52.
Gan WQ, Man SF & Sin DD (2005). The interactions between cigarette smoking
and reduced lung function on systemic inflammation. Chest 127, 558-564.
Hamada T, Sale DG, MacDougall JD & Tarnopolsky MA (2003). Interaction of fibre
type, potentiation and fatigue in human knee extensor muscles. Acta
Physiol Scand 178, 165-173.
Jones DA (1996). High-and low-frequency fatigue revisited. Acta Physiol Scand
156, 265-270.
Klausen K, Andersen C & Nandrup S (1983). Acute effects of cigarette smoking
and inhalation of carbon monoxide during maximal exercise. Eur J Appl
Physiol Occup Physiol 51, 371-379.
Larsson L & Örlander J (1984). Skeletal muscle morphology, metabolism and
function in smokers and non-smokers. A study on smoking-discordant
monozygous twins. Acta Physiol Scand 120, 343-352.
Larsson L, Örlander J, Ansved T & Edstrom L (1988). Effects of chronic nicotine
exposure on contractile enzyme-histochemical and biochemical properties
Chapter 4
86
of fast- and slow-twitch skeletal muscles in the rat. Acta Physiol Scand
134, 519-527.
Montes de Oca M, Loeb E, Torres SH, De Sanctis J, Hernandez N & Talamo C
(2008). Peripheral muscle alterations in non-COPD smokers. Chest 133,
13-18.
Morse CI, Pritchard LJ, Wüst RCI, Jones DA & Degens H (2008). Carbon
monoxide inhalation reduces skeletal muscle fatigue resistance. Acta
Physiol 192, 397-401.
Mündel T & Jones DA (2006). Effect of transdermal nicotine administration on
exercise endurance in men. Exp Physiol 91, 705-713.
Nakatani T, Nakashima T, Kita T & Ishihara A (2003). Effects of exposure to
cigarette smoke at different dose levels on extensor digitorum longus
muscle fibres in Wistar-Kyoto and spontaneously hypertensive rats. Clin
Exp Pharmacol Physiol 30, 671-677.
Narkiewicz K, van de Borne PJ, Hausberg M, Cooley RL, Winniford MD, Davison
DE & Somers VK (1998). Cigarette smoking increases sympathetic outflow
in humans. Circulation 98, 528-534.
Nelson L (2006). Acute cyanide toxicity: mechanisms and manifestations. J Emerg
Nurs 32, S8-11.
Örlander J, Kiessling KH & Larsson L (1979). Skeletal muscle metabolism,
morphology and function in sedentary smokers and nonsmokers. Acta
Physiol Scand 107, 39-46.
Pryor WA, Arbour NC, Upham B & Church DF (1992). The inhibitory effect of
extracts of cigarette tar on electron transport of mitochondria and
submitochondrial particles. Free Radic Biol Med 12, 365-372.
Rietbrock N, Kunkel S, Worner W & Eyer P (1992). Oxygen-dissociation kinetics in
the blood of smokers and non-smokers: interaction between oxygen and
carbon monoxide at the hemoglobin molecule. Naunyn Schmiedebergs
Arch Pharmacol 345, 123-128.
Scott WB, Lee SC, Johnston TE, Binkley J & Binder-Macleod SA (2006).
Contractile properties and the force-frequency relationship of the paralyzed
human quadriceps femoris muscle. Phys Ther 86, 788-799.
Seppanen A (1977). Physical work capacity in relations to carbon monoxide
inhalation and tobacco smoking. Ann Clin Res 9, 269-274.
Shield A & Zhou S (2004). Assessing voluntary muscle activation with the twitch
interpolation technique. Sports Med 34, 253-267.
Stienen GJ, Kiers JL, Bottinelli R & Reggiani C (1996). Myofibrillar ATPase activity
in skinned human skeletal muscle fibres: fibre type and temperature
dependence. J Physiol 493, 299-307.
Smoking history and muscle function
87
Tsuchiya M, Asada A, Kasahara E, Sato EF, Shindo M & Inoue M (2002). Smoking
a single cigarette rapidly reduces combined concentrations of nitrate and
nitrite and concentrations of antioxidants in plasma. Circulation 105, 1155-
1157.
Wüst RCI & Degens H (2007). Factors contributing to muscle wasting and
dysfunction in COPD patients. Int J Chron Obstruct Pulmon Dis 2, 289-
300.

Based on:
Wüst RCI, Gibbings SL & Degens H (2009). Fibre capillary supply related
to fibre size and oxidative capacity in human and rat skeletal muscle.
Advances in Experimental and Medical and Biology 645, 75-80.

Oxidative capacity and capillary supply
91
Abstract
The capillary supply of a muscle fibre is thought to be determined by its type,
oxidative capacity, size and metabolic surrounding. Size and oxidative capacity,
however, differ between fibre types. To investigate which of these factors
determines the capillary supply of a myofibre most we analysed in sections from
human vastus lateralis (n=11) and rat plantaris muscle (n=8) the type, succinate
dehydrogenase (SDH) activity, reflecting oxidative capacity, and capillary supply of
individual fibres. Capillary fibre density differed between fibre types in rat (P<0.03)
but not in human muscle. In human muscle only, the local capillary to fibre ratio
(LCFR) correlated with the integrated SDH-activity (fibre cross-sectional area x
SDH-activity) of a fibre (r=0.62; P<0.001). Backward multiple regression revealed,
however, that the LCFR was primarily determined by fibre size, type (r=0.71,
human) and surrounding of the fibre (r=0.62; rat plantaris muscle), i.e. whether it
came from the deep or superficial region of the muscle (all P<0.001) and not SDH-
activity. In conclusion, size, type and metabolic surrounding rather than
mitochondrial activity determine the capillary supply to a muscle fibre.
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Introduction
Since the pioneering work of Krogh (1919), many scientists have tried to
understand the factors underlying the distribution of capillaries in skeletal muscle
(Hoppeler et al., 1981; Mathieu-Costello et al., 1992; Degens et al., 1994; Ahmed
et al., 1997). Oxidative muscles generally having a denser capillary network than
glycolytic muscles (Saltin & Gollnick, 1983; Egginton, 1990; Degens et al., 1992),
but the capillary density of skeletal muscles varies widely between different
species, muscles and even within a single muscle (Hoppeler et al., 1981). Within
the plantaris muscle for instance the deep, oxidative region has a denser capillary
network than the superficial, glycolytic region (Degens et al., 1992). The capillary
supply to individual muscle fibres is thought to be determined by its oxidative
capacity (Degens et al., 1992; Mathieu-Costello & Hepple, 2002), size (Degens et
al., 1992; Ahmed et al., 1997) and type (Saltin & Gollnick, 1983; Degens et al.,
1992). The main function of the capillaries is often thought to be oxygen supply, but
removal of metabolites and heat and supply of substrates may be a more important
function of the capillary bed. Thus, although all oxidative capacity, size and type of
the fibre have been reported to be related to capillary supply, to what extent the
capillary supply of an individual fibre is determined by each of these factors and
how these relations may vary between human and rat is not systematically
investigated.
Therefore, the primary aim of the present study is to quantify to what extent fibre
type, oxidative capacity, fibre size and metabolic surrounding determine the
capillary supply of an individual fibre, and whether or not these relations are
qualitatively and quantitatively the same in rats and humans. As a measure for the
oxidative capacity of a fibre we used sections stained for succinate dehydrogenase
(SDH)-activity. It has been shown that using our methodology, the staining intensity
of a muscle fibre for this enzyme from the citric acid cycle correlates very well with
the maximum cellular oxygen uptake (Van der Laarse et al., 1989), and hence the
maximum demand for oxygen that has to be supplied by the surrounding
capillaries.
Materials and methods
A more detailed description of the methods applied in this chapter is given in the
appendix.
Rat biopsies
Eight male Wistar rats (11 weeks old) were killed by an intraperitoneal injection of
an overdose of pentobarbital sodium and the plantaris muscles carefully excised,
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slightly stressed to minimise bias related to tortuousity of capillaries, directly frozen
in liquid N2 and stored at -80oC until further analysis.
Human biopsies
Eleven healthy participants (5 men and 6 women, age: 42 ± 18 years) volunteered
to participate in this study. Written informed consent was obtained from each
participant prior to taking the percutaneous biopsy. All procedures were approved
by the local ethics committee of the Manchester Metropolitan University (UK). After
local anesthesia with 2 % lidocaine, a percutaneous biopsy of the vastus lateralis
muscle (at ~50 % of the muscle length) was obtained using a conchotome. The
biopsy was placed on cork, frozen in liquid N2 and stored at -80 oC.
Histochemistry
Transverse 10 µm sections were cut in a cryostat at -20 oC. The sections were
stored at -80 °C until further analysis, unless otherwise stated.
Fibres were classified as type I, IIa, or IIx (IIx/b in rats) based on the pH sensitivity
of their myofibrillar ATPase, using the methods first described by Brooke & Kaiser
(1970); type I myofibrillar ATPase is acid stable and alkaline labile, while type IIa
myofibrillar ATPase is acid labile and alkaline stable with that of IIx/b in between.
The fibres thus appear dark, white and grey after acid pre-incubation, respectively
(Figure 5.1). Sections were pre-incubated for 10 minutes in a buffer containing 0.1
M NaAc and 0.1 M KCl at pH 4.55 set with acetic acid, quickly rinsed in 20 mM
glycin and 20 mM CaCl2 at pH 9.4 (set with NaOH) and subsequently incubated for
25-30 minutes at 37 °C in 40 mM glycin, 20 mM CaCl2 and 2.5 mM ATP at pH 9.4
(set with NaOH). Sections were quickly rinsed with 1 % CaCl2, left in 2 % CoCl2 for
3 minutes, washed with distilled water and coloured in 2 % (NH4)2S and washed in
water.
A serial section was stained for SDH-activity (Van der Laarse et al., 1989;
appendix; Figure 5.1). Succinate dehydrogenase (SDH) is an enzyme in the citric
acid cycle and part of the respiratory chain. It has been shown by our lab that the
calibrated histochemical method described below is linearly related to the
maximum rate of oxygen uptake by the muscle fibre (Van der Laarse et al., 1989).
Immediately after cutting, sections were dried for 15 min and stained for SDH-
activity (Van der Laarse et al., 1989; Pool et al., 1979). Thereto, the sections were
incubated at 37 °C in the dark for 20 min in a medium consisting of 37 mM sodium
phosphate buffer (pH 7.6), 74 mM sodium succinate and 0.4 mM tetranitroblue
tetrazolium (TNBT). The reaction was stopped with a 30 s incubation in 0.01 M HCl
and fixed in 10 % formalin for 20 min. The staining intensity was determined as the
Chapter 5
94
optical density of the final reaction product using an interference filter of 660 nm at
a magnification of x 20 (ImageJ, National Institute of Health, Bethesda, USA) and
was calculated as the absorbance at 660 nm per μm section thickness per second
of staining time (ΔA660 μm-1 s-1).
Figure 5.1. Example of a plantaris muscle of the Wistar rat. On the left, the section
is stained for SDH-activity (see text), while the right serial section was stained for
acid myofibrillar ATPase (pH=4.55). The dark fibres on the right are classified as
type I, while the white fibres are classified as type IIa and the grey fibres as type
IIx/b. One can observe that the type I and IIa fibres have, as expected, a higher
SDH-activity. Note that on the right hand corner of the muscle, a small part of the
gastrocnemius muscle is still visible.
Another serial section were stained with alkaline phosphatase (rat; Degens et al.,
1992) or lectin (human; Ahmed et al., 1997) to depict capillaries. In short, rat
sections were fixed in chloroform-aceton (1:1; 4 °C), quickly rinsed in distilled water
and subsequently stained for 1 h in 0.01 % nitro blue tetrazolium (NBT) and 0.002
% 5-bromo-4-chloro-3-indolyl phosphate p-toluidine salt in 6.9 mmol MgSO4.7H2O
and 27.5 mmol Na2B4O7.10H2O buffer adjusted to pH 9.2 with boric acid. After
quickly rinsing the sections in distilled water and a postfixation in 10 % formalin (4
% formaldehyde), slides were mounted in gelatin-glycerol.
Human sections were fixed in acetone (4 °C), kept in HEPES for 15 minutes,
incubated in PBS containing 0.9 % 30 % H2O2 for 30 minutes to reduce
background staining and subsequently incubated with lectin (Ulex Europeus) in
HEPES with 1 % BSA (2000 μg/ml). The capillaries were visualised using a
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Vectastain ABC and DAB substrate kit (Vector Laboratories, Peterborough, UK)
before mounting in gelatin-glycerol.
Determination of capillarisation
The capillarisation was analyzed with the method of capillary domains (Hoofd et
al., 1985; Degens et al., 1992; appendix). In short, domains were constructed
around capillaries, defined as the area surrounded by a capillary delineated by
equidistant boundaries from adjacent capillaries. The fibre cross-sectional area
(FCSA) was determined by tracing the outlines of the fibres on the digitizing tablet.
The capillary supply to a fibre was given as the local capillary to fibre ratio (LCFR),
calculated as the sum of the fractions of the capillary domains overlapping a given
fibre.
Statistics
A 3x3 ANOVA was performed with as factors fibre type and muscle origin using
SPSS (SPSS Inc., Chicago, IL, USA). If interactions were found, a repeated
measures ANOVA (with Bonferroni post-hoc tests) was done to detect differences
between fibre types within a muscle or muscle region, and an ANOVA (with
Bonferroni post-hoc tests) for muscle origin was done to detect whether a certain
fibre type differed between human and rat deep or superficial region. To test which
factor predicted the capillary supply of the muscle most, backwards multiple
regression analysis was performed. Correlations and differences were considered
significant at P≤0.05. Data are presented as mean ± SD.
Results
Per animal/human, 45 ± 7 fibres were analysed for the deep plantaris region, 70 ±
18 fibres for the superficial plantaris and 40 ± 10 fibres for the human quadriceps.
The results from fibre size, capillary supply and oxidative capacity are given in
Table 5.1. The overall capillary to fibre ratio (C/F) and capillary density (CD) are
shown in Table 5.1 under ‘Total’. In line with previous observations (Bekedam et
al., 2003) we found a significant correlation between the LCFR and SDH x FCSA in
human (r=0.62; P<0.001), but not in rat muscle. However, backward multiple
regression revealed that the local capillary to fibre ratio was not determined by
SDH-activity, but determined by fibre size and type in the human vastus lateralis
muscle (r=0.71) and also surrounding of the fibre (r=0.62; rat plantaris muscle); i.e.
whether it came from the deep or superficial region of the muscle (all P<0.001).
Figure 5.2A shows the positive correlation between LCFR and FCSA for each
muscle.
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Table 5.1. Indices of fibre size and capillary supply in the human vastus lateralis
(VL) and the deep and superficial region of the plantaris muscle of male Wistar
rats.
Area %
FCSA
(µm2)
LCFR
CFD
(mm-2)
SDH-activity
(ΔA660 μm-1 s-1)
Human VL
I 52.2 ±
5.4#+†
4068 ± 1300
#+
1.51 ± 0.68
+†
362 ±
145 #
1.64 ± 0.12
x 10-5 +†
IIa 45.3 ±
5.3 #+†
3754 ± 1555
#+
1.33 ± 0.70
+
325 ±
138 #
1.34 ± 0.22
x 10-5 +†
IIx 2.5 ±
1.9 #+
3669 ± 1382 0.90 ± 0.69
#
254 ±
105 #
1.28 ± 0.12
x 10-5 +
Total
(n=426)
3897 ± 1387
#
1.33 ± 0.67 349 ±
140 #
1.42 ± 0.10
x 10-5 #
Rat plantaris, deep region
I 8.8 ±
4.7 +Δ†
1694 ± 218 † 1.28 ± 0.35
+†
765 ±
245 +Δ†
1.26 ± 0.55
x 10-5 +†
IIa 24.3 ±
5.3 †
1998 ± 452 † 1.24 ± 0.25
†
640 ±
148 +†
1.57 ± 0.69
x 10-5 +†
IIx/b 66.8 ±
8.3
3116 ± 641 1.81 ± 0.37 613 ±
174 +
0.87 ± 0.49
x 10-5 +
Total
(n=571)
2581 ± 523 + 1.55 ± 0.31
+
638 ±
170 +
1.14 ± 0.49
x 10-5 +
Rat plantaris, superficial region
I (n=5) 0.8 ±
1.0 Δ†
1271 ± 266 † 0.56 ± 0.26
+†
494 ±
268 †
1.04 ± 0.49
x 10-5 †
IIa 14.4 ±
20.0 †
2174 ± 1103
†
0.76 ± 0.33
†
395 ±
119
0.88 ± 0.48
x 10-5 †
IIx/b 83.8 ±
20.2
3605 ± 739 1.09 ± 0.23 329 ± 58 0.50 ± 0.38
x 10-5
Total
(n=347)
3453 ± 449 1.07 ± 0.16 334 ± 55 0.50 ± 0.23
x 10-5
VL: vastus lateralis; FCSA: fibre cross-sectional area; LCFR: local capillary to fibre ratio;
CFD: capillary fibre density. #: significantly different from rat plantaris deep region at
P<0.02; +: significantly different from rat plantaris superficial region at P<0.02; Δ: different
from type IIa of same origin at P<0.05; †: different from type IIx (or IIx/b) of same origin at
P<0.05.
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Figure 5.2. Relationships between (A) FCSA and LCFR for rat deep region, rat
superficial region and human vastus lateralis, (B) SDH-activity and LCFR and (C)
SDH-activity and CFD for the deep region only. SDH-activity between two
capillaries are shown in D-F (D: type I, E: type IIa, F: type IIx (IIx/b)).
There was even a negative relation within fibre types between LCFR and capillary
fibre density (CFD=LCFR/FCSA) with SDH-activity of a fibre, as shown in Figure
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5.2B and C for the deep region of the rat plantaris muscle. However, if we
controlled for FCSA and fibre type, the correlations between SDH-activity and
capillarisation disappeared (r<0.1, NS). As mitochondria are not homogenously
distributed within a muscle cell we plotted the mitochondrial distribution against the
fraction of the intercapillary distance, where capillaries were located at opposite
sites of the muscle cell. The mitochondrial density was highest in close proximity of
the capillaries (subsarcolemmal mitochondria) and exhibited a steep decline to the
centre of the myofibre (interfibrillar mitochondria) in the oxidative type I and IIa
fibres. Furthermore, the profile of the mitochondrial density was flatter in glycolytic
type IIx/b than in the more oxidative type I and IIa fibres (Figure 5.2 D-F). Where in
human muscle type IIx fibres have a higher LCFR than type I and IIa fibres, the
opposite was found in rat muscle. This apparent discrepancy is largely related to
fibre size (Table 5.1). To take this into account we also determined the CFD for
each fibre type and it appeared that type I fibres had a higher CFD than type IIx/b
fibres in both the deep and superficial region of the rat plantaris muscle (Table 5.1),
but not in human muscle.
Table 5.1 and Figure 5.1A show that the relation between LCFR and FCSA is not
fixed, but differs between human and rat muscle and also between the deep and
superficial region of the rat plantaris muscle. In terms of CFD, the capillary supply
to a fibre is highest in the deep region of the plantaris muscle and no significant
difference was observed between the CFD of fibres from the human vastus
lateralis muscle and the superficial region of the rat muscle, even though the SDH-
activity of the human fibres was higher.
Discussion
The main observation of the present study is that in both human and rat muscle the
capillary supply to a fibre is primarily determined by its type and size, while the
oxidative capacity plays no significant role.
Many studies have shown a significant relation between capillarisation and
oxidative capacity in muscle tissue (Saltin & Gollnick, 1983). Also the capillary
supply to individual fibres has been reported to be related to mitochondrial volume
or integrated SDH-activity, in hummingbirds (Mathieu-Costello et al., 1992) and
humans (Bekedam et al., 2003). As there is a hyperbolic relationship between fibre
size and SDH-activity (Van der Laarse et al., 1998), correlations between capillary
supply and oxidative capacity may be confounded by fibre size. Indeed, it has been
observed in both rat (Degens et al., 1994) and human muscle (Ahmed et al., 1997)
that size is an important determinant of capillary supply to a fibre. Here we took
into account both fibre size and SDH-activity and found that not SDH-activity, but
fibre size was an important determinant of capillary supply to a fibre in both rat and
human muscle (Figure 5.1A). Moreover, in rat muscle (integrated) SDH-activity did
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not correlate significantly with capillary supply to a fibre. Thus, taking into account
both fibre size and oxidative capacity it appeared that size, rather than oxidative
capacity is a significant predictor of the local capillary to fibre ratio.
Although Ahmed et al. (Ahmed et al., 1997) suggested that there was no effect of
fibre type we did observe with backward regression that also the type of the fibre
had an impact on the capillary supply of a fibre. Nevertheless, in line with what we
found they observed that the average LCFR was type I > IIa > IIx/b. The effect of
type is, however, rather small, as both Ahmed et al. (1997) and we observed that
the CFD, which takes into account the size of the fibre, was similar in each fibre
type. In the rat plantaris muscle, on the other hand, the CFD of type IIx/b fibres was
lower than that of type I and IIa fibres, but this difference was not explicable by
differences in SDH-activity between fibre types as revealed with backward
regression for type and SDH-activity. Even the spatially integrated SDH-activity, as
a measure for the total demand for O2 of the myofibre (Bekedam et al., 2003), did
not significantly correlate with the capillary supply to a fibre in the rat plantaris
muscle.
As the mitochondria ultimately consume O2 one would have expected that the
oxidative capacity is the main determinant of the capillary supply to a fibre. It
should be noted, however, that mitochondria are not homogenously distributed
within the fibre, where the density is highest at the sarcolemma, decreasing steeply
to the interior of the cell (Hoppeler et al., 1981). Here, we confirm that observation
and show that the density distribution shows a flatter profile in human than rat
fibres and in type IIx/b than type I and IIa fibres. Such a profile would considerably
shorten the diffusion distance to the majority of the mitochondria, and hence result
in an adequate O2 supply to the mitochondria. This would, at least partly, explain
why there is no significant relation between the oxidative capacity of a fibre and its
capillary supply.
Finally, in line with previous observations (Degens et al., 1992) we observed that
the capillary supply to a fibre is modulated by the metabolic surrounding of the
fibre. This is reflected by the different slope of the FCSA-LCFR relation and the
lower CFD for each fibre type in the superficial than the deep region of the muscle.
In conclusion, in both rat and human muscle size and type rather than
mitochondrial activity is the primary determinant of capillary supply to a muscle
fibre.
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Abstract
We investigated whether the lower fatigue resistance in smokers than non-smokers
is caused by a compromised muscle oxidative metabolism. Using calibrated
histochemistry, we found no differences in succinate dehydrogenase (SDH)-
activity, myoglobin concentration and capillarisation in sections of the vastus
lateralis muscle of five smokers and five non-smokers. The relationship between
fatigue resistance and SDH-activity in non-smokers (r=0.93, P=0.02) is absent in
smokers. This indicates that the lower muscle fatigue resistance of smokers is
likely due to other causes than differences in oxidative metabolism and local
capillarisation.
Chapter 6
104
Introduction
Chronic obstructive pulmonary disease (COPD) is associated with a reduced
exercise tolerance and, in general, reduced muscle fatigue resistance (Gosselink &
Decramer, 1998; Chapter 1). The main determinants of skeletal muscle fatigue
resistance are: oxygen delivery to the muscle, oxygen transport from interstitial
space to the core of the muscle fibres, fibre type composition and the oxidative
capacity (Degens & Veerkamp, 1994), which is proportional to succinate
dehydrogenase (SDH) activity (Van der Laarse et al., 1989). The oxygenation of
muscle tissue is largely dependent on capillary density (Hoofd et al., 1985),
myoglobin concentration (Richardson et al., 2001) and fibre cross-sectional area
(Hill, 1965). In patients with COPD, muscle fibre atrophy and a reduction in
capillarisation and oxidative capacity all negatively affect muscle fatigue resistance
(Maltais et al., 1996; Jobin et al., 1998; Green et al., 2008; Chapter 1). As cigarette
smoking is associated with over 80 % of the COPD cases (Yawn & Kaplan, 2008),
smoking may be an important factor in the muscle adaptations that compromise
the strength and fatigue resistance of COPD patients; skeletal muscle fatigue
resistance is already lower in young, healthy smokers than age- and physical
activity-matched non-smokers (Chapter 3). Although inhaled carbon monoxide
(CO), a constituent of cigarette smoke, that reached 6 % carboxyhemoglobin
(COHb) resulted in a 8 % reduction in the fatigue resistance of non-smoking
subjects (Morse et al., 2008), it is not clear whether this is the sole explanation.
Given the determinants of skeletal muscle fatigue resistance described above, we
hypothesised that in skeletal muscle mitochondrial volume density, capillary
density and/or myoglobin concentration would be lower in smokers, and/or that the
proportion of fast muscle fibres would be higher in the skeletal muscle of smokers
than of non-smokers.
Methods
A more detailed description of the methods applied in this chapter are given in the
appendix.
Participants
Five non-smokers (2 men and 3 women) and 5 smokers (2 men and 3 women)
participated in this study. Exclusion criteria were known cardiovascular,
neuromuscular or respiratory diseases. Written informed consent was obtained
from each participant prior to testing. All procedures were approved by the local
ethics committee of the Manchester Metropolitan University (UK). The age of the
non-smokers (range: 23-72 years, median: 45 years) and smokers (range: 25-72
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years, median: 40 years) was similar. The smokers smoked on average 15 ± 9
cigarettes d-1, while the non-smokers never smoked. Mean cigarette pack years
(packs smoked d-1 x the number of years of smoking) was 12.9 (range: 2.6-35.0,
median: 9.9) pack years. The physical activity score of the subjects assessed by
questionnaire (Baecke et al., 1982), was 8.1 ± 1.3 and 7.1 ± 1.2 for the non-
smokers and smokers, respectively (P=0.20). A physical activity score of < 6
indicates a sedentary lifestyle, whereas scores > 9 represent a high level of
activity.
Maximal strength, fatigue resistance and anatomical cross-sectional area
Maximal strength of the quadriceps muscle was determined as the highest value
during a maximal voluntary contraction at optimal knee angle (for more details, see
Chapter 2, 3 and 4). Fatigue resistance of the quadriceps muscle was assessed
using electrical stimulation (1 s on 1 s off, 30 Hz, 2 min; constant stimulus intensity
corresponding to 22 ± 4 % of maximal strength in the non fatigue state).
Anatomical cross sectional area (ACSA) was measured at 50 % of femur length
with magnetic resonance imaging (MRI). The procedures are detailed in chapter 2,
3 and 4 and in the appendix.
Skeletal muscle biopsy
A percutaneous biopsy of the vastus lateralis muscle was obtained from each
participant using a conchotome. The site of the biopsy was anesthetised with 2 %
lidocaine and a 1-cm incision was made at ~20 cm above the patella. The biopsy
was frozen in liquid nitrogen and stored at -80 oC.
Enzyme histochemistry
Transverse 10 µm sections were cut in a cryostat at -20 oC. Sections were stained
for myofibrillar adenosine triphosphatase (mATPase), after pre-incubation at pH
4.7, to classify fibres as type I or type II (Brooke & Kaiser, 1970, Chapter 5). Serial
sections were incubated for myoglobin concentration (Van Beek-Harmsen et al.,
2004) and SDH-activity (Bekedam et al., 2003, appendix), which is proportional to
the maximum rate of oxygen consumption when oxygen is not rate-limiting (Van
der Laarse et al., 1989). SDH-activity is given as the absorbance increase at 660
nm per micrometer section thickness per second incubation time (ΔA660 μm-1 s-1).
The myoglobin concentration in individual muscle fibres was determined as
described previously (Van Beek-Harmsen et al., 2004). Frozen sections were
defrosted in vacuum to avoid condensation and consequent redistribution of
myoglobin. Sections were then vapour-fixed for 1 h in paraformaldehyde at 70°C.
Subsequently, the sections were fixed for 10 min at room temperature in 2.5 %
glutaraldehyde in 0.07 M sodium phosphate buffer (pH=7.4) and quickly rinsed with
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distilled water. To detect myoglobin sections were incubated for 1 h at room
temperature in a medium containing 59 ml 50 mM TRIS/80 mM KCl buffer
(pH=8.0), 25 mg ortho-toluidine dissolved in 2 ml 96 % ethanol (at ~50 °C) and
1.43 ml 70 % tertiary-butyl-hydroperoxide. Sections were then washed with distilled
water, mounted and scanned on a calibrated DMRB microscope (Leica, Wetzlar,
Germany) with an interference filter of 436 nm. A 3rd order calibration line was
obtained before scanning each section using grey filters with a known absorbance.
The red blood cells in the capillaries contain haemoglobin which was visible as
dark spots at the edges of the muscle fibres. The myoglobin concentration was,
however, homogeneously distributed within the cell and therefore the mean optical
density was obtained from the centre of each fibre. After subtracting the optical
density of the background (a part of the section that did not contain myoglobin),
optical density values were converted to absorbance values. Using a calibration
line, obtained from absorbance values from 10 µm sections cut from a gelatin block
containing 0.1, 0.2, 0.3 and 0.4 mM myoglobin, absorbance values were converted
into concentrations (Van Beek-Harmsen et al., 2004).
Capillarisation
Another serial section was stained with lectin to depict capillaries (Ahmed et al.,
1997, appendix). Capillarisation was analysed with the method of capillary domains
described by Degens et al. (1992). This method gives not only the overall indices
of capillary density and capillary to fibre (C/F) ratio, it also takes into account the
presence of different fibre types and the heterogeneity in capillary spacing
(standard deviation of the log-transformed radius of the capillary domain
(LogRSD)). Domains were defined as the area surrounded by a capillary delineated
by equidistant boundaries from adjacent capillaries. The fibre cross-sectional area
(FCSA) was determined by tracing the outlines of the fibres on a digitizing tablet
(Model MMII 1201, Summagraphics Digitizers, Austin, Tex, USA). The capillary
supply to a fibre was given as the local fibre to capillary ratio (LFCR), calculated as
the sum of the fractions of the capillary domains overlapping a given fibre. The
capillary fibre density (CFD in mm-2) was calculated as the LCFR/FCSA.
Statistical analysis
We used multilevel analyses to evaluate differences between smokers and non-
smokers (MLwiN version 2.0, Bristol, UK). This method incorporates nominal
variables (Twisk, 2006), as well as variance at the level of the cell and the
individual. Slow and fast fibres were analysed separately and gender, age and
physical activity were included as covariates. Significance level was set at P<0.05.
Unless otherwise stated, values are given as means ± standard error of the mean
(SEM).
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Results
The correlation coefficient between the physical activity score and the fibre-type
weighted mean SDH-activity was 0.87 for non-smokers (P=0.06) and 0.88 for
smokers (P=0.01). All participants had a normal respiratory function (data not
shown).
Maximal strength and fatigue resistance
Maximal torque and ACSA were not different in non-smokers and smokers, with
201 ± 24 vs. 203 ± 35 Nm (P=0.96) and 61 ± 4 vs. 54 ± 6 cm2 (P=0.32) for torque
and ACSA respectively. Fatigue resistance, however, was significantly reduced by
smoking: torque dropped to 77.4 ± 4.5 vs. 61.4 ± 4.5 % of initial value in non-
smokers and smokers, respectively (P<0.05). The correlation coefficient between
physical activity levels and fatigue index was 0.83 (P=0.08) and -0.88 (P=0.05) for
the non-smokers and smokers, respectively. No significant relationship was
observed between cigarette smoking history and the fatigue index: correlation
coefficients were 0.73, -0.32 and 0.45 for cigarettes d-1, years of smoking and
cigarette pack years, respectively.
Muscle biopsies
On average 160 (SD: 45) fibres were analysed for each subject. Figure 1 shows
examples of mATPase staining (Figure 6.1A), capillaries (Figure 6.1B), SDH-
activity (Figure 6.1C) and myoglobin concentration (Figure 6.1D). The fibre type
composition was similar in smokers and non-smokers, with 55 ± 4 vs. 59 ± 11 %
and 45 ± 4 vs. 41 ± 11 % for type I and II, respectively. Although no differences
were observed in ACSA, mean FCSA was 25 % lower in smokers than in non-
smokers (P=0.001; Figure 6.1E). Although ~50% lower in the smokers,
capillarisation in terms of LCFR for both fibre types and overall C/F ratio did not
differ between smokers and non-smokers, with 1.07 ± 0.23 vs. 1.53 ± 0.35 for
smokers and non-smokers, respectively (Figure 6.1F), but was higher in type I than
type II fibres (P<0.001). The CFD, however, was similar for type I and type II fibres
and did not differ between smokers and non-smokers (365 ± 69 vs. 354 ± 95 for
type I and 344 ± 63 vs. 289 ± 109 for type II fibres in non-smokers and smokers,
respectively). Similarly, the overall capillary density did not differ significantly
between smokers and non-smokers (314 ± 72 vs. 333 ± 60 mm-2). The logRSD was
also similar in both groups: 0.098 ± 0.009 vs. 0.108 ± 0.016 for non-smokers and
smokers, respectively. SDH-activity was higher in type I than type II fibres
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Figure 6.1. Serial cross-sections of a representative sample and results of fibre
types and fibre cross-sectional area (A + E), capillary staining and local capillary to
fibre ratio or capillary to fibre ratio (for ‘total’; B + F), calibrated succinate
dehydrogenase (SDH)-activity (C + G) and myoglobin concentration (D + H). The
white bars represent the non-smokers and the grey bars represent the smokers.
Total is the weighted average of the type I and II cells. Bars in photomicrographs
indicate 100µm and * indicate the same fibre. In A, black is type I, white is type IIa
and grey is type IIx. Values are mean (SEM). In E-H, # and * denote statistical
differences between type I and II and between smokers and non-smokers
respectively.
(P<0.001). However, the SDH-activity (Figure 6.1G) and FCSA x SDH-activity
(spatially integrated SDH-activity) of each fibre type were similar in the two groups,
indicating a similar total oxidative capacity of the muscle cells in smokers and non-
smokers. The myoglobin concentration was higher in type I than type II cells
(P<0.001), but was not significantly altered by smoking (Figure 6.1H).
Figure 6.2. Effects of smoking on the relation between succinate dehydrogenase
(SDH)-activity and fatigue index. The fatigue index is the torque at the end of the
fatigue resistance test, expressed as a percentage of the initial torque. A linear
relationship between SDH-activity and fatigue resistance was found for the non-
smokers (P=0.02), but was absent in the smokers (P=0.21).
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Interestingly, the correlation coefficients of the fatigue resistance and overall SDH-
activity was 0.93 (P=0.02) in controls, but was not significant in smokers (r=-0.67;
P=0.21; Figure 6.2). The slope of the relationship between SDH-activity and fatigue
resistance was significantly different between smokers and non-smokers: 3.56 ±
0.8 x 106 vs. -2.43 ± 1.52 x 106 % s µm A660-1 for non-smokers and smokers
respectively (P=0.01).
The correlation of the percentage of type I fibres and the fatigue resistance in the
non-smokers was 0.97 (P=0.01), while it was not significant in the smokers (r =-
0.60, P=0.28).
No significant relationships were observed between the capillarisation or myoglobin
concentration and fatigue resistance in either group. Neither were any parameters
(percentage type I, SDH-activity, capillarisation, myoglobin) related to smoking
history in terms of cigarettes smoked per day or cigarette pack years (data not
shown).
Discussion
The main observation of this study is that the lower fatigue resistance in smokers
compared with non-smokers (Chapter 3) is not related to differences in fibre type
composition, oxidative capacity, myoglobin concentration or capillarisation. The
correlation between SDH-activity and fatigue resistance in non-smokers was lost in
smokers. These data suggest that the reduced fatigue resistance in smokers is not
due to alterations in determinants of oxidative metabolism, but may be related to
factors in cigarette smoke that affect the delivery of oxygen and the function of the
respiratory chain.
We took special care to match the physical activity level of the non-smokers and
smokers. This is important as there is a positive correlation between physical
activity and SDH-activity (Den Hoed et al., 2008), which we also observed in our
data (r=0.83). The absence of a significant relationship between myoglobin
concentration or capillary density and fatigue resistance in the vastus lateralis
muscle of smokers and non-smokers suggests that these parameters are not
determinants of the fatigue resistance elicited by our protocol using electrical
stimulation. Interestingly, the SDH-activity did not correlate with fatigue resistance
in smokers (Figure 6.2).
Because of the small sample size there is a risk for false negative effects. We
minimised this risk by selecting subjects for age, gender and physical activity level,
and by using multilevel analysis. In addition, power analysis revealed that for a
power of 0.8 for most of the parameters, except for LCFR, more than 50 subjects
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were required to reach significance for non-significant differences in figure 6.1,
indicating that the differences between the means of these parameters are small
anyway, and unlikely to explain the difference in fatigue resistance.
Cigarette smoking has been associated with an enhanced expression of factors
involved in muscle protein degradation (Petersen et al., 2007) and type I fibre
atrophy (Montes de Oca et al., 2008). Although the decline in ACSA was not
significant, we observed that the FCSA of both type I and type II fibres in smokers
was significantly smaller than in non-smokers. This reduction in FCSA would result
in reduced oxygen diffusion distances from the periphery to the centre of the fibre
(Hill, 1965) which may delay the development of fatigue. Reduced FCSA is
associated with a lower minimal interstitial oxygen tension, which prevents an
anoxic core in maximally working fibres (PO2crit), calculated with Hill’s oxygen
diffusion model, including myoglobin-facilitated oxygen diffusion (for details, see
Van Beek-Harmsen et al. 2004) in the type I and type II fibres in smokers than non-
smokers, with 9.1 ± 1.8 vs. 6.8 ± 3.4 mm Hg in type I and 6.6 ± 1.7 vs. 4.3 ± 2.6
mm Hg in type II for non-smokers and smokers respectively. Despite this (non-
significant) 25 to 34 % reduction in PO2crit at the level of the muscle fibre, overall
fatigue resistance was lower in the smokers.
Taken together, the results of this study suggest that other factors determining
oxygen supply and/or the ability to utilise oxygen are affected by smoking and limit
muscle performance in smokers. A diminished oxygen supply may also occur when
COHb is formed; the inhalation of CO until COHb reached 6% caused an 8%
reduction in fatigue resistance (Morse et al., 2008). Because the PO2crit is reduced
and the mean blood COHb level in smokers is reported to vary from 4 – 5 %
(Hampson et al., 2006), less than half of the difference in the fatigue index between
smokers and non-smokers can be explained by this effect of CO. However, CO
also causes a left-shift of the HbO2 dissociation curve, hampering the release of
oxygen, and it impairs the facilitated transport of oxygen within the muscle cell by
binding to myoglobin (Gorman et al., 2003). Finally, CO inhibits the function of
complex IV of the electron transport chain (Alonso et al., 2003). A combination of
these factors attenuates not only delivery but also utilisation of oxygen. The
delivery of oxygen may further be hampered by an impaired peripheral blood flow
in smokers (Ronnemaa et al., 1999), due to endothelial dysfunction through
oxidative stress and the reduced bioavailability of nitric oxide (Ambrose & Barua,
2004; Montes de Oca et al., 2008). The nature and relative contribution of each of
these factors in determining smoking-related fatigue warrant further investigation.
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We conclude that while muscle fibre size was smaller in the smokers, fibre type
distribution, capillarisation and SDH-activity of the muscle are similar in physical
activity-matched smokers and non-smokers. We suggest that the main cause of
increased peripheral fatigue may be impaired oxygen delivery and/or utilisation by
the muscle through acute effects of smoking, such as those conveyed by CO in
cigarette smoke.
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Abstract
Chronic exposure to hypoxia is generally associated with muscle atrophy (i.e.
reduction in muscle fibre cross-sectional area), reduced oxidative capacity and
capillary growth. As some controversy still exists in the literature to what extend
these changes are muscle and fibre type specific, we hypothesize that different
regions of the same muscle would also respond differently to severe chronic
hypoxia. To investigate this we compared the deep (oxidative) and superficial
(glycolytic) region of the plantaris muscle of 8 male rats exposed to 4 weeks
hypobaric hypoxia (410 mm Hg) with those of 9 normoxic rats. The haematocrit
was higher in chronic hypoxic than control rats (59 vs. 50 %; P<0.001). Using
histochemistry, we observed a 10 % fibre atrophy (P<0.05) in both regions of the
muscle, but no shift in fibre type composition and myoglobin concentration of the
fibres. In hypoxic rats, the succinate dehydrogenase (SDH)-activity was elevated in
fibres of each type in the superficial (25 %, P<0.05), but not in the deep region,
while in the deep, but not the superficial region, the number of capillaries supplying
a fibre was elevated (14 %, P<0.05). Model calculations showed that the region-
specific alterations in fibre size, SDH-activity and capillary supply to a fibre
prevented the occurrence of anoxic areas in the deep region, but not in the
superficial region. We conclude that the determinants of tissue oxygenation show
region specific adaptations, resulting in a marked differential effect on tissue
oxygen tension.
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Introduction
Chronic hypoxia has been suggested to be one of the factors that contribute to
changes in muscle structure and function in patients suffering from several cardio-
respiratory diseases such as chronic obstructive pulmonary disease, severe
pneumonia and heart failure (Serres et al., 1998; Gosker et al., 2000; Raguso et
al., 2004; Chapter 1). Oxygen is crucial for aerobic energy metabolism and even a
brief reduction in oxygen supply due to hypoxia leads to an acutely diminished
muscle performance (Hogan et al., 1999; Degens et al., 2006b; Romer et al.,
2007). During long-term exposure, skeletal muscle adapts to the reduced oxygen
tension by marked changes in skeletal muscle fibre size and cellular metabolism
(Green et al., 1989a; Ferretti et al., 1990; Hoppeler & Vogt, 2001; Mathieu-
Costello, 2001; Yun et al., 2005).
An increase in capillary density in rat muscle after 6 weeks of exposure to 12%
oxygen (Deveci et al., 2001, 2002) may serve to facilitate oxygen supply to the
muscle cells by reducing the diffusion distances of oxygen in the muscle tissue. A
further improvement of the oxygen supply to the mitochondria might be realized by
an increase in the myoglobin concentration that would enhance facilitation of intra-
cellular diffusion of oxygen (Scholander, 1960). This response is realised by
angiogenesis (Deveci et al., 2001, 2002) and/or a decrease in fibre cross-sectional
area (FCSA, Banchero, 1987; Ferretti et al., 1990; Bigard et al., 1991). These
results, however, are not consistent as an unaltered FCSA (Snyder et al., 1985;
Deveci et al., 2002), capillarisation (Sillau, 1980; Abdelmalki et al., 1996) and/or
myoglobin concentration (Sillau & Banchero, 1977) in response to chronic hypoxia
have also been reported.
A factor that is often overlooked, but may have a major impact on the tissue
oxygenation is the distribution of the capillaries: a more homogeneous distribution
of capillaries might enhance tissue oxygenation, while a strong heterogeneous
distribution of capillaries may result in anoxic areas (Piiper & Scheid, 1991; Degens
et al., 2006a; Goldman et al., 2006). Differences between and within muscles have
been observed, where capillaries in oxidative muscles and muscle regions are less
heterogeneously distributed than glycolytic areas and muscles (Egginton et al.,
1988; Degens et al., 1992). Hypoxia may result in a more homogeneously
distributed capillary network, enhancing the tissue oxygenation.
Besides adaptations in capillarisation, chronic hypoxia might also affect energy
metabolism. In both human and rat muscle a decreased oxidative capacity has
been reported and is accompanied by an increased glycolytic capacity (Green et
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al., 1989b; Hoppeler et al., 1990; Howald et al., 1990; MacDougall et al., 1991;
Abdelmalki et al., 1996; De Palma et al., 2007). Others, however, report that the
oxidative capacity is unchanged (Leon-Velarde et al., 1993) or even increased after
exposure to hypoxia (Gimenez et al., 1977; Hochachka et al., 1983).
It is clear that different adaptations to chronic hypoxia are reported in the literature.
The observation that adaptations to hypoxia are muscle-specific and even specific
to the region within a muscle could explain these discrepancies (Sillau & Banchero,
1977; Snyder et al., 1985; Deveci et al., 2001; Faucher et al., 2005; Esteva et al.,
2008; Panisello et al., 2008). Part of the controversy might be related to the
duration and severity of exposure to normobaric or hypobaric hypoxia, the addition
of a training programme to the exposure to hypoxia and/or the study of different
muscles. Indeed, it has been reported that slow and fast muscles respond
differently to chronic exposure of hypoxia (Deveci et al., 2001; Faucher et al.,
2005), but also to chronic stimulation (Badr et al., 2003) or disuse (Stevens et al.,
2000). Even within one muscle with a non-uniform fibre type distribution, the
capillary adaptation to hypoxia seems to depend on the region of the muscle,
where the hypoxia-induced angiogenesis was greater in muscles with a overall
higher oxidative capacity and regions within a muscle with a lower oxidative
capacity (Deveci et al., 2001).
To date, most studies have focussed only on one aspect of adaptation of skeletal
muscle to hypoxia, such as alterations in either oxidative capacity (Howald et al.,
1990), capillarisation (Deveci et al., 2001; Mathieu-Costello, 2001; Deveci et al.,
2002), fibre type composition (Bigard et al., 1991) or myoglobin concentration
(Reynafarje, 1962). Of course the overall ability to utilize oxygen of the muscle cell
depends on the interplay between capillary supply, myoglobin concentration and
oxidative capacity and while there may be no adaptation in one factor, the muscle
may still adapt to ensure adequate tissue oxygenation by alterations in other
factors. To investigate whether adaptations to chronic hypoxia were fibre type-
and/or region-specific we used the rat plantaris muscle that contains distinct
oxidative and glycolytic regions. Rats were exposed for 4 weeks to chronic
hypobaric hypoxia (equivalent to an altitude of ~5000 m). We used an integrative
approach to assess the skeletal muscle fibre adaptations to chronic hypoxia by
determining changes in fibre type, size, capillary supply, oxidative capacity and
myoglobin concentration in individual muscle cells in serial histological sections.
We hypothesised that (a) overall there is atrophy and a decrease in oxidative
capacity, (b) in the superficial region of the muscle angiogenesis is more
pronounced than in the deep region and (c) that these adaptations prevent the
occurrence of anoxic areas during hypoxia in both regions of the muscle. To
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address the latter hypothesis and to obtain an indication whether possible
adaptations are sufficient to prevent anoxic tissue areas, we used a Krogh (Krogh,
1919; Hoofd, 1995) and a Hill model (Hill, 1965; Des Tombe et al., 2002) to
calculate the critical capillary and interstitial oxygen tensions required to prevent
anoxic core at the muscle fibre’s maximal oxygen consumption ( V O2max).
Methods
A more detailed description of the methods applied in this chapter are given in the
appendix.
Animals
Seventeen male Wistar rats, aged 8 weeks at the start of the study, were used.
The experimental rats (n=8) were housed in a hypobaric hypoxic chamber at a
barometric pressure of 410 mm Hg and 20.9 % O2 (equivalent to ~5000 m altitude).
The normobaric rats (n=9) lived in the same room, but at ambient pressure (~760
mm Hg). All rats were kept at room temperature and a 12 h light-dark cycle. Food
and water were given ad libitum and the cage was opened for cleaning maximal
half an hour every week. After 4 weeks exposure to hypobaric hypoxia or the
normobaric condition, the rats were anaesthetised by intraperitoneal injection of
pentobarbital sodium (70 mg kg-1) and the plantaris muscle was dissected from the
surrounded tissue blotted dry and weighed. Then the muscle was pinned on cork in
a slightly stretched condition to minimise any bias in the determination of fibre
cross-sectional area and capillary parameters, related to differences in muscle
length, quickly frozen in liquid nitrogen and stored at -80 °C until further analysis.
All protocols and procedures were approved by the University of Nijmegen
institutional animal care and use committee.
Haematocrit
The haematocrit was determined in blood samples taken from the right orbita.
Myosin heavy chain composition
To determine the myosin heavy chain (MyHC) composition (type I, IIA, IIX and IIB)
of the plantaris muscle we used a modification of the SDS-PAGE method used
previously (Degens et al., 1998). In short, a 10 µm section was dissolved in 300 µl
Laemmli buffer (Laemmli, 1970) and 11 µl was loaded onto 6 % acrylamide gels.
Gels were run at 250 V for 25 hours and subsequently stained with a Silverstain
Plus Kit (Biorad, Hemel Hempstead, UK).
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Histological section staining
Serial 10 μm sections from the middle of the plantaris muscle were cut on a
cryostat at -20 °C and mounted on polylysine-coated slides. The sections were
stored at -80 °C until further analysis, unless otherwise stated. All sections were
mounted in glycerin-gelatin after staining.
Myosin ATPase
Unfixed sections were stained for myosin ATPase to classify fibres as I, IIa and
IIx/b after pre-incubation at pH 4.55, as described previously (Brooke & Kaiser,
1970; appendix). The fibre type distribution was given as the area percentage of
each fibre type.
Succinate dehydrogenase (SDH) activity
The SDH-activity in individual muscle cells in histological sections was determined
immediately after cutting as described previously (Pool et al., 1979; appendix).
Myoglobin concentration
The myoglobin concentration in individual muscle cells was determined as
described previously (Van Beek-Harmsen et al., 2004; appendix).
Capillarisation
Capillaries were depicted by staining sections for alkaline phosphatase as
described previously (Degens et al., 1992; Deveci t al., 2001, 2002; appendix). The
capillarisation was analysed using the method of capillary domains (Hoofd et al.,
1985; Degens et al., 1992; appendix).
Modelling of skeletal muscle tissue oxygenation
We applied the Hill and an extended Krogh model to obtain some insight on how
the observed adaptations affected tissue oxygenation during hypoxia. Both models
assume that oxygen diffuses over the cell membrane and through the cytoplasm
into the mitochondria and take into account myoglobin-facilitated oxygen diffusion.
The Hill model assumes a homogeneous oxygen tension (PO2) in the interstitial
space around the fibre, while the Krogh model assumes that oxygen diffuses from
point-sources of oxygen (capillaries). We assumed that at V O2max the flow through
and PO2 in all capillaries is the same.
Hill model
The critical extra-cellular oxygen tension required to prevent the development of an
anoxic core in a cylindrical cell (PO2crit, mm Hg) at maximal rate of oxygen
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consumption of the muscle fibre ( V O2max) was calculated with the Hill model (Hill,
1965; Murray, 1974):
PO2crit=( V O2max · FCSA - 4π · DMb · [MbO2]R) / 4π · αM · DO2
where V O2max in mM s-1 is calculated using SDH-activity (Van der Laarse et al.,
1989), FCSA in mm2, DMb is the radial diffusion coefficient of myoglobin (0.27 x 10-4
mm2 s-1, Baylor & Pape, 1988), [MbO2]R is the concentration of oxygenated
myoglobin at the sacrolemma (in mM) and calculated using the methods described
in Des Tombe et al. (2002), αM is the solubility of oxygen in skeletal muscle, DO2 is
the diffusion coefficient for oxygen in skeletal muscle. The product of the latter two
(αM · DO2) is known as the Krogh’s diffusion coefficient (2.00 nM mm2 mm Hg-1 s-1,
Van der Laarse et al., 2005).
Krogh model
The critical oxygen tension at the capillary required to prevent the development of
anoxic tissue areas when the muscle is working at V O2max (PO2cap, mm Hg) was
calculated using a universal Krogh’s tissue model (Hoofd, 1995). We used
photomicrographs of sections with a representative capillarisation for each region
and condition. For the model calculations the capillary radius was set at 2.4 μm.
The weighted average V O2max and myoglobin concentration were fed into the
model. Where the Hill model calculates a PO2 that should be uniformly present
around a muscle fibre, Krogh’s tissue model calculates a minimal PO2 at the
capillary that ensures the absence of anoxic areas.
We also used the Krogh’s tissue model to estimate the distribution of oxygen
pressure within the muscle tissue during normoxia (PaO2 100 mm Hg), acute
hypoxia (40 mm Hg, both conditions using tissue characteristics of the normoxic
situation) or chronic hypoxia (40 mm Hg, using the tissue characteristics of the
tissue adapted to hypoxia).
Statistical analysis
Independent t-tests were used to compare means between the two groups.
Multilevel analysis (MLwiN, version 2.02, Centre for Multilevel Modelling, London,
UK) was used to test for significant differences in capillarity, oxidative capacity,
myoglobin concentration and fibre size between region, fibre type and
hypoxia/normoxia. Multilevel analysis can be considered as an extension to the
commonly used linear regression analysis, which has the disadvantage that only a
continuous outcome variable can be analysed (Twisk, 2006). Differences were
considered significant at P<0.05. Values are presented as mean ± SEM.
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Results
The body mass of the hypoxic (357 ± 12 g) and control (382 ± 8 g) rats were not
significantly different. The mass of the hypoxic plantaris muscle was 7 % lower
compared to the control, but was not significantly different (397 ± 23 vs. 370 ± 13
mg in control and hypoxia, respectively). The hypoxic rats had a higher haematocrit
than the control rats: 50 ± 1 vs. 59 ± 1 % (P<0.001). In total, 990 control and 1130
hypoxic fibres were analysed. For each fibre all parameters were assessed in
serial sections; a typical example is shown in Figure 7.1.
Figure 7.1. Typical example of serial sections stained for (A) ATPase after pre-
incubation at pH 4.55, (B) capillaries, (C) succinate dehydrogenase (SDH) activity
and (D) myoglobin concentration (note the dark spots stained for haemoglobin).
Type I cells (stained dark for ATPase) had a higher capillary fibre density, higher
SDH-activity and more myoglobin. * indicates same fibre in each section; bar
presents 50 µm.
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Figure 7.2. (A) Myosin heavy chain (MyHC) composition in the EDL (lane 1),
normoxic plantaris muscle (lane 2-4), hypoxic plantaris muscle (lane 5-7) and
soleus muscle (lane 8) of rats using 6% gel electrophoresis. (B) No significant
differences were observed between normoxia (n=8) and hypoxia (n=9).
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Figure 7.3. (A) Effects of hypoxia on the muscle fibre type distribution (percentage
area occupied) and (B) fibre cross sectional area (FCSA) in the deep and
superficial region of the plantaris muscle. The deep (oxidative) region has a
significantly higher percentage of type I fibres (P<0.001) compared to the
superficial (glycolytic) region. No significant fibre type shift was observed after 4
weeks of hypoxia. FCSA decreased significantly after exposure to hypoxia
(P<0.05) in all fibre types and both regions. See Results section for further
statistically significant differences between types and regions.
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Fibre type composition and fibre cross sectional area (FCSA)
The overall myosin heavy chain composition of the plantaris muscle did not change
significantly after exposure to hypoxia (Figure 7.2). The deep region had a higher
proportion of type I fibres and a lower proportion of type IIx/b fibres than the
superficial region (P<0.001), while there was no significant regional difference in
the proportion of type IIa fibres. In line with the myosin heavy chain data, hypoxia
did not result in an altered fibre type composition (Figure 7.3A).
In both regions, the size of the fibres was in the order I < IIa < IIx/b (P<0.05). Type I
fibres in the deep region were larger and type IIx/b fibres smaller than those of the
superficial region (P<0.05), while type IIa fibres had a similar size in both regions.
Hypoxia resulted in an overall 10 % reduction in FCSA (P<0.05; Figure 7.3B). The
absence of an interaction between fibre type and/or region with hypoxia indicates
that this effect was similar for each fibre type and independent of region.
Succinate dehydrogenase (SDH) activity
SDH-activity in type IIx/b fibres was lower than that in the other fibres (P<0.001;
Figure 7.4A). Interestingly, in the deep region only, the SDH-activity of type IIa
fibres was higher than that of type I fibres (P<0.001). Overall, the SDH-activity was
26% lower in the superficial region than the deep region (P<0.001). This was
explicable by the larger number of type IIx/b fibres in the superficial than the deep
region. In addition, the SDH-activity in the type IIx/b fibres in the superficial region
was lower than that in the deep region (P<0.001), while there was no significant
difference in activity in the type I and IIa between the two regions. Hypoxia induced
a 25% increase in the SDH-activity in fibres of each type in the superficial region
(P<0.05), while no change in the SDH-activity occurred in the deep region.
The integrated SDH-activity is proportional to the V O2max per mm fibre length (in
nmol mm-1 s-1) of the cell (Van der Laarse et al., 1989). In the control rats, type I
fibres had a lower integrated SDH-activity compared to type II fibres (IIa and IIx/b;
P<0.001), while there was no difference between IIa and IIx/b fibres (Figure 7.4B).
The integrated SDH-activity was higher in fibres from the deep compared to the
superficial region (P<0.001). This was due to a higher integrated SDH-activity of
type II (P<0.001), but not type I fibres, in the deep than the superficial region of the
muscle. After exposure to hypoxia, this difference between the two regions
disappeared (P=1.00).
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Figure 7.4. (A) Succinate dehydrogenase (SDH)-activity and (B) spatially
integrated SDH-activity in different fibre types and regions of the plantaris muscle
after 4 weeks hypoxia compared to normoxia. The SDH-activity in the superficial
region was increased by 25% in the hypoxic group (P<0.05), but this did not occur
in the deep region. The difference in spatially integrated SDH-activity between the
deep and superficial region which was apparent in the control rats (P<0.001),
disappeared after hypoxia (P=1). See Results section for further statistically
significant differences between types and regions.
Chapter 7
128
Figure 7.5. Myoglobin concentration in different fibre types and regions of the
plantaris muscle after 4 weeks hypoxia compared to normoxia. No significant
differences were observed after exposure to hypoxia. See Results section for
statistically significant differences between fibre types and regions.
Myoglobin concentration
Overall, fibres in the superficial region of the plantaris muscle had a 30% lower
myoglobin concentration ([Mb]) than those in the deep region (P<0.001, Figure
7.5). The [Mb] of type IIa fibres in both the deep and superficial region was higher
than that of type I fibres (P<0.05), while type IIx/b fibres had the lowest [Mb]
(P<0.001). Hypoxia did not significantly affect [Mb] in fibres of all type or region.
Capillarisation
The local capillary to fibre ratio (LCFR) for each fibre type and the overall capillary
to fibre ratio (C/F, depicted as ‘total’) are displayed in Figure 7.6A. In both regions
the LCFR of type IIx/b fibres was higher than that of the other fibres (P<0.001). In
the deep region, type I and IIa fibres had a similar LCFR, while in the superficial
region the LCFR of the type IIa was higher compared to type I fibres (P<0.001).
The LCFR for each fibre type was higher in the deep compared to the superficial
region (P<0.001). There was an interaction between region and hypoxia (P<0.001),
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which was apparent as a 14% increase in LCFR after hypoxia of fibres in the deep
(P<0.05), but not in the superficial region.
The capillary fibre density (CFD) of fibres of each type was lower in the superficial
than the deep region (P<0.001, Figure 7.6B). The CFD of type IIx/b was lower than
that of type I and IIa fibres (P<0.001), which had a similar CFD. Hypoxia resulted in
a 24% higher CFD in the deep (P<0.01), but not the superficial region of the
muscles.
The heterogeneity of capillary spacing (logRSD) was larger in the superficial
compared to the deep (0.097 ± 0.013 vs. 0.112 ± 0.011) region (P<0.001), but was
not significantly changed by hypoxia in either region (0.091 ± 0.010 and 0.118 ±
0.022; deep and superficial region, respectively).
Relationships between capillarisation, SDH-activity and FCSA
To investigate how the adaptations in response the hypoxia affected oxygen supply
and demand, we calculated the relationships between LCFR, SDH-activity and
FCSA for all fibre types. In Figure 7.7 the relations for type IIa and IIx/b fibres are
shown, as they are the predominant fibres in the plantaris muscle.
As expected, LCFR was linearly related to the maximal oxygen uptake of the cell
(as reflected by the spatially integrated SDH-activity) in type I (R2 ranging from
0.165 - 0.640 for each region and condition, P<0.001), type IIa (R2 ranging from
0.110 - 0.336, P<0.001, Figure 7.7A) and in type IIx/b (R2 ranging from 0.070 -
0.284, P<0.001, Figure 7.7B), except for type IIx/b fibres in the normoxic superficial
region (R2=0.012, P=0.06). After hypoxia, the correlation coefficient and slope of
this relation increased for the type IIx/b fibres in both regions (P<0.001). There was
no significant relationship between LCFR and SDH-activity for the type I (R2
ranging from 0.000 - 0.144) and IIa fibres (R2 ranging from 0.008 - 0.052, Figure
7.7C) and in the type IIx/b fibres in the superficial region a slight negative
relationship was observed (R2=0.018, P<0.01, Figure 7.7D dotted line), which
disappeared (P<0.03) after exposure to hypoxia (R2=0.000).
While no correlation was found between LCFR and the SDH-activity, LCFR did
positively correlate with FCSA in type I (R2 ranging from 0.226 – 0.487), IIa (R2
ranging from 0.115 – 0.491, Figure 7.7E) and IIx/b fibres (R2 ranging from 0.127 –
0.341, Figure 7.7F). For all fibre types, the slope between FCSA and LCFR
significantly increased in the deep (P<0.05), but not in the superficial region after
hypoxia. Interestingly, while the region-specific difference in the slope was not
significant in normoxia, hypoxia amplified the difference in the slope between the
deep and superficial region for all fibre types, which was entirely due to an
increased slope in the deep region only. This indicated that at a given FCSA the
type I, IIa and IIx/b fibres in the superficial region had a similar LCFR, while those
in the deep region had a higher LCFR after hypoxia (P<0.001). This was reflected
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Figure 7.6. (A) Local capillary to fibre ratio (LCFR) and (B) capillary fibre density
(CFD) in different fibre types and regions of the plantaris muscle after 4 weeks
hypoxia compared to control values. Note that the total value in both regions is the
overall capillary to fibre ratio (C/F) (A) or overall capillary density (CD) (B). Hypoxia
increased LCFR in the deep region (P<0.05), but not in the superficial region. CFD
increased in the deep (P<0.01), but not in the superficial region. See Results
section for further statistically significant differences between types and regions.
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Figure 7.7. Relationship between LCFR and spatially integrated SDH-activity (A
and B), SDH-activity (C and D) and FCSA (E and F) for type IIa (A, C and E) and
IIx/b fibres (B, D and F). See legend for the conditions and regions. The correlation
between the spatially integrated SDH-activity and the capillary supply (A and B)
was due to a significant correlation between FCSA and LCFR (E and F), rather
than a correlation between LCFR and SDH-activity (C and D). For R2 and P-values,
see Results section.
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by the increased CFD for each fibre type in the deep, but not in the superficial
region during hypoxia (Figure 7.6B). Overall, the CFD of type I fibres was higher
than that for type IIa fibres. Type IIx/b fibres had the lowest CFD (P<0.001).
Model calculations
Model calculations were used to asses the functional consequences of the
observed adaptations. During normoxia the PO2crit for each individual muscle fibre
(Hill model) was higher in the deep compared to the superficial region (P<0.001;
Figure 7.8A). In response to chronic hypoxia, the regional difference in PO2crit
disappeared, due to a decrease in the deep and an increase in the superficial
region (interaction between hypoxia and region, P<0.001). The decrease in PO2crit
in the deep region was caused by muscle fibre atrophy, while the increase in the
superficial region resulted from an increase in SDH-activity.
Subsequently, we calculated the PO2 that is required in the capillaries to prevent
the occurrence of any anoxic area at V O2max (as was calculated for PO2crit), which
is referred to as the critical capillary PO2 or PO2cap. Thereto, we chose photographs
with representative capillary distributions for each region and condition. The PO2cap
in the superficial region was higher compared to the deep region. The PO2cap in the
deep region did not differ between normoxia and hypoxia, but hypoxia resulted in a
25 % increase in PO2cap in the superficial region of the muscle (Figure 7.8B).
The PO2 distribution, shown as a cumulative curve (in %), in the muscle tissue at
V O2max was calculated using the Krogh model in normoxia (Figure 7.9A capillary
PO2 set at 100 mm Hg), acute hypoxia (Figure 7.9B capillary PO2 set at 40 mm Hg)
and during hypoxia (capillary PO2 set at 40 mm Hg) in the adapted situation (Figure
7.9B). While during normoxia no anoxic regions were present in either the deep or
superficial region of the muscle (Figure 7.9A), acute hypoxia (40 mm Hg) resulted
in a marked left-shift in the PO2 distribution in the tissue; during acute hypoxia
approximately 10 % of the skeletal muscle tissue in the superficial region was
anoxic, while hardly any anoxic regions were observed in the deep region. The
adaptations of the skeletal muscle tissue to chronic hypoxia resulted in a marked
region-specific adaptation: while in the deep region a right-shift occurred compared
to the acute hypoxic situation, indicating an improved tissue oxygenation, an
unexpected left-shift was observed in the superficial region.
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Figure 7.8. Minimal oxygen tension around the fibre (Hill model, A) and in the
capillary (Krogh model, B) that prevents the development of an anoxic core when
the fibres work at their maximal oxygen consumption ( V O2max). The region-
specific difference in PO2crit in (A) disappeared after exposure to hypoxia. Using the
Krogh-model (incorporating the capillary supply), the critical capillary PO2 did not
change in the deep region, while it increased with 25 % in the superficial region.
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Figure 7.9. The cumulative PO2 distribution (in %) in the muscle tissue calculated
at V O2max using the Krogh model in normoxia (A, PaO2=100 mm Hg), during
acute hypoxia (B: ● and ▲, PaO2=40 mm Hg) and after adaptations to chronic
hypoxia (B: ○ and Δ). A marked differential response in both regions can be 
observed.
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Discussion
Using an integrative approach to study the parameters determining the oxygen
delivery and utilization, we observed that the muscular adaptations to chronic
hypoxia are region-specific and not fibre type-specific, which was in accordance
with our hypothesis. Overall, hypoxia did cause a ~10% muscle fibre atrophy,
irrespective of fibre type and muscle region. In the deep oxidative region of the
plantaris muscle this and angiogenesis resulted in improved capillarisation. In the
superficial glycolytic region there was no angiogenesis, but contrary to our
expectations, a 25 % increase in the oxidative capacity, indicating mitochondrial
biogenesis. The absence of a change in the oxidative capacity in the deep
(oxidative) region of the muscle indicates that the loss of mitochondria was
proportional to the degree of atrophy. While the adaptations to chronic hypoxia in
the deep region attenuated the reduction in tissue PO2 and prevented the
occurrence of anoxic areas during hypoxia, the increased oxidative capacity in the
superficial region appeared to aggravate problems with tissue oxygenation during
conditions of elevated oxygen demand by the muscle.
What determines the capillary supply in skeletal muscle in normoxia and hypoxia?
The general idea is that in many species, including birds (Mathieu-Costello et al.,
1992), humans (Bekedam et al., 2003) and rats (this Chapter; Chapter 5) the
capillary supply to a fibre is related to its oxidative capacity. This relationship is
modulated by the metabolic surrounding of a fibre, where a fibre in an oxidative
region has a larger capillary supply than a similar fibre surrounded by glycolytic
fibres (Degens et al., 1992). Here we show using quantitative histochemistry that
although the number of capillaries supplying a fibre (LCFR) was indeed related to
its V O2max, as estimated from its integrated SDH-activity, LCFR correlated more
with fibre size (Figure 7.7, Maxwell et al., 1980; Chapter 5). The lack of a
correlation between SDH-activity per mm-2 and LCFR could be due, at least in part,
to the fact that the mitochondrial density within a fibre decreases from the
periphery to the centre of the fibre (Swatland, 1984; Chapter 5). We observed that
the capillary supply per unit fibre perimeter is more or less constant (data not show;
Degens et al., 2006a;), suggesting that diffusion distance or capillary contact per
fibre perimeter, rather than the total number of mitochondria in a cell, is a more
important determinant of the capillary supply to a fibre.
Capillaries do not only supply oxygen, but also remove waste products and heat
from the exercising muscle cell. This may explain the absence of a positive
relationship between the integrated SDH-activity and LCFR of the glycolytic fibres
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with a low oxidative capacity (type IIx/b) in the glycolytic region of the muscle
(Figure 7B).
During exposure to hypoxia the integrated SDH-activity in these fibres increased
and the relationship between spatially integrated SDH-activity and LCFR became
stronger for the type IIx/b fibres only. This suggests that during hypoxia the
function of the capillaries to deliver oxygen to the (previously low oxidative) muscle
cells becomes more important.
Overall adaptations to chronic hypoxia
Similar to previous studies, we observed no differences in the fibre type
composition (Green et al., 1989b; Panisello et al., 2008). Hypoxia did, however,
cause a ~10 % muscle atrophy (Ferretti et al., 1990; Bigard et al., 1991;
Desplanches et al., 1996; Deveci et al., 2001) in fibres of each type and region,
which may serve to decrease the diffusion distance from the capillaries to the
interior of the muscle fibres.
The heterogeneity of capillary spacing (logRSD) may have a significant impact on
tissue oxygenation. A homogeneous capillary spacing would improve tissue
oxygenation (Piiper & Scheid, 1991; Goldman et al., 2006; Degens et al., 2006a In
the deep oxidative region of the muscle, with a higher demand of oxygen, the
capillaries were more homogenously distributed than in the superficial glycolytic
region. Yet, we did not observe a more homogeneous distribution of capillaries
after exposure to hypoxia, not even in the glycolytic region that became more
oxidative. Also during hypertrophy (Degens et al., 2009) and atrophy (Degens et
al., 2008) the heterogeneity of capillary spacing remains unaltered, and it has been
suggested that the absence of changes might be related to physical constraints,
determined by the morphology of the muscle fibres, of placing new capillaries
(Degens et al., 2009).
Myoglobin might act to facilitate diffusion of oxygen (Scholander, 1960). An
elevated myoglobin concentration during hypoxia (Reynafarje, 1962) might thus
serve to enhance intracellular oxygen transport and ensure an adequate tissue
oxygenation. In agreement with previous observations (Van der Laarse et al.,
1985), we observed that oxidative type I and IIa fibres contain more myoglobin
than glycolytic IIx/b fibres (Van Beek-Harmsen et al., 2004). Although the oxidative
capacity of fibres in the superficial region was elevated after hypoxia, we observed
no change in the myoglobin concentration in fibres of any type or region after
exposure to hypoxia. Other studies also report no change in the myoglobin protein
content (Sillau & Banchero, 1977), even when endurance training was
superimposed (Masuda et al., 2001). Iron deficiency in the diet may limit the
formation of functional myoglobin as it has been shown that elevated myoglobin
mRNA levels do not necessarily translate into elevated myoglobin protein levels
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(Robach et al., 2007). Iron deficiency, however, would also hamper mitochondrial
synthesis (Hood et al., 1992), something that did not appear to be limited in our
study. Whatever the cause of the unchanged myoglobin content, our model
calculations show that the facilitation of oxygen diffusion by myoglobin in our tissue
was at most equivalent to a reduction of 5 mm Hg in the required PO2cap (data not
shown).
Region-specific adaptation to hypoxia
We observed that the deep oxidative and superficial glycolytic region of the muscle
differed in their adaptations in capillarisation and oxidative capacity to chronic
hypoxia. While in the deep region capillary proliferation took place, as reflected by
the increased LCFR, no capillary proliferation occurred in the superficial region. On
the other hand, the spatially integrated SDH-activity, reflecting the total number of
mitochondria per fibre, decreased in the deep and increased in the superficial
region. Our model calculations showed that the improved capillarisation in the deep
region served to improve tissue oxygenation, while in the superficial region the
adaptations did not appear to improve tissue oxygenation, as reflected by both an
increased proportion of anoxic tissue areas and an elevated PO2crit.
In the deep region the decreased integrated SDH-activity per fibre is explicable by
atrophy. This, together with an unaltered SDH-activity per mm2, reflecting the
number of mitochondria per volume of tissue (Takekura & Yoshioka, 1989),
indicates that atrophy is accompanied by a proportional loss of mitochondria in the
deep region. The increased integrated SDH-activity in the superficial region, on the
other hand, indicates that though atrophy also occurred in this region,
mitochondrial biogenesis was elevated.
It is interesting to note that the adaptations were region- and not fibre type-specific.
In other words, no matter what type a fibre was, its integrated SDH-activity was
increased in the superficial and its capillary supply in the deep region. This is
surprising as training appears to result in a fibre type-specific change in oxidative
capacity (Takekura & Yoshioka, 1989). During training, however, only a subset of
fibres may be recruited, while during hypoxia all fibres are affected. Nevertheless,
though speculative, it might be that paracrine factors, such as VEGF, and/or other
substances are excreted by or diffuse out of the cell in relatively larger quantities
from cells that are recruited more, such as in the deep region (Clanton & Klawitter,
2001) than elsewhere, and hence affect the adaptation processes of fibres in
different regions differently, overwhelming the fibre type-specific adaptations.
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Possible explanation for differences in regional adaptation to hypoxia
Region-specific increase in capillarity
Similar to us, other investigators have also observed region-specifc adaptations in
capillarisation (Deveci et al., 2001, 2002; Badr et al., 2003). During submaximal
exercise particularly the deep oxidative region of the muscle is recruited (Kernell,
1998). To deliver the same amount of oxygen the blood flow to the muscle at a
given submaximal workload is increased as is the extraction of oxygen (King et al.,
1987) and it is thus expected that particularly in the deep, and less so in the
superficial glycolytic region, the endothelium is exposed to elevated shear stress,
which is a potent stimulant for angiogenesis (Hudlicka et al., 1992). Also in the
superficial region an increased blood flow and shear stress is to be expected,
which may, however, be too little to induce angiogenesis; if so it would suggest that
there is a threshold in duration and/or magnitude of elevated blood flow, above
which shear-stress would induce angiogenesis.
Although our model calculations show that the degree of hypoxia is more severe in
the superficial than the deep region of the muscle during maximal exercise, it is
possible that muscle fibers in the deep region, being recruited more also during
normal activity, is exposed to much longer periods of low oxygen pressures than
the superficial region. Hypoxia-inducible factor 1-α (HIF1-α) protein expression is
elevated during hypoxia and is a master transcription regulator in the adaptations,
such as those of the capillary network, to hypoxia (Semanza, 2000). Indeed,
elevated HIF1-α expression induces an increased expression of vascular
endothelial growth fact (VEGF) and its receptor (FLT-1). Thus, though speculative,
it might also be that paracrine factors, such as VEGF, and/or other substances are
excreted by, or diffuse out of, the cell in relatively larger quantities from cells that
are recruited more, such as in the deep region (Clanton and Klawitter, 2001) than
elsewhere, and hence affect the capillary proliferation in different regions
differently.
Region-specific adaptation in oxidative capacity
During hypoxia, even during submaximal exercise an accelerated breakdown of
PCr and fall in pH occur (Hogan et al., 1999). The increased rate of accumulation
of metabolites may require the earlier recruitment of glycolytic fibres, even during
submaximal activity. This more frequent recruitment may be compared to an
endurance training programme inducing an increase in the oxidative capacity. An
additional 5 % duration of recruitment has been shown to be sufficient to increase
the oxidative capacity of a muscle cell as seen with electrical stimulation (Kernell et
al., 1987) and also training during hypoxia induces an increase in the oxidative
capacity (Terrados et al., 1990; Abdelmalki et al., 1996). It is not clear why the
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oxidative capacity in the deep region is not affected, but our observations are
analogous to the observation that the increase in oxidative capacity following
electrical stimulation is inversely related to the original oxidative capacity of the
muscle or muscle region (Reichmann et al., 1985).
The Hill model indicated that in the superficial region the PO2 allowing the muscle
cell to work at V O2max was elevated during hypoxia. This corresponded with an
increase in the capillary PO2, calculated with the Krogh model, required for the
tissue to work at V O2max without the development of anoxic tissue areas. The
higher PO2cap than PO2crit can be ascribed to the different assumptions of both
models (homogeneous PO2 around the fibre in the Hill model vs. oxygen diffusing
from point sources in the Krogh-model). The increased oxidative capacity in the
superficial region after chronic hypoxia does not appear to help, but rather to
aggravate the situation as reflected by the increased prevalence of anoxic tissue
areas as estimated with the Krogh model. Thus in terms of tissue oxygenation this
seems to be an inappropriate adaptation to hypoxia. The respiration of the
mitochondria is a hyperbolic function of the PO2 the mitochondria experience and
when the PO2 becomes too low the respiration of the mitochondria will decrease
(Gnaiger et al., 2000). Yet, the demand for ATP by the fibres in the superficial
region may increase, because of a more frequent recruitment as discussed above.
An increase in mitochondria may enhance the flux of oxygen and hence total
respiration, even though each individual mitochondrion is not working maximally
(Hochachka et al., 1983). According to our model calculations there are virtually no
anoxic areas during hypoxia in the deep region of the muscle, suggesting that the
mitochondria may still be able to work near-maximally. It is thus not necessary to
increase their number to enhance flux in this region of the muscle.
The region-specific adaptation in mitochondrial biogenesis might be related to
differential upregulation of HIF1-α in both regions as HIF1-α is reported to inhibit
mitochondrial biogenesis (Mason et al., 2007). Other potential mediators for the
region-specific adaptation in oxidative capacity are differences in the expression of
factors that are involved in transcriptional regulation of mitochondrial genes, such
as PPARγ and its ligand PGC-1α (Kramer et al., 2006).  
Conclusions
In conclusion, the adaptation of skeletal muscle to hypoxia is region- rather than
fibre-type specific. Overall, hypoxia results in muscle atrophy. In oxidative regions,
hypoxia results in angiogenesis which helps to attenuate a reduction in tissue PO2,
while fibres in a more glycolytic region of the muscle increase their oxidative
capacity. Without improvements in the delivery of oxygen, such as those brought
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about by increases in haematocrit and blood flow, the latter may cause problems
with tissue oxygenation, we hypothesise that the increased oxidative capacity may
serve to ensure an adequate aerobic ATP generation during hypoxia by
maintaining the flux of oxygen. It is currently unknown which cellular pathways
underlie these region-specific adaptations to chronic hypoxia. Finally, when
considering the effects of hypoxia during chronic cardio-respiratory disorders one
has to consider that different muscles or muscle regions might be affected
differently.
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The aim of this final chapter is to provide an overview of what the results described
in this thesis have added to the literature in this area and to discuss their possible
relevance for patients with COPD. Subsequently, suggestions for future studies will
be given.
The main objective of the present thesis was to investigate the effects of smoking
and hypoxia on skeletal muscle structure and function. Smoking is the main cause
of COPD, a condition where muscle weakness and, probably, premature fatigue
seriously exacerbate the problems associated with the primary lung disease.
Chronic systemic hypoxaemia is commonly observed in these patients and it is
thus likely that this factor can contribute to muscle wasting and dysfunction.
The first three experimental chapters report the results of studies looking for
changes in muscle function in subjects who were smokers but did not have any
symptoms of lung disease. There were no obvious difference in strength or muscle
sizes between the smokers and matched control subjects. A difference was
detected, however, in fatigability but because there appeared to be sex differences
it was necessary to examine this further to understand the basis of this difference.
In Chapter 2, 3 and 4 we have used a fatigue test involving electrical evoked
contractions of the quadriceps muscle (2 minutes 30 Hz with duty cycle of 0.5; 1 s
on, 1 s off at an intensity equal to 30 % of MVC). Using such protocols, peripheral
fatigue can be distinguished from central fatigue and contractile properties can be
measured. This differs from more widely used methods that have used voluntary
contractions to study muscle fatigue. Using voluntary contractions to assess
skeletal muscle fatigue resistance does not allow one to distinguish between
peripheral and central causes of fatigue. As electrical stimulation by-passes central
motivation and neural causes of fatigue, protocols using electrically evoked
contractions reflect only the contribution of factors beyond the motoneuron to
muscle function and fatigue.
In Chapter 2 we report that, using this protocol, women were less prone to
peripheral muscle fatigue than men, as already suggested by Hunter et al. (2006).
We also observed slightly slower contractile properties in women than men
suggesting that women may have a higher percentage of slower muscle fibres
giving them an advantage in terms of aerobic metabolism or energy utilization.
Several studies have shown that women do have a higher proportion of type I
fibres than men (Nygaard, 1981; Simoneau & Bouchard, 1989; Staron et al., 2000;
Jaworowski et al., 2002; Roepstorff et al., 2006), and the question arises what
caused these differences. We have carefully selected our participants with regards
to physical activity level, as a high level of physical activity is associated with a high
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fatigue resistance (Gerrits et al., 2002), although probably by increasing aerobic
capacity rather than changing MHC expression.
The fact that differences in fatigability between the sexes persisted even when the
muscle was made ischaemic indicates that the difference probably lies in the rate
of energy utilisation rather than energy supply, implicating differences in MHC
content.
One possibility that could be explored in future studies is whether, and to what
extent, contractile properties are affected by differences in circulating hormones
between men and women. That this might play a role is suggested by an increase
in frog skeletal muscle fibre size and faster contractile properties (maximal
shortening velocity, contraction and relaxation time) after testosterone
supplementation (Girgenrath & Marsh, 2003). However, to what extent these
findings can be extrapolated to humans and how circulating hormones affect
fatigue resistance is currently unknown. While hypogonadism has been observed
in male patients with COPD (Van Vliet et al., 2005), possible changes in exercise
intolerance and muscle structure and function after testosterone supplementation
have not been extensively studied (Casaburi et al., 2004). The few that are
available indicate that testosterone supplementation in patients with COPD
enhances muscle strength, while no data is currently available describing possible
effects on contractile properties and muscle fatigue.
The results described in Chapter 3 suggest that young men with a mild smoking
history were less fatigue resistant than non-smoking, age- and physical activity-
matched peers. The lower fatigue resistance was not related to the duration of the
smoking when testing a cohort of smokers of a wide range of age and smoking
history (Chapter 4) or with a lower oxidative capacity or changed fibre type
(Chapter 6). Although the results from this last study need confirmation using a
larger cohort of smokers, the results suggest that the higher muscle fatigability is
not necessarily dose-related, but rather related to an acute, and possibly
reversible, impairment either in the supply or ability to use oxygen for aerobic
energy generation by the muscle. In this respect the difference between smokers
and non-smokers is not the same as between male and female control subjects
discussed above. If the difference is due to altered oxygen supply or utilisation we
would expect that smokers and non-smokers would have similar fatigue profiles
when the muscles were made ischaemic. Unfortunately we were unable to test this
hypothesis as the smokers were unwilling to undergo an ischaemic fatigue test (too
painful) but this is clearly something that should be included in any future studies in
this area.
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CO is a major toxic component of cigarette smoke that causes a left-shift of the
HbO2 dissociation curve, hampering the release of oxygen. It also impairs the
facilitated transport of oxygen within the muscle cell by myoglobin as its oxygen
binding site is occupied by CO (Gorman et al., 2003) and inhibits the function of
complex IV of the electron transport chain (Alonso et al., 2003). A combination of
these factors attenuates not only delivery but also utilisation of oxygen. The
delivery of oxygen may further be hampered by an impaired peripheral blood flow
in smokers (Ronnemaa et al., 1999), due to endothelial dysfunction through
oxidative stress and the reduced bioavailability of nitric oxide (Montes de Oca et
al., 2008). A diminished oxygen supply may also occur when COHb is formed; the
inhalation of CO until COHb reached 6 % caused an 8 % reduction in fatigue
resistance (Morse et al., 2008). The mean blood COHb level in smokers is reported
to vary from 4 – 5 % (Hampson et al., 2006), somewhat less than the levels used
by Morse et al. (2008) suggesting that CO may not be the entire explanation for the
increased fatigability. There are, however, other toxic substances in tobacco
smoke, such as CN, that would have similar effects to CO.
Future work might focus on the effects of smoking cessation on muscle function
and fatigue. If muscle fatigue is increased due to an acute impairment in oxygen
delivery and/or utilization, then it is likely that the effect will be fairly rapidly
reversed on smoking cessation. Earlier work on short-term smoking and smoking
abstinence has already pointed in this direction. Smoking 3 cigarettes per hour for
5 hours has a detrimental effect on maximal oxygen uptake in humans (Hirsch et
al., 1985) and smoke inhalation acutely reduces swimming endurance in rats
(Hrubes & Battig, 1970). A six or seven day abstinence, on the other hand,
prolonged the time to exhaustion, mainly due to an improved oxygen transport to
the muscles (Hashizume et al., 2000). Also mitochondrial respiratory chain function
(activity of complex IV), measured in peripheral lymphocytes, was lower in heavy
smokers, but returned to normal values after 28 days of smoking abstinence
(Cardellach et al., 2003). However, to what degree skeletal muscle fatigue
resistance will improve after smoking cessation is not known and a study to
determine this would clearly be an important continuation of the present work.
Muscle fatigue protocols involving percutaneous electrical or magnetic stimulation
are uncommon, but have been used successfully in patients with advanced COPD
(Degens et al., 2005; Swallow et al., 2007). Using a comparable intensity and duty
cycle to the present study, Swallow et al. (2007) observed that COPD patients
experienced a higher muscle fatigability, while Degens et al. (2005) did not observe
a difference in fatigue resistance between COPD patients and controls. The
discrepancy in results might be related to the significantly lower physical activity
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levels in COPD patients than controls in the study by Swallow et al. (2007) while in
the study by Degens et al. (2005) patients and control subjects were matched for
physical activity level. It is interesting to note that all the COPD patients tested by
Degens et al. (2005) had stopped smoking at the time of the experiment (H.
Degens, personal communication) while it is not clear whether the patients in the
Swallow study were smoking. Firm conclusions about the role of smoking in the
exercise intolerance in patients with COPD cannot be drawn as long as smoking
characteristics are not mentioned (or controlled).
The muscle atrophy and dysfunction seen in many patients with COPD is likely to
have multiple causes including factors such as disuse, inflammation, reactive
oxygen species and/or hypoxia. A small, but significant degree of muscle fibre
atrophy was found in the small subgroup of smokers compared with non-smokers.
Recently, it has been reported that smokers (without COPD) have a lower FCSA of
type I fibres than non-smokers (Montes de Oca et al., 2008), but it is not clear to
what extent this result was due to an inappropriate selection of the control group
(Wagner, 2008; Wüst et al., 2008). The observation that the rate of protein
synthesis in skeletal muscle is lower in smokers might be an explanation for the
observed muscle atrophy (Petersen et al., 2007).
The aim of the work described in Chapter 7, was to determine the effects of
hypoxaemia per se on skeletal muscle. Rats were exposed for 4 weeks to chronic
hypobaric hypoxia equivalent to a PO2 of 410 mm Hg. As in other studies, a 10 %
muscle atrophy was observed in the plantaris, an important muscle for locomotion,
indicating that hypoxia could be an significant factor contributing to muscle atrophy
in conditions where oxygen supply is compromised. It was found that the
adaptation to chronic hypoxia was region- rather than fibre type-specific: capillary
proliferation occurred only in the deep, oxidative region, while only in the superficial
glycolytic region did mitochondrial biogenesis occur. The implication for patients
with COPD is that some muscles or muscle regions may be more or less affected
by hypoxia than others.
The aetiology of skeletal muscle dysfunction and its relationship to reduced
exercise tolerance are poorly understood. The results from this thesis on smokers
before they developed COPD and rats exposed to chronic hypoxia provide
indications that smoking and hypoxia might contribute to peripheral fatigue and
muscle atrophy in clinical situations. In the future, the relative contribution of
smoking (amongst other factors, such as hypoxia, inflammation and disuse) should
be studied to come to an integrative theory about muscle dysfunction and fatigue in
patients with COPD.
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Het doel van dit laatste hoofdstuk is een overzicht te geven van de resultaten die in
dit proefschrift beschreven zijn. In dit hoofdstuk zal ook de relevantie van deze
resultaten voor patiënten met chronisch obstructief longlijden (COPD)
bediscussieerd worden. Het hoofdstuk wordt afgesloten met suggesties voor
vervolgonderzoek.
Het belangrijkste doel van het onderzoek dat in dit proefschrift beschreven is was
de effecten van roken en hypoxie op de structuur en functie van skeletspieren te
bepalen. Roken is de belangrijkste oorzaak van COPD, een ziekte waar
spierzwakte en waarschijnlijk vroegtijdige spiervermoeidheid de problemen van de
primaire longaandoening ernstig kunnen verergeren. Chronische blootstelling van
het spierweefsel aan een lagere zuurstofdruk (hypoxie) is een vaakvoorkomend
verschijnsel bij patiënten met COPD en zou daardoor een factor kunnen zijn die
bijdraagt aan de spieratrofie en spier-disfunctie.
In de eerste drie hoofdstukken worden de resultaten beschreven van de studies
naar de spierfunctie van gezonde rokers, die nog geen symptomen van chronisch
longfalen hebben. Geen verschillen werden er gevonden in de maximale kracht of
spiermassa tussen de rokers en hun niet-rokende leeftijdsgenoten. Echter, een
verhoogde spievermoeidheid werd gevonden in de rokers. Omdat er ook
verschillen in de weerstand tegen vermoeidheid werden gevonden tussen mannen
en vrouwen, was net nodig deze verschillen eerst te begrijpen.
In hoofdstuk 2 hebben we een test ontwikkeld die met behulp van elektrische
stimulatie specifiek de perifere spiervermoeidheid meet (2 minuten, 30 Hz met een
duty cycle van 0.5; 1 s aan, 1 s uit), waarbij vergelijkingen gemaakt kunnen worden
tussen individuen welke niet beïnvloed worden door eventuele verschillen in
motivatie. Omdat de electrische stimulatie geen gebruik maakt van de centrale
motivatie en voorkomt dat het centrale element van het ontstaan van vermoeidheid
de resultaten beïnvloedt, kunnen de gevonden verschillen toegewezen worden aan
factoren distaal van de motoneuron. We vonden dat vrouwen over het algemeen
meer weerstand tegen vermoeidheid hadden dan mannen en dat dit fenomeen niet
gerelateerd was aan verschillen in spiergrootte. Wanneer de bloedtoevoer naar de
spier geblokkeerd werd (en dus ook het verbruik van zuurstof), waren vrouwen nog
steeds minder vatbaar voor vermoeidheid, wat een efficiëntere spiercontractie
impliceert. Dit en de tragere contractiele eigenschappen van spieren van vrouwen
ten opzichte van die van mannen, suggereert dat vrouwen een hoger percentage
langzamere spiervezels hebben, welke efficiënter zijn tijdens isometrische
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contracties. Er was geen verschil tussen jonge en oude proefpersonen wat erop
duidt dat leeftijd geen directe invloed heeft op de spiervermoeidheid.
De resultaten beschreven in hoofdstuk 3 laten zien dat jonge mannen met een
rokersverleden van 2.5 (3.1) pack years (= 1 pakje per dag gedurende 2.5 jaar)
minder resistent tegen vermoeidheid waren (met hetzelfde protocol als beschreven
in hoofdstuk 2) dan niet-rokers met een overeenkomstige leeftijd en fysieke
activiteit. Omdat er geen verschil gevonden werd tussen deze twee groepen in de
contractiele eigenschappen, concluderen we dat een eventueel verschil in
vezelsamenstelling het verschil in vermoeidheid niet kan verklaren.
De afname van maximale kracht en omvang van de bovenbeenspier tijdens
veroudering wordt niet versneld in rokers met overeenkomstige fysieke activiteit.
Ook de spiervermoeidheid was niet gerelateerd aan de duur van het roken, zoals
bleek uit de vergelijking van de spiervermoeidheid in een cohort van rokers met
een grote range van leeftijd en rokersverleden (hoofdstuk 4). Dit geeft aan dat de
hogere vermoeidheid in de rokers niet noodzakelijkerwijs gerelateerd is aan de
dosis, maar waarschijnlijk meer aan de acute, en mogelijke omkeerbare,
achteruitgang in de zuurstoftoevoer naar de spier en/of de mogelijkheid tot het
gebruik van zuurstof voor aerobe stofwisseling.
In de hoofdstukken 5, 6 en 7 zijn histologische methoden toegepast om de
oxidatieve capaciteit en de capillarisatie van individuele spiercellen te onderzoeken
in rokers en niet-rokers en in ratten na chronische hypoxie. Op deze wijze kan een
beter inzicht verkregen worden in de aanpassingen in het transport van zuurstof
naar en het verbruik van zuurstof in de spier en of veranderingen hierin de
onderliggende oorzaak kunnen zijn van de verlaagde weerstand tegen
vermoeidheid in de rokers. Over het algemeen wordt aangenomen dat de
capillarisatie van individuele spiervezels gerelateerd is aan de oxidatieve capaciteit
van de cel. De resultaten van de cross-sectionele studie beschreven in hoofdstuk
5, waarbij zowel spieren van ratten als mensen onderzocht zijn, duiden er echter
op dat de grootte en het type van de spiervezel een betere indicatie zijn voor de
capillarisatie van de spiervezel dan de oxidatieve capaciteit (bepaald ann de hand
van de succinaat dehydrogenase (SDH) activiteit).
Met behulp van dezelfde methoden als in hoofdstuk 5 werd in hoofdstuk 6 de
hypothese getest dat de oxidatieve capaciteit en capillarisatie van de m. vastus
lateralis van rokers verlaagd zou zijn t.o.v. niet-rokers. Het bleek dat de oxidatieve
capaciteit en capillarisatie niet verschilden tussen beide groepen. De significante
relatie tussen SDH activiteit en mate van spiervermoeidheid in de niet-rokers, was
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verdwenen in de rokers. Dit bevestigt ons eerder idee dat er sprake is van een
acuut en mogelijk reversibel effect van roken op de zuurstoftoevoer naar en/of het
zuurstofverbruik van de spier bij de rokers omdat deze gegevens laten zien dat de
toegenomen spiervermoeidheid niet verklaard kan worden door morfologische
aanpassingen van de spiervezels en/of microcirculatie.
De effecten van chronische blootstelling van ratten aan hypobare hypoxie op
determinanten van zuurstoftoevoer en -verbruik in de spier worden beschreven in
hoofdstuk 7. De resultaten laten zien dat chronische hypoxie tot een regio- en niet
een vezeltype-afhankelijke aanpassing van de m. plantaris van de rat leidt.
Alhoewel hypoxie tot spieratrofie in beide regio’s van de spier leidde, trad
uitbreiding van het capillaire netwerk alleen op in het diepe, oxidatieve gedeelte,
terwijl alleen in de oppervlakkige, glycolytische regio mitochondriële biogenese
optrad. Modelberekeningen lieten zien dat de potentiële impact van deze
aanpassingen de aanwezigheid van anoxische gebieden in het diepe gedeelte
verhinderde, terwijl de weefseloxygenatie in het oppervlakkige gedeelte
problematischer werd tijdens hypoxie. De ogenschijnlijk tegenstrijdige toename in
oxidatieve capaciteit in de oppervlakkige regio van de spier is mogelijk het
resultaat van een trainingseffect, dat veroorzaakt werd door een hogere
spiervezelrecrutering in deze regio. De implicatie voor patiënten met COPD is dat
sommige spieren, of spierregio’s, afhankelijk van hun spiervezelsamenstelling,
meer of minder beïnvloed kunnen worden door hypoxie. Daarnaast wijzen deze
resultaten erop dat chronische hypoxie bijdraagt aan de spieratrofie in deze
patiëntengroep.
Relevantie en toekomstig onderzoek
In hoofdstuk 1 wordt aangegeven dat patiënten met COPD over het algemeen
lijden aan een grotere mate van vermoeidheid en spierzwakte dan gezonde
leeftijdsgenoten. De etiologie van deze verminderde functie van de skeletspieren
en hoe deze relateert aan een lagere inspanningstolerantie is niet volledig bekend.
De resultaten, die in dit proefschrift beschreven zijn, laten zien dat roken en
hypoxie een bijdrage kunnen leveren aan de hogere perifere spiervermoeidheid en
spierzwakte in patiënten met COPD.
In hoofdstuk 3 en 4 wordt data gepresenteerd die aangeven dat rokers zonder
klinische symptomen van COPD (onomkeerbare luchtstroom beperking) een
grotere spiervermoeidheid ervaren dan niet-rokers. De cross-sectionele studie in
hoofdstuk 4 in een groot cohort van rokers laat zien dat deze lagere weerstand
tegen vermoeidheid niet beïnvloed wordt door de duur van roken. Dit impliceert dat
roken de vermoeidheid niet in een dosis-afhankelijke manier aantast. Hoewel we
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voor beperkte uitademingscapaciteit, een belangrijk diagnostisch criterium voor
COPD, gecheckt hebben, weten we niet of dit cohort van rokers COPD zal
ontwikkelen in de toekomst. Om daar meer inzicht in te krijgen is een longitudinale
studie waarin rokers gedurende vele jaren gevolgd worden van groot belang. Een
dergelijke studie is echter moeilijk realiseerbaar.
Het mogelijke onderliggende mechanisme leidend tot een lagere weerstand tegen
vermoeidheid bij rokers wordt bediscussieerd in hoofdstuk 4 en 6. Samenvattend
kan worden gesteld dat de potentiële toxische effecten van sigarettenrook op
functioneren van hemoglobine, myoglobine, epitheel cellen en mitochondriënleiden
tot een lagere zuurstoftoevoer naar en/of lager zuurstofverbruik van de spiervezel.
Dat dit inderdaad het geval kan zijn, wordt ondersteund door de observatie dat
niet-rokers, blootgesteld aan koolstofmonoxide (CO) totdat 6 % van hun
hemoglobine verzadigd was met CO, ook een verlaagde weerstand tegen
vermoeidheid hadden (Morse et al., 2008).
Door het toepassen van elektrische spierstimulatie wordt elke verandering in
vezelrecrutering en vrijwillige activatie uitgesloten, zodat de contractiele
eigenschappen en de vermoeidheid van de spier in detail beschreven kunnen
worden. Dergelijke studies worden niet vaak beschreven in de literatuur, maar zijn
in het verleden succesvol toegepast bij patiënten met gevorderde COPD (Degens
et al., 2005; Swallow et al., 2007). Echter, met een vergelijkbare intensiteit en duty
cycle werd in de ene studie gevonden dat patiënten met COPD een lagere
weerstand tegen vermoeidheid hadden (Swallow et al., 2007), terwijl de andere
studie geen verschil in weerstand tegen vermoeidheid vond tussen COPD
patiënten en gezonde proefpersonen (Degens et al., 2005). Het verschil tussen
deze studies kan mogelijk verklaard worden door een lagere fysieke activiteit in de
COPD patiënten in de studie van Swallow et al. (2007), terwijl in de studie van
Degens et al. (2005) de patiënten een vergelijkbare dagelijkse fysieke activiteit
hadden als de gezonde proefpersonen. Het feit dat fysieke activiteit een rol speelt
in de weerstand tegen vermoeidheid wordt ondersteund door de positieve relatie
tussen deze twee factoren, zoals ook beschreven in hoofdstuk 6 en de appendix.
Omdat de resultaten in dit proefschrift erop wijzen dat roken de zuurstoftoevoer
naar en/of het -verbruik in de spier kan belemmeren, is het belangrijk met het
rookgedrag rekening te houden. Het is daarom frappant te zien dat er in de meeste
studies over inspanningstolerantie bij COPD patiënten niets over het actuele
rookgedrag gemeld wordt. In dit verband is het interessant te melden dat alle
patiënten met COPD getest door Degens et al. (2005) waren gestopt met roken op
het moment van testen (H. Degens, persoonlijke communicatie). Zolang deze
karakteristieken van patiënten niet genoemd worden in toekomstige experimenten
kunnen eenduidige conclusies met betrekking tot de rol van roken in het ontstaan
van vermoeidheid bij COPD patiënten niet getrokken worden.
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Een kleine mate van spieratrofie (vezeloppervlak; FCSA) werd gevonden bij een
kleine groep rokers waarbij een spierbiopsie was afgenomen, ondanks dat het
anatomische cross-sectionele oppervlak (ASCA) van de hele m. quadriceps
femoris niet verschillend was van die van niet-rokers. De verklaring voor dit verschil
is niet bekend, maar kan wellicht worden toegeschreven aan de grote gevoeligheid
van de histologische bepaling van vezelgrootte in vergelijking met de bepaling van
de ACSA met behulp van MRI. Recent is aangetoond dat rokers zonder COPD een
lagere FCSA in de type I vezels hebben dan niet-rokers (Montes de Oca et al.,
2008). Het is echter onduidelijk tot op welke hoogte deze resultaten verklaard
kunnen worden door een fysiek actievere controlegroep (Wagner, 2008; Wüst et
al., 2008). De lagere snelheid van eiwitsynthese in de spier van rokers zou een
verklaring kunnen zijn voor de spieratrofie in rokers (Petersen et al., 2007).
De hogere spiervermoeidheid in rokers was niet gerelateerd aan een groter
rookvolume per dag of leeftijd. Het is daarom onwaarschijnlijk dat de progressie
van de lagere inspanningstolerantie en verminderde spierfunctie met de progressie
van COPD verklaarbaar is door het roken op zich. Andere factoren, zoals een
verminderde fysieke activiteit, een chronische ontstekingsreactie, medicatie,
zuurstofradicalen en/of hypoxie zullen hoogstwaarschijnlijk een bijdrage leveren
(Wüst & Degens, 2007). In hoofdstuk 7 wordt aangetoond dat ratten die
blootgesteld zijn aan vier weken hypoxie (~5000 m) 10% spieratrofie vertonen. Dit
suggereert dat hypoxie inderdaad een bijdrage kan leveren aan de spieratrofie in
COPD patiënten.
In het licht van verhoogde ontstekingsfactoren in de bloedbaan bij COPD
patiënten, moet worden aangetekend dat cytokines niet alleen leiden tot
spieratrofie (Langen et al., 2006), maar dat ze ook bijdragen aan centrale
fenomenen zoals ‘sickness behaviour’, verminderde voedselinname en verlies van
motivatie. Deze factoren kunnen bijdragen aan algemene vermoeidheid en de
neerwaartse spiraal van fysieke activiteit (Spath-Schwalbe et al., 1998). Het is
bijvoorbeeld aangetoond dat toediening van interleukine-6 (IL-6; een cytokine) aan
gezonde proefpersonen tot een directe afname in prestatie leidt (Robson-Ansley et
al., 2004), wat waarschijnlijk verklaard kan worden via een aangepaste
(serotonerge) hersenactiviteit die leidt tot een verhoogde sensatie van algemene
vermoeidheid en niet door veranderingen in perifere factoren (Polkey, 2003).
Uit de resultaten beschreven in hoofdstuk 2, 3 en 4 kan geconcludeerd worden
dat wanneer contractiele eigenschappen en spiervermoeidheid gemeten worden in
patiënten met COPD, het van belang is factoren zoals fysieke activiteit, geslacht en
rookgedrag mee te nemen om de variatie tussen experimentele groepen te
verkleinen en verkeerde conclusies te voorkomen. Daarnaast leidt hypoxie niet tot
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een uniforme aanpassing van het skeletspierweefsel, waardoor het onmogelijk is
veranderingen in oxidatieve capaciteit of capillarisatie te relateren aan een
verlaagde zuurstofspanning in de bloedbaan van patiënten met COPD.
Toekomstig onderzoek zal gericht moeten worden op het mechanisme welke ten
grondslag ligt aan de verlaagde perifere spiervermoeidheid in de rokers. Het zou
interessant zijn te onderzoeken of, en in welke mate, de vermoeibaarheid
verandert als rokers stoppen met hun verslaving. Hoewel dit proefschrift geen
direct antwoord geeft op de vraag waarom patiënten met COPD een lagere
spiermassa hebben en een verhoogde vermoeidheid ervaren, blijkt uit dit
proefschrift dat de rookverslaving, hypoxie en de fysieke activiteit belangrijke
factoren zijn. In de toekomst zullen de relatieve bijdrage van deze factoren (en
andere) onderzocht moeten worden om tot een integratieve theorie over
spiervermoeidheid en spierzwakte bij deze patiëntengroep te komen.
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In this appendix, the procedures described in this thesis are explained in more
detail. First, the in vivo measurements of skeletal muscle size and function are
described including some comparison of data obtained on a custom-made
isometric chair with those that were gathered from the same subjects on the
apparatus used in this body of the work. Finally, the detailed protocols of the
histochemical staining methods and analyses are provided and discussed.
In vivo measurements of skeletal muscle size and function
Anatomical cross-sectional area
The anatomical cross-sectional area (ACSA) of the quadriceps was measured with
magnetic resonance imaging (MRI), using a fixed 0.2 T MRI scanner (E-Scan,
ESAOTE Biomedica, Genova, Italy), at 50 % of femur length. Using ultrasound, the
head of the trochantor and the most distal point of the femur were identified with
the participant in a supine position (with the knee joint in an extended position).
Reference markers were placed along the upper leg on the skin to indicate 50% of
the total length. Subjects were supine for 15 min prior to the scan to make sure any
fluid shifts had stabilised.
After pilot studies, the following scanning parameters were chosen to give the best
images of the four heads of the quadriceps muscle. Scans were obtained with a T1
weighted, high resolution, gradient echo profile, with the following scanning
parameters: echo time: 0.016 s; repetition time: 0.1 s; field of view: 0.33 x 0.254 m
and a slice thickness of 0.005 m.
Muscle function: Cybex dynamometer
The type of Cybex norm dynamometer (Ronkonkoma, New York, USA) used in
these studies is widely used for measurement of in vivo skeletal muscle contractile
properties (Harridge et al., 1996; Reeves et al., 2004). All torque measurements
were performed on the right quadriceps femoris muscle. Participants were seated
with the hips at 90° flexion and shoulders strapped to minimise extraneous
movements. The lateral epicondyle was aligned with the axis of rotation of the
dynamometer identified by a laser beam from the centre of rotation of the
dynamometer. Since the maximal voluntary torque requires the participants’
maximal effort, they were first familiarized with the setup on a separate occasion
and during the actual data collection visual feedback of the torque signal was given
together with verbal encouragement (McNair et al., 1996). |Maximum voluntary
contractions (2-3 seconds each) were repeated 2 or 3 times at knee joint angles of
60, 70 and 80˚ (full extension=0˚) in a random order with two minutes rest between
each contraction to prevent the development of fatigue. The angle at which the
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highest torque was achieved was defined as the optimal joint angle and the
maximum torque was the highest torque achieved during the three repetitions at
that angle. All further measurements were done at optimal knee joint angle.
Percutaneous muscle stimulation
Percutaneous electrical stimulation (square wave, pulse width 50 s; DSV
Digitimer Stimulator, Digitimer Ltd., Herts, UK) was applied using carbon-rubber
pads (76 mm x 127 mm, Versastim, Conmed Corp., N.Y., USA). The anode was
placed over the proximal region of the quadriceps and the cathode over the distal
third of the upper leg. The voltage was set at 400 V and was kept constant during
the course of the experiment.
Voluntary activation
To assess the ability of the subjects to activate the knee extensors during isometric
contractions, voluntary activation (VA) levels were determined using a variant of
the interpolated twitch technique (Shield & Zhou, 2004). To increase the sensitivity
of the test, a doublet (inter-pulse interval 10 ms) was applied instead of a single
twitch. The current used to test for activation was determined using single pulses
with the subject in a relaxed state, starting from 100 mA, and increasing until no
further increase in torque was observed. The first doublet was applied with the
subject in a relaxed state and a second (interpolated) doublet was delivered during
the plateau phase of the MVC. The ratio of interpolated and resting doublets was
used to provide an index of activation (Allen et al., 1995) as follows:
Voluntary activation (%) = 100 x
(1 – (superimposed doublet torque/resting doublet torque))
where the superimposed doublet torque is the additional torque during the MVC
caused by the doublet.
Torque-frequency relationship
The stimulation current for the determination of the torque-frequency relationship
and fatigue protocols was adjusted so that a 1-s 100-Hz tetanus produced ~30 %
of maximal voluntary isometric torque. Five minutes after the last MVC, the
quadriceps muscle was stimulated with 5 single twitches at 1Hz and then 1s tetani
at 10, 15, 20, 30, 50 and 100 Hz applied in random order, each separated by 1
min.
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Fatigue tests
Five minutes after determining the torque-frequency relationship of the quadriceps
muscle, the resistance to fatigue was determined by a series of electrically evoked
isometric contractions (60 contractions, 30 Hz, 1 s on 1 s off (or 0.5 s off) at the
current used to determine the torque-frequency relationships). Generally the test
was carried out with the circulation to the leg intact but in one series the blood
supply to the leg was occluded with a pneumatic thigh cuff (Accoson, Harlow, UK)
inflated to ~240 mm Hg.
Analysis of variables
All torque signals were sampled at a frequency of 2000 Hz (Acknowledge, Biopac
Systems, Santa Barbara, CA, USA) and off-line analysis was performed using
Matlab (Matlab, the Mathwork Inc., S. Natik, MA, USA). Each torque signal was
filtered with a low-pass fourth order Butterworth filter with a 30 Hz cut-off frequency
to reduce the noise in the signal.
From the 30 or 100 Hz tetanus of the frequency-torque relationship, the contraction
time was measured as the time from activation until 90% of the maximal torque
was reached, and the relaxation time as the time for the torque to decline to 50% of
maximal torque after cessation of stimulation. The maximal rate of relaxation
(MRR, s-1) was determined from the 30 Hz tetanus and calculated as the lowest
value of the differentiated torque signal expressed relative to the highest torque
recorded during that contraction.
The fatigue index was expressed as the highest torque recorded during the last
contraction divided by that during the first contraction (expressed as a %). To
obtain an indication of the time course of fatigue, the torque and maximal
relaxation rate (MRR) for each contraction during the fatigue protocol were
expressed as percentages of the initial value.
Compliance in the system
One of the key parameters for assessing contractility is the maximal rate of
contraction and relaxation (MRC and MRR respectively). To ensure a rapid
contraction and relaxation, the system needs to be rigid, such that the torque
exerted by the muscle can be transferred to the transducer without first stretching a
compliance. Two factors that affect the transduction of the torque exerted by the
muscle to the transducer of the Cybex dynamometer are the compliance of the
patella tendon and the stiffness of the Cybex dynamometer. The first is a biological
factor and was not of principle interest in the present study. Therefore, no
measurements have been made to account for this factor. Tendon compliance is
related to the physical activity level of the participant (Reeves et al., 2003; De Boer
et al., 2007), and the participants in the present studies were carefully matched for
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physical activity level. It is unlikely therefore that the results discussed in Chapter 2
(gender-related differences in fatigue resistance) and in Chapter 3 and 4 (smokers
vs. non-smokers) are explicable by differences in the tendon compliance. Further
studies, however, might be interesting to determine the contribution of tendon
compliance to the torque-frequency relationship and fatigue resistance since the
greater the compliance the more movement and work is done and this would be
reflected in the energy demands of the fatigue tests.
Figure 9.1. (A) Participant in the Cybex NORM dynamometer. The anatomical axis
of rotation of the knee joint was aligned with the machine's axis of rotation and
safety stops placed at the extremes of extension and flexion. Note the weights on
the lever arm used to reduce the slack in the system. (B) Participant in the
MMUscle chair. No alignment of the axis of rotation of the knee joint is needed, as
the forces are transferred through the shin pad.
The other factor, the stiffness of the Cybex dynamometer has been reduced as far
as possible. The shin pad was modified such that the cushion was replaced with a
more rigid pad and care was taken when strapping the participant in the seat
(Figure 9.1A). In addition, a counterweight was placed on the Cybex lever arm to
decrease the slack in the system. However, these changes have not totally
ensured the measurements were ‘slack-free’, as it was observed in a previous
study that the knee joint can move up to 20 degrees during a maximal voluntary
contraction (MVC; Tsaopoulos et al., 2007). We have recently obtained a custom-
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made isometric chair (MMUscle) that is stiffer, and specially designed by the
Department of Physical and Medical Technology at the VU University Amsterdam
(Figure 9.1B), which allows testing the contractile properties of the quadriceps
muscle with a stiffer system. In a validation study the contractile properties of four
healthy male volunteers were compared on both systems. Figure 9.1 shows a
representative example of one participant on both systems.
The maximal rate of contraction (MRC) and relaxation (MRR) were determined at
each frequency during the torque-frequency relationship and calculated as the
highest (MRC) and lowest (MRR) value of the differentiated torque signal
normalised to the maximal torque during that contraction. Because the higher
contribution of the slack during the lower frequencies (especially the single twitch),
the MRR and MRC were expressed relative to the highest torque recorded during
the 100 Hz contraction. The torque-frequency relationship was found to be
significantly shifted to the left in the stiffer MMUscle chair (P<0.05; Figure 9.2A).
This left-shift was mainly caused by a significantly higher MRC relative to the
maximal torque at 100 Hz at the lower frequencies (Figure 9.3B), resulting in a
more rapid transmission of torque from the muscle to the transducer.
Figure 9.2. Torque-frequency relationship of four healthy men tested on the Cybex
and on the MMUscle chair (A). A significant left-shift was found when tested in the
MMUscle chair. In (B) and (C) a typical example of one participant on both systems
are shown. Note the smoother rise in torque in the stiffer set-up (C). Values are
shown as mean and SD. * denotes significant difference (P<0.05).
Appendix
174
The results from this validation study show that the torque-frequency relationship
can be affected by the stiffness of the system on which the participant is tested.
This is mainly due to a faster and therefore higher rise in torque at the lower
frequencies (1-15 Hz).
Paradoxically, the oscillation in the 10, 15 and 20 Hz torque signals seem to be
slightly less when tested with the MMUscle chair. An explanation of this might be
that the contractions in the Cybex are not fully isometric, so the muscle fibres
themselves are shortening, resulting in a lower torque (due to the torque-velocity
relationship) during contractions with a low stimulation frequency. This might also
explain the significantly quicker rise in torque in the MMUscle chair at lower
frequencies (Figure 9.3B). At higher frequencies, the results from the Cybex seem
to be comparable with the MMUscle chair (Figure 9.3B and D).
Figure 9.3. The maximal rate of contraction (MRC, A and B) and relaxation (MRR,
C and D) were determined from each frequency during the torque-frequency
relationship and calculated as the highest and lowest value of the differentiated
torque signal respectively. In A and C this value was expressed relative to the
highest torque recorded during the same contraction, while this value was
expressed as the highest torque recorded during the 100 Hz contraction in B and
D. This enables comparison between the stiffness of both systems. Significant
differences at lower frequencies were observed in the MRC (B, P<0.05), but not in
the MRR (D).
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The relationship between contractile properties and muscle fibre type
A factor that has received little attention in the literature is the extent to which the in
vivo contractile properties of the quadriceps muscle are related to the fibre type
distribution of the muscle. From the data shown in the Introduction (Figue 1.3 and
4), rat muscles such as the soleus muscle have slower maximal rates of
contraction (MRC) and relaxation (MRR) compared to fast muscles, such as the
EDL muscle. However, in a mixed muscle, such as the quadriceps muscle, the
relationship between fibre type and contractile speed is less obvious (Wiles et al.,
1979). In the few participants from which both the MRR and the fibre type of the
quadriceps muscle (n=10) were obtained no correlation (R2=0.47; P=0.163) was
observed between MRR at 30 Hz and the area percentage of type I. Nevertheless,
it was interesting to note that one old male participant in this study had only type I
fibres in the quadriceps muscle (99.7 %), and also had the slowest MRR at 30 Hz
(-11.1 s-1), compared to -15.0 ± 2.3 s-1 in the others with 52.4 ± 11.0 % type I fibres.
The cause of the absence of a strong relationship might relate to the distribution of
fibre types within the quadriceps muscle (Lexell et al., 1983). As was also observed
in the rat plantaris muscle (Figure 7.3 and 9.4), a predominance of type I fibres has
been shown in the deeper regions of the quadriceps muscle (Lexell et al., 1983).
Therefore, it may not be possible to extrapolate the fibre type composition obtained
from one specific region of the vastus lateralis muscle to the whole quadriceps
muscle group, and hence directly relate fibre type composition to in vivo contractile
speed. Nonetheless, a significant correlation (R2=0.40, P=0.002) existed between
the MRR and the results from the fatigue test under ischemia (Figure 2.4),
indicating that the slower the muscle at the start of the fatigue test, the less the
muscle will fatigue which is consistent with the expected behaviour of different
mixtures of fibre types.
Histochemical staining methods
Results of histochemical staining methods on sections of muscle tissue of rats and
humans are reported and discussed in Chapter 5, 6 and 7.
Wistar rats (11-week-old, all male) were kept at room temperature and a 12 h light-
dark cycle. Food and water were given ad libitum. They were killed by an
intraperitoneal injection of an overdose of pentobarbital sodium (70 mg kg-1). The
plantaris muscles was carefully excised, blotted dry, weighed, slightly stretched to
minimise bias related to tortuousity of capillaries, directly frozen in liquid N2 and
stored at -80 oC. All protocols and procedures were approved by the University of
Nijmegen Institutional Animal Care and Use Committee.
Eleven healthy participants volunteered to provide a biopsy of their vastus lateralis
muscle. Written informed consent was obtained from each participant prior to
taking the percutaneous biopsy. All procedures were approved by the local ethics
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committee of the Manchester Metropolitan University (UK). The entire procedure
was carried out under aseptic conditions. After local anaesthesia with 2 %
lidocaine, a small incision was made with a scalpel and the percutaneous biopsy of
the vastus lateralis muscle (at ~50 % of the muscle length) was obtained using a
conchotome. The wound was closed with steristrips and covered with bandage for
up to 2 days. The biopsy was placed on cork with the longitudinal axis of the fibres
perpendicular to the surface of the cork, quickly frozen in liquid N2 with vigorous
shaking to prevent development of ice-crystals, and stored at -80 oC.
Histochemistry
Transverse serial 10-μm sections were cut on a cryostat at -20°C and mounted on
polylysine-coated slides. The sections were stored at -80°C until further analysis,
unless otherwise stated. All sections were mounted in glycerine-gelatine after
staining. The thickness of the slices was verified by cutting 10 μm sections of a
gelatine block containing a homogeneous myoglobin concentration (see below) on
a recently calibrated cryostat and compared to identical sections cut on the
cryostat where the human and rat samples were cut. Serial sections were used to
identify the same fibres stained for different enzyme activities or structural features.
In this way, fibre type, SDH-activity, capillary density and myoglobin concentration
were determined in the same fibre. To our knowledge, this is the first study that has
determined all this number of variables in the same muscle fibre.
In the rat plantaris muscle two regions with different fibre type composition can be
distinguished (Figure 9.4); near the tendon, a higher proportion of type I fibres (and
SDH-activity) can be observed (this region is referred to as the deep, or oxidative
region), while at the other side of the muscle hardly any oxidative fibres can be
found (referred to as the superficial, or glycolytic region).
Determination of fibre type
Fibres were classified as type I, IIa, or IIx (IIx/b in rats) based on the pH sensitivity
of their myofibrillar ATPase, using the methods first described by Brooke & Kaiser
(1970); type I myofibrillar ATPase is acid stable and alkaline labile, while type IIa
myofibrillar ATPase is acid labile and alkaline stable with that of IIx/b in between.
The fibres thus appear dark, white and grey after acid pre-incubation, respectively.
Sections were pre-incubated for 10 minutes in a buffer containing 0.1 M NaAc and
0.1 M KCl at pH 4.55 set with acetic acid, quickly rinsed in 20 mM glycin and 20
mM CaCl2 at pH 9.4 (set with NaOH) and subsequently incubated for 25-30
minutes at 37 °C in 40 mM glycine, 20 mM CaCl2 and 2.5 mM ATP at pH 9.4 (set
with NaOH). Sections were quickly rinsed with 1 % CaCl2, left in 2 % CoCl2 for 3
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minutes, washed with distilled water and coloured in 2 % (NH4)2S and washed in
water.
Figure 9.4. Example of a plantaris muscle of the Wistar rat (taken from chapter 7).
On the left, the section is stained for SDH-activity (see text), while the right serial
section was stained for acid myofibrillar ATPase (pH=4.55). The dark fibres on the
right are classified as type I, while the white fibres are classified as type IIa and the
grey fibres as type IIx/b. One can observe that the type I and IIa fibres have, as
expected, a higher SDH-activity. Note that on the right hand corner of the muscle,
a small part of the gastrocnemius muscle is still visible.
Determination of SDH-activity
Succinate dehydrogenase (SDH) is an enzyme in the citric acid cycle and part of
the respiratory chain. It has been shown by our lab that the calibrated
histochemical method described below is linearly related to the maximum rate of
oxygen uptake by the muscle fibre (Van der Laarse et al., 1989). Immediately after
cutting, sections were dried for 15 min and stained for SDH-activity (Pool et al.,
1979; Van der Laarse et al., 1989). Sections were incubated at 37 °C in the dark
for 20 min in a medium consisting of 37 mM sodium phosphate buffer (pH 7.6), 74
mM sodium succinate and 0.4 mM tetranitroblue tetrazolium (TNBT). The reaction
was stopped with a 30 s incubation in 0.01 M HCl and fixed in 10 % formalin for 20
min. The staining intensity was determined as the optical density of the final
reaction product using an interference filter of 660 nm at a magnification of x 20
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(ImageJ, National Institute of Health, Bethesda, USA). A 3rd order calibration line
was obtained before scanning each section using grey filters with a known
absorbance. By carefully outlining the muscle fibre, the mean optical density for
each fibre was obtained. After subtracting the optical density of the background (a
part of the section that did not express SDH-activity), optical density values were
converted to staining rate, expressed as absorbance units (ΔA660) per micrometer
section thickness per second of incubation time (ΔA660 μm-1 s-1). Besides giving an
estimate of the aerobic capacity of the fibre, another advantage of this method is
that values from different samples and studies can be compared, as the values are
calibrated.
SDH-activity and physical activity level
The human participants discussed from Chapter 6 were matched for their physical
activity level, which was assessed with a physical activity questionnaire (Baecke et
al., 1982). The questionnaire has been validated with pedometers (Baecke et al.,
1982) and with maximal oxygen uptake (Jacobs et al., 1993; Richardson et al.,
1995). In addition, the data in the thesis show a strong correlation (r=0.83,
P=0.001) between the overall SDH-activity (weighted for fibre type) and physical
activity level (Figure 9.5).
Figure 9.5. Relationship between physical activity score measured with the
Baecke questionnaire and the oxidative capacity, measured as the SDH-activity.
Pearson’s correlation coefficient for non-smokers is r=0.87 (P=0.06) and r=0.88
(P=0.01) for smokers. Overall, the correlation coefficient was 0.83 (P=0.001).
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Determination of capillarisation
Sections were stained with alkaline phosphatase (rat; Degens et al., 1992) or lectin
(human; Ahmed et al., 1997) to identify capillaries.
Rat sections were fixed in chloroform-acetone (1:1; 4 °C), quickly rinsed in distilled
water and subsequently stained for 1 h in 0.01 % nitro blue tetrazolium (NBT) and
0.002 % 5-bromo-4-chloro-3-indolyl phosphate p-toluidine salt in 6.9 mmol
MgSO4.7H2O and 27.5 mmol Na2B4O7.10H2O buffer, adjusted to pH 9.2 with boric
acid. After quickly rinsing the sections in distilled water and a post-fixation in 10 %
formalin (4 % formaldehyde), slides were mounted in gelatine-glycerol.
Human sections were fixed in acetone (4 °C), kept in HEPES for 15 minutes,
incubated in PBS containing 0.9 % 30 % H2O2 for 30 minutes to reduce
background staining and subsequently incubated with lectin (Ulex Europeus) in
HEPES with 1 % BSA (2000 μg/ml). The capillaries were visualised using a
Vectastain ABC and DAB substrate kit (Vector Laboratories, Peterborough, UK)
before mounting in gelatine-glycerol.
Capillaries were analyzed using the method of capillary domains (Hoofd et al.,
1985; Degens et al., 1992). This method not only provides the overall indices of
capillary to fibre ratio (C/F) and capillary density (CD), but also provides measures
of the capillary supply to individual fibres of different fibre types, even when they
lack direct capillary contacts. Since the deep and superficial region of the muscle
differ in their fibre type composition and capillary supply, these regions were
analysed separately. Photomicrographs of cross-sections of the human vastus
lateralis muscle and the deep and superficial region of the rat plantaris muscle
were taken. The fibre type distribution was assessed and the outlines of the muscle
fibres as well as location of each capillary were digitised on a calibrated digitising
tablet (Model MMII 1201, Summagraphics Digitisers, Austin, Tex, USA). The
overall capillary density (CD) was defined as the number of capillaries mm-2 of
tissue. Capillary domains, defined as the area surrounding a capillary delineated by
equidistant boundaries from adjacent ones, were constructed and their surface
area calculated. From the overlap of the domains with muscle fibres, the local
capillary to fibre ratio (LCFR) and the capillary fibre density (CFD) were obtained.
The LCFR for a fibre was defined as the sum of the fractions of each domain area
overlapping the fibre. This variable has a continuous distribution and is more
sensitive than e.g. capillaries around a fibre. It also allows determination of the
capillary supply to a fibre even when it lacks direct capillary contacts. Such
situations were observed occasionally in the glycolytic region of the rat plantaris
muscle. CFD, which is LCFR divided by the FCSA, provides the capillary density of
that fibre and is expressed as the number of capillaries mm-2.
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Determination of myoglobin concentration
The myoglobin concentration in individual muscle cells was determined as
described previously (Van Beek-Harmsen et al., 2004). Frozen sections were
defrosted in vacuum to avoid condensation and consequent redistribution of
myoglobin. Sections were then vapour-fixed for 1 h in paraformaldehyde at 70°C.
Subsequently, the sections were fixed for 10 min at room temperature in 2.5 %
glutaraldehyde in 0.07 M sodium phosphate buffer (pH=7.4) and quickly rinsed with
distilled water. To detect myoglobin sections were incubated for 1 h at room
temperature in a medium containing 59 ml 50 mM TRIS/80 mM KCl buffer
(pH=8.0), 25 mg ortho-toluidine dissolved in 2 ml 96 % ethanol (at ~50 °C) and
1.43 ml 70 % tertiary-butyl-hydroperoxide. Sections were then washed with distilled
water, mounted and scanned on a calibrated DMRB microscope (Leica, Wetzlar,
Germany) with an interference filter of 436 nm. A 3rd order calibration line was
obtained before scanning each section using grey filters with a known absorbance.
The red blood cells in the capillaries contain haemoglobin which was visible as
dark spots at the edges of the muscle fibres. The myoglobin concentration was,
however, homogeneously distributed within the cell and therefore the mean optical
density was obtained from the centre of each fibre. After subtracting the optical
density of the background (a part of the section that did not contain myoglobin),
optical density values were converted to absorbance values. Using a calibration
line, obtained from absorbance values from 10 µm sections cut from gelatine
blocks containing 0.1, 0.2, 0.3 and 0.4 mM myoglobin, absorbance values were
converted into concentrations (Van Beek-Harmsen et al., 2004).
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Dankwoord
Tijdens mijn studie Bewegingswetenschappen in Amsterdam werd duidelijk waar
mijn toekomst zou liggen: onderzoek doen in de spier- en inspanningsfysiologie.
Met dit boekje heb ik een eerste stap in deze richting gezet, maar dit was nooit
mogelijk geweest zonder de hulp en inzet van velen. Iedereen die mij tijdens mijn
promotietraject heeft geholpen wil ik ontzettend bedanken; een paar mensen wil ik
graag in het bijzonder noemen.
Beste Hans, hoewel je niet wist dat ik tijdens mijn studie de cursus ‘spierfysiologie’
niet in één keer gehaald had, bood je me deze mogelijkheid voor een
dubbelpromotie bij de Manchester Metropolitan University in Alsager en de
Faculteit der Bewegingswetenschappen in Amsterdam aan. Bedankt voor de
goede samenwerking in de afgelopen jaren, ik stond versteld van je onuitputtelijke
enthousiasme, ook als projecten niet naar wens verliepen. Soms moest ik even
nadenken over je grappen, maar sterk waren ze wel (nou ja, niet altijd). Typerend
was een moment dat we op Schiphol stonden te wachten op een vertraagd
vliegtuig, de radar in Londen was kapot. Doodmoe van een paar lange dagen
overleg en metingen in Nederland wilde ik maar één ding: naar huis.
Onvermoeibaar als altijd vertel je een paar Engelsen zakenlui dat ‘first you couldn’t
get into England because they had a radar and now you can’t get in, because they
don’t have a radar’. Jouw expertise en werkhouding waren zeer motiverend,
waarvoor mijn welgemeende dank. Hopelijk kunnen we onze samenwerking
voortzetten tijdens mijn postdoc periode in Leeds.
Dear David, your expert supervision, valuable advice and guidance through my
PhD were invaluable. I always looked forward to our discussions and your down-to-
earth opinion about the results was always clear and well thought-out. Your broad
knowledge is inspiring and I would like to sincerely thank you for your supervision
during my PhD. I remember an email you once sent from Thailand: ‘It’s raining
here and I am bored, can you send me this paper please?’
Beste Arnold, ontzettend bedankt voor de waardevolle samenwerking met de
Faculteit der Bewegingswetenschappen aan de Vrije Universiteit. Zonder jouw
inzet en de samenwerking met Amsterdam had ik niet zoveel ervaring kunnen
opdoen. Je kennis, feedback en kritische blik op artikelen (en mijn tentamen
‘spierfysiologie’) waren erg constructief voor het ontstaan van dit boekje. Bedankt
voor het bieden van deze dubbel-promotie.
Chris Morse, many thanks for teaching me how to use the Cybex, the electrical
stimulation and MRI-scanner.
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Richard Jaspers, speciaal voor jou is de mobiele telefoon uitgevonden, anders zou
niemand je kunnen vinden. Je kritische en scherpe blik hebben er toe geleid dat
hoofdstukken duidelijker, scherper en vollediger werden.
Willem van der Laarse, Arno van Heijst en Louis Hoofd, ontzettend bedankt voor
de prettige en waardevolle samenwerking tijdens de laatste projecten en jullie
contributie aan één of meerdere hoofdstukken. Willem, ontzettend bedankt dat ik
‘op de eerste’ terecht kon voor metingen. Henriëtte van Olst, Guus Baan, Brechje
van Beek-Harmsen, Micha Paalman en Peter Verdijk, zonder jullie technische
ondersteuning in Amsterdam had ik in Engeland niet op eigen benen kunnen
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